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MVDA  Multivariate data analysis 
m/z  Mass charge ratio 
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PCA  Principal component analysis 
QC  Quality control 
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PLS  Partial least square 
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ROC  Receiver-operating characteristic 
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I. Pesticides-induced neurotoxicity 
Right from the beginning of agriculture in the fertile lands of Mesopotamia about 
10,000 years ago, farmed crops suffering from pests and diseases could cause a 
large loss in yield posing the population at famine risk. Nowadays, despite the 
scientific and technological progress, the economic losses due to pests and diseases 
are on average 35-40% of all potential food and fiber crops
1
. Over the next 20 
years, the increase in population will increase the demand of crop and its 
production will have to raise in order to meet the new needs
2
. Despite European 
policies to reduce the use of pesticides to food crops, the annual application 
exceeds 140,000 tonnes and their 
consumption is not decreasing
3
. 
Before the 1940s inorganic substances, such 
as sodium chlorate and sulphuric acid, or 
organic chemicals derived from natural 
sources like pyrethrum, which is derived 
from the dried flowers of Chrysanthemum 
cinerariaefolium, were widely used in pest 
control
4
. The industrial production of 
synthetic pesticides started with the 
discovery of the properties and effects of 
dichlorodiphenyltrichloroethane, better 
known as DDT
5
. Due to the high 
environmental persistence and their 
bioaccumulation in wildlife, organochlorine 
pesticides like DDT, aldrin and dieldrin were 
banned in the EU in the 1970s and replaced 
in most countries with the more degradable 
organoposphate compounds (OPs) such as 
parathion, malathion, methyl parathion, chlorpyrifos, diazinon and dichlorvos. 
Besides OP pesticides another class of widely used pesticides is the carbamates, 
like aldicarb, carbofuran, carbaryl, pirimicarb and methomyl. Most of the 
pesticides belonging to these classes were also banned from the EU but few 
substances are still authorized in the EU market like chlorpyrifos (EU decision, 
05/72/EC) and pirimicarb (EU decision, 06/39/EC). 
Nowadays, the pesticides market is dominated by a relatively new class of 
insecticides: the neonicotinoids
6,7
. This class of pesticides is currently the most 
effective for the control of sucking insect pests
7
. Bayer CropScience launched 
Pesticides are defined by the International 
Union of Pure and Applied Chemistry 
(IUPAC) as “substances or mixtures of 
substances intended for preventing, 
destroying, or controlling any pest, 
including vectors of human or animal 
disease, unwanted species of plants or 
animals causing harm or otherwise 
interfering with the production, 
processing, storage, transport, or 
marketing of food, agricultural 
commodities, wood, wood products, or 
animal feedstuffs, or which may be 
administered to animals for the control of 
insects, mites/spider mites, or other pests 
in or on their bodies”1. The different types 
of pesticides are named according to their 
target species. 
Chapter 1  Introduction and objectives 
13 
 
imidacloprid in 1991, the forerunner of this pesticide class, which has been for 
many years the most sold insecticide globally
8
. In several countries, imidacloprid 
concentrations in water bodies have been found to exceed the regulatory norms 
because of its extensive application and its high persistency and leaching 
potential
9–14
. Recently, this compound gathered attention due to its significant 
ecotoxicological effects since it was related to the honey bee colony collapse
15
. On 
the basis of this evidence, the European Commission has adopted a proposal to 
restrict the use of three pesticides belonging to the neonicotinoid family: 
clothianidin, imidacloprid and thiametoxam. The restriction applies only to seed 
treatment, soil application (granules) and foliar treatment on bee attractive plants 
and cereals and exceptions are limited to the possibility of treating bee-attractive 
crops in greenhouses and in open-air fields only after flowering. The restrictions 
began in December 2013 for a provisional period of two years. Other pesticides 
belonging to this class like acetamiprid and thiacloprid are currently allowed by the 
EU. The US Environmental Protection Agency (EPA), despite the concern for the 
honey bee colony collapse disorder, is not posing a ban or a restriction in the use of 
the neonicotinoids.  
Pesticides are often targeting the nervous system directly and others by disrupting 
the general cellular mechanisms necessary to support the high metabolic activity of 
the nervous system
16
. The neurotoxic consequences of acute pesticide exposure are 
well known, and their exposure is associated with a range of symptoms as well as 
deficits in neurobehavior
17
. 
OPs and carbamate pesticides exert the same mode of action by inhibiting the 
activity of the enzyme acetylcholine esterase (AChE). The enzyme AChE has a 
crucial role in the cholinergic neurotransmission by degrading acetylcholine into 
choline in the synaptic cleft. When this enzyme is inhibited, the cholinergic 
function in the central nervous system (CNS), the peripheral nervous system and 
the motor components is impaired and the accumulation of acetylcholine in the 
synaptic cleft induces an over-stimulation of the neuronal cells
16
. AChE can be 
permanently inhibited by OPs whereas the carbamate pesticides bind reversibly to 
the enzyme. Because of this transient inhibition, carbamate insecticides can induce 
acute toxicity events that can resolve in few hours
18
 while OP effects can last for 
months
17
.  
Neonicotinoid pesticides, on the contrary, are acting as agonist of insects nicotinic 
acetylcholine receptors (nAChRs)
19,20
. Even though this class of pesticide was 
considered to be insect-specific, due to the structural differences between insect 
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and mammalian nicotinic receptors
21
, adverse effects have also been reported in 
vertebrate and invertebrate non-target species
14,23,24
.  
The vast majority of studies investigating neurotoxic effects induced by pesticides 
concerns AChE inhibitors pesticides
24
. To evaluate the toxicity induced by these 
pesticide classes the AChE bioassay, measuring the enzyme inhibition in-vitro, is 
usually applied. The use of this single endpoint can only be restricted to carbamates 
and OP pesticides, which induce a direct enzyme inhibition. In this bioassay 
acetylthiocholine is used instead of acetylcholine, the natural precursor for the 
enzymatic reaction catalysed by AChE, which is transformed in thiocholine and 
acetate. Thiocholine reacts with dithiobisnitrobenzoate (DTNB) to form TNB 
which results in a yellow color. The AChE inhibition is inversely proportional to 
the color intensity produced by the enzymatic reaction
25
. Since the neonicotinoids 
are targeting the nAChRs, the AChE bioassay is not suitable to test their toxicity 
and for this reason a different testing strategy should be found. To this extent, 
promising alternatives might be found in the field of system ecotoxicology.  
A relevant non-target species to study neurotoxic effects is the freshwater snail 
Lymnaea stagnalis. This species is a globally widespread inhabitant of freshwater 
ecosystems and has been used as model organism in environmental toxicology and 
neurobiology
26,27
. The CNS of the freshwater snail L. stagnalis consists of 20,000 
large and identifiable neurons, of which many were shown to express functional 
nAChRs
28
. In particular, in well described neuronal networks, various nAChR 
subtypes were shown to mediate synaptic transmission
29
. The interest in this 
species is also growing in the omics field, as shown by the increasing number of 
publications promoting L. stagnalis as model organism
30–32
. The neuronal 
transcriptome sequencing has been subject of several recent studies
30,33
. The 
transcriptomic expression of different organs has been explored and the genomic 
response to a pesticide exposure has been investigated
34
. Proteomics has been 
applied to investigate endocrine disruptor chemicals effects on L. stagnalis 
reproductive organs
35
, and to study protein phosphorylation
36
. Silverman-Gavrila et 
al. (2009, 2011) have investigated L. stagnalis CNS proteome associated to 
learning and memory, and its alteration in chronic hypoxia
31,32
.  
Another model organism widely used in the field of ecotoxicology is the zebraﬁsh 
(Danio rerio). This model organism is providing many advantages over 
mammalian model organisms because of the small size, the ex-utero development 
of the embryo, the short reproductive cycle and transparency of the embryos
37,38
. 
The last unique feature makes this species very valuable for developmental studies 
since the whole development can easily be observed under a microscope until the 
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embryos hatch after 72 hours post fertilization (hpf)
38–40
. In the field of 
environmental toxicology zebrafish embryos are very often applied for toxicity 
testing in the zebrafish embryo acute toxicity test (ZFET), included in the OECD 
guidelines
41
. Since zebrafish embryos up to 96 hpf are not considered as test 
animals, they are not regarded as an official animal test, which avoids long ethical 
procedures prior to the experiments
42
. In addition, due to the high homology of the 
zebrafish genome to that of humans
43
, this species is used as model organism to 
study cancer
44,45
 and other diseases
46,47
.  
 
II. Toxicogenomics and system ecotoxicology 
To address the need of new toxicity testing, encouraging alternatives are coming 
from the “omics” field48. Toxicogenomics is a combination of toxicology and 
genomics and it is defined as “the study of the relationship between the structure 
and activity of the genome and the adverse biological effects of exogenous 
agents”49. The combination of transcriptomics, proteomics and metabolomics into a 
system ecotoxicology approach is promising to accurately determine the 
mechanism of action of toxicants and improve environmental risk assessment
50
. 
This field has several advantages compared to traditional toxicity testing. These 
techniques can focus on multiple endpoints (genes, transcript, protein and 
metabolites) simultaneously
51
 in contrast to bioassays that are focusing on one 
specific endpoint. Changes at the molecular level occurring at lower concentrations 
than traditional toxicity tests can be measured with these approaches, providing 
more sensitive endpoints. Moreover, they offer the advantage to perform in-vivo 
testing resulting in a more realistic environmental exposure scenario. Finally, the 
‘omics’ technologies can elucidate toxicants modes of action due to the non-
targeted and non-biased approach which can be a basis for the development of 
novel bioassays. Besides the many advantages described before, the “omics” 
techniques return a huge amount of data making the data analysis process very 
challenging
52
. 
Transcriptomics, focusing on the analysis of transcripts, has the advantage of 
requiring less sophisticated techniques and equipment than proteomics and 
metabolomics. This is mainly due to the high physicochemical heterogeneity of the 
proteome and metabolome, whereas messanger ribonucleic acid (mRNA) has a 
relatively simple structure based on the repetition of four subunits (nucleobases)
53
. 
The main drawback is the occurrence of posttranscriptional regulations making the 
transcript levels not exclusively related to the gene activity. The same limitation 
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applies to proteomics since proteins can undergo posttranslational modifications
54
. 
Nevertheless, proteomics is very promising to identify new endpoints because 
proteins have been shown to be severely altered under pathological conditions
52
. 
From a technological point of view, the analysis of the proteome represents a 
challenge since proteins levels vary over a broad concentration range of six orders 
of magnitude. The most abundant proteins can mask and hide the many low 
abundant proteins which very often result to be altered
55
. Although the 
metabolome, with approximately 5,000 metabolites, is relatively small compared to 
the proteome and transcriptome, it comprises a higher molecular complexity and 
diversity that requires sophisticated techniques for its analysis. Moreover, 
metabolite identification is less automated than protein identification for which 
many dedicated libraries and databases are available. A comparison of advantages 
and disadvantages of the “omics” techniques is summarized in Table 1.1. From a 
toxicological perspective, metabolomics offers a unique advantage since 
metabolites are highly conserved across species and can, therefore, result in a 
conserved endpoint
55,56
. Furthermore, since the metabolome is the final product of 
gene expression in which all changes at higher upstream levels are amplified
52
, 
there might be higher chances to discover alterations. Finally, the metabolome is 
closest to phenotypical changes in biological systems and is, therefore, of greater 
biological interest
57
.  
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Table 1.1 Comparison of the “omics” techniques (transcriptomics, proteomics and 
metabolomics). 
 Transcriptomics Proteomics Metabolomics 
A
d
v
a
n
ta
g
es
 
- Fewer techniques 
required to analyse the 
entire transcriptome 
than proteome and 
metabolome
52,53
 
- Proteins are most 
likely to be affected 
in diseases and are 
therefore promising 
for endpoint 
discovery
52
 
- Metabolites are more 
conserved across 
species
55,56
 
- Changes at a higher 
upstream level could be 
amplified in the 
metabolome, which is the 
final product of gene 
expression
52
 
- Closest to the phenotype of 
biological systems
57
 
L
im
it
a
ti
o
n
s 
- Transcript is not totally 
related to gene 
expression
53
 
- Large number of 
different proteins (> 
100,000)
52
 
- Challenge to 
accurately detect low-
abundance proteins 
54,55
 
- Proteome is not 
totally related to 
translation
54
 
- Although number of 
different metabolites is 
relatively small (~5,000), 
it is more diverse, making 
it physically and 
chemically more 
complex
52
 
- Challenge to accurately 
detect low-abundance 
metabolites
52,55
 
- Challenge to accurately 
identify metabolites
52,55
 
 
III. Metabolomics 
Metabolomics is currently a well-established scientiﬁc ﬁeld dealing with the study 
of naturally occurring low molecular weight organic metabolites within a cell, 
tissue or bioﬂuid. 
In the field of environmental studies it is ‘‘the application of metabolomics to the 
investigation of both free-living organisms obtained directly from the natural 
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environment (whether studied in that environment or transferred to a laboratory for 
further experimentation) and of organisms reared under laboratory conditions 
(whether studied in the laboratory or transferred to the environment for further 
experimentation), where any laboratory experiments speciﬁcally serve to mimic 
scenarios encountered in the natural environment”58. Most of the environmental 
metabolomics studies can be dived in laboratory or field based studies used for 
toxicity testing or environmental monitoring
56
. Laboratory studies have been 
carried out with both aquatic organisms like the commonly applied model 
organism Daphnia magna
59
 and soil organisms like earthworms
60,61
. Many of these 
studies have identified biomarkers of exposure related to various class of 
environmental toxicants
62
. Even though metabolomics on field-sampled organism 
represent an exciting application in the environmental field, this approach has 
shown several pitfalls. The main disadvantage is represented by the high biological 
variability: a key recommendation in this type of study is the phenotypic 
anchoring. Therefore, before establishing a relation between the metabolic 
alteration and the environmental stressor a deep a priori characterization of the 
species, gender and age should be carried out in order to address the contribution of 
these components to the metabolome
62
. The definition of the normal metabolic 
operating range is the starting point to investigate the effects causing an alteration 
of the metabolism
63
. Another recent application of metabolomics for effect-based 
monitoring in situ consists in the exposure of organism breed under laboratory 
conditions in the field. Skelton et al. (2014) have used metabolomics to assess 
hepatic effects of waste water treatment plant on fathead minnows (Pimephales 
promelas) that were held in mobile monitoring units and exposed on-location to 
surface waters upstream and downstream of the effluent point source, as well as to 
the actual effluent at three different sites in Minnesota, USA
64
. 
From a technological perspective, metabolomics rapidly evolved during the past 
decades due to major technological and instrumental improvements. As a result, 
highly sophisticated techniques have been developed, which insure elevated 
robustness, reproducibility, efficiency and sensitivity
64
. In metabolomics two main 
types of instrumentations are commonly applied: nuclear magnetic resonance 
(NMR) and mass spectrometry (MS). NMR-based metabolomics has the 
advantages of shorter analysis time, convenient automation, higher reproducibility 
and non-destructivity of the sample
55,64,65
. However, due to the higher sensitivity of 
MS, which detects metabolites down to 10,000-fold lower concentrations than 
NMR
55
, many more researcher are moving towards the application of MS-based 
metabolomics.  
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Contrary to NMR, MS is commonly coupled to a separation technique. The 
literature shows many platform-specific oriented strategies using liquid 
chromatography (LC), gas chromatography (GC) or capillary electrophoresis 
(CE)
66–69
. Among these techniques reverse phase LC (RPLC) is the most applied 
one
70
. The separation method of choice has a large influence on the type of 
metabolites which will be detected in the samples. This is due to the fact that each 
analytical separation can effectively separate a relatively small fraction of the 
entire metabolome, because of the broad chemical diversity of metabolites in terms 
of polarity, molecular weight and charge
65
. For the analysis of charged and very 
polar metabolites, RPLC is not suited, whereas CE is the preferred technique
71
. 
Nevertheless, CE has some important drawbacks such as a lower reproducibility 
and sensitivity compared to chromatographic techniques. To retain this class of 
metabolites, hydrophilic liquid chromatography (HILIC) can be applied in 
metabolomics studies and over the last years this platform reached similar 
performances of RPLC
72,73
. The application of only one platform would imply the 
inevitable loss of information in terms of detected metabolites. As a consequence, 
the recent trend is to move towards a combination of several analytical 
platforms
74,75
. There is a limited number of studies comparing cross-platform 
methodologies
76–78
. Metabolomics studies can use either a targeted or a non-
targeted approach, depending on the nature of the experiment. In hypothesis driven 
studies a targeted strategy would be preferred to focus on the different levels of 
certain metabolites of interest
73
. On the contrary, for hypothesis-free and holistic 
analysis, a global profiling strategy is commonly employ to be able to detect as 
many metabolites as possible
68,79
. For a quantitative targeted approach a triple 
quadruple MS (QqQ), which sacrifices resolution over sensitivity and robustness, is 
often applied whereas for a non-targeted strategy a high resolution MS (HRMS) is 
required to assure an optimal mass accuracy. This is a crucial parameter in 
screening strategies since it determines the metabolite identification success. The 
use of HRMS in combination with simultaneous acquisition of MS/MS 
fragmentation spectra provides a high level of identification accuracy facilitated by 
the query in web-based databases, even though the LC-MS libraries are still limited 
compared to GC-MS. Due to the high relevance of metabolite identification for 
biomarker discovery, the chemical analysis working group of the Metabolomics 
Standards Initiative defined four different levels of metabolite identification 
confidence
80
. For an accurate and definitive identification, the comparison of two 
or more orthogonal properties (e.g., retention time, m/z, fragmentation mass 
spectrum) to a chemical standard analyzed under identical analytical conditions is 
required. 
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In non-targeted metabolomics the acquired raw data in full scan mode needs to be 
converted into extracted data in order to generate the peak table
81
. This step of 
preprocessing includes noise filtering, baseline correction, spectra centering, 
normalization, peak picking and peak alignment to take into account possible 
retention time shift along the chromatographic sequence. The result of these 
operations is the creation of the so called metabolite feature for which the mass and 
retention time of the peak are merged together into a unique item
82
. Commonly MS 
instrument vendors offer a range of software solutions to carry out the MS data 
preprocessing but open-source software programs or computing scripts can also be 
applied
72,83,84
.  
Statistical analysis in metabolomics can be distinguished in univariate and 
multivariate statistics. Univariate statistics is applied when only one variable is 
analyzed out of all extracted features by hypothesis testing, such as t-test or 
analysis of variance (ANOVA)
85
. Multiple hypothesis testing are very susceptible 
to false discovery and, to prevent the attribution of a false marker, a corrected and 
more conservative p-value should be considered. To this extent Bonferrroni’s 
correction might be a too conservative approach since all the variables are treated 
as independents. Therefore, false discovery rate (FDR) correction is usually 
preferred
86
. Multivariate statistics analyzes simultaneously the relationships 
between more variables or features. For data exploration, unsupervised methods 
such as principal component analysis (PCA) facilitate to identify outliers in the 
dataset and to observe groups or trends among the observations. For biomarker 
discovery supervised statistical models should be preferred in which a priori 
knowledge of the class is given. Prediction and classification models like partial 
least square (PLS) and orthogonal PLS (OPLS) analysis are commonly used and, 
especially OPLS models are suited since a stronger class distinction can be found 
and a simpler interpretation can be achieved
87,88
. With these types of models it is 
crucial to perform a proper validation to avoid model overfitting and provide 
adequate reliable results
81
. In multivariate statistics cross-validation is a good 
approach in which the dataset is divided in a training set and a test set that will be 
used as an independent dataset. In such a way it is possible to determine how well 
the model will predict this independent set of “unknown” data and generalize the 
model prediction capabilities. 
 
IV. EDA-EMERGE project 
The main part of this research was conducted within the EDA-EMERGE 
(http://www.eda-emerge.eu) Marie Curie initial training network (ITN) (MC-ITN, 
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European Commission, 7
th
 Framework Program). In this project 13 PhD students 
and one postdoc were trained in many interdisciplinary techniques required to meet 
the major challenges in the monitoring, assessment and management of toxic 
pollution in European river basins. This project aims at developing new effect-
directed analysis (EDA) approaches for the identification of toxicants in European 
surface and drinking waters
89
. EDA combines biotesting, fractionation and 
chemical identification of bioactive compounds in complex mixtures and it has 
proven to be a successful approach to direct chemical monitoring of 
(eco)toxicological relevant chemical contaminants
90
. It is well known that 
conventional chemical methods targeting priority pollutants can only provide a 
partial picture of the chemicals in the aquatic environment. Moreover, these 
methods are not taking into account the biological effects of the chemicals. For this 
purpose, the integration of effect-based assessment and chemical analyses is 
increasingly being developed to identify toxicants responsible for biological 
effects. A schematic representation of the EDA strategy is shown in Figure 1.1.  
 
Figure 1.1 Scheme of EDA of complex mixture. 
In the EDA strategy, the environmental samples that show a toxic effect in the 
bioassay are fractionated on the basis of the physicochemical properties of the 
compounds in order to decrease the complexity of the samples. This process is 
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iterated to further reduce the samples complexity to a limited number of causative 
chemicals that can be more successfully identify by chemical analysis.  
Biological assessment of environmental samples is a crucial factor of EDA studies 
since it is driving the whole EDA procedure. Currently, many established bioassays 
have proven to be useful in EDA studies
91,92
 but they have also important 
limitations in terms of the relevance of toxicological information. Therefore, the 
current challenge for EDA innovation is the improvement of the existing biotesting 
strategies to enhance the ecological relevance and, as a consequence, the 
environmental risk assessment. One of the major limitations of the current 
biodiagnostic tools is the a priori selection of the toxicological endpoint since it 
limits the identification of compounds in the samples to a class of toxicants. 
Moreover, most of the existing tools are in-vitro assays and their ecotoxicological 
relevance to predict in vivo effects on aquatic species is still under debate and 
questionable. For this reason, the development of new testing strategies that 
enables the assessment of potential toxic effects of mixtures is a major issue. Very 
promising alternatives are provided by the use of cutting-edge techniques such as 
transgenic organisms and “omics” techniques that can characterize toxic effects 
(multiple endpoints and pathway analysis) of complex mixture in-vivo.  
 
 
V. Aim and outline of this thesis 
The aim of this thesis was: 
i. Develop analytical methods for targeted metabolomics to study neuronal 
metabolism, 
ii. Apply these methods to determine the baseline neurotransmitter profiles of 
the CNS of the model organism L. stagnalis and of D. rerio embryos and 
larvae, 
iii. Develop and apply a strategy for non-targeted metabolomics for L. 
stagnalis after exposure to imidacloprid, 
iv. Investigate the effects of the neonicotinoid pesticide imidacloprid and other 
selected pesticides on the neuronal metabolism of these non-target species, 
v. Explore the application of metabolomics in an EDA case study to evaluate 
the toxicity of surface water extracts, of the most abundant chemicals 
(imidacloprid, pirimicarb and thiacloprid) and their mixture. 
The main focus of this project was the assessment of pesticide-induced 
neurotoxicological effects in non-target species. 
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To this extent, a new methodological strategy was developed and validated to 
determine metabolites involved in the neuronal metabolism, such as the main 
neurotransmitters, their precursors and their metabolites. Different HILIC columns, 
particularly suited for polar compounds, were tested to separate and quantify 
twenty metabolites. This analytical method was developed to profile 
neurotransmitters in the CNS of the freshwater snail L. stagnalis (Chapter 2). 
The targeted methodology was applied to characterize the neurotransmitters profile 
during zebrafish (D. rerio) early stage development and to investigate the effect 
induced to neurotransmitters levels by pesticide exposure in D. rerio larvae 
(Chapter 3).  
In parallel to this targeted approach a more comprehensive strategy has been 
developed to extract and profile hydrophilic and hydrophobic metabolites of the 
freshwater snail organs. Concerning the sample preparation, two commonly used 
tissue disruption methods have been evaluated: ultrasound assisted extraction and 
beads beating homogenization. In order to reduce the analysis time and increase the 
throughput simultaneous extraction of hydrophilic and lipophilic metabolites was 
carried out by using a mixture of water, methanol and chloroform in a beads 
beating system. Complementary and orthogonal analytical techniques have been 
combined like LC and GC coupled to HRMS (Chapter 4). 
In Chapter 5, these two methodologies were integrated and applied to investigate 
the neurotoxic induced effect of the neonicotinoid pesticide imidacloprid in the 
CNS of the non-target species L. stagnalis. In this study, a ten day exposure to 
imidacloprid environmentally relevant and sublethal concentrations (0.1 µg/L, 1.0 
µg/L, 10 µg/L and 100 µg/L) was carried out. Statistical analysis based on multiple 
testing with false discovery rate correction, pathway analysis and visualization 
tools like biochemical network mapping were used to highlight which metabolite 
levels were significantly changed by the exposure conditions.  
The application of the developed metabolomic strategy and its integration in an 
effect directed analysis study was explored in Chapter 6. This project was carried 
out in collaboration with the EDA-EMERGE project partner KWR (KWR, 
Watercycle Research Institute, Department of Chemical Water, Nieuwegein, the 
Netherlands). In this study surface water was sampled with a large volume solid 
phase extractor (LVSPE) in an agricultural area of the Netherlands that from 
previous monitoring campaigns was known to be affected by pesticide 
contamination. Water pollutants were absorbed on three cartridges placed in series 
comprising different sorbent functionalities: a neutral sorbent, a cationic sorbent 
and an anionic sorbent. Target chemical analysis of 125 chemicals ranging from 
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herbicides, insecticides, fungicides and pharmaceuticals was performed on the 
eluents of the three. To assess the toxicity of the cartridges eluates the AChE 
bioassay was performed. An EDA study using an on-line HPLC-MS fractionation 
system combined to the AChE bioassay in a 96-wells plate was carried out in order 
to detect and identify the chemicals that showed the AChE activity in the 
environmental extracts. To further investigate the toxicity of the most toxic 
cartridge (neutral sorbent) a targeted and non-targeted metabolomic exposure study 
with L. stagnalis was carried out. L. stagnalis was also exposed to the most three 
abundant chemicals in this cartridge individually and as a mixture. 
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Abstract 
Neurotransmitters are endogenous metabolites that allow the signal transmission 
across neuronal synapses. Their biological role is crucial for many physiological 
functions and their levels can be changed by several diseases. Because of their high 
polarity, hydrophilic interaction liquid chromatography (HILIC) is a promising tool 
for neurotransmitter analysis. Due to the large number of HILIC stationary phases 
available, an evaluation of the column performances and retention behaviours has 
been performed on five different commercial HILIC packing materials (silica, 
amino, amide and two zwitterionic stationary phases). Several parameters like the 
linear correlation between retention and the distribution coefficient (Log D), the 
separation factor k and the column resolution Rs have been investigated and the 
column performances have been visualized with a heat map and hierarchical 
clustering analysis. An optimized and validated HILIC-MS/MS method based on 
the ZIC-cHILIC column is proposed for the simultaneous detection and 
quantification of twenty compounds consisting of neurotransmitters, precursors and 
metabolites: 3-methoxytyramine (3-MT), 5-hydroxyindoleacetic acid (5-HIAA), 5-
hydroxy-L-tripthophan, acetylcholine, choline, L-3,4-dihydroxyphenylalanine (L-
DOPA), dopamine, epinephrine, γ-aminobutyric acid (GABA), glutamate, 
glutamine, histamine, histidine, L-tryptophan, L-tyrosine, norepinephrine, 
normetanephrine, phenylalanine, serotonin and tyramine. The method was applied 
to neuronal metabolite profiling of the central nervous system of the freshwater 
snail Lymnaea stagnalis. This method is suitable to explore neuronal metabolism 
and its alteration in different biological matrices. 
 
Introduction 
Neurotransmitters function by exciting or inhibiting postsynaptic receptors that 
produce changes in postsynaptic membrane polarization and ionic conductance
1
. 
Neurotransmitters also perform functions unrelated to the nervous system such as 
immunoregulation
2,3
. To this extent acetylcholine exhibits an immune inhibitory 
role whereas adrenaline may exert an immunoenhancing effect in the central 
nervous system (CNS). Furthermore, catecholamines such as L-DOPA and 
dopamine are involved in tissue pigmentation and in melanin formation in the 
mammalian epidermis
4
 and insect cuticles
5
. In addition to these well-established 
functions, catecholamines might also be important in cell development
6
. 
Neurotransmitters play an essential role in many physiological functions and 
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imbalanced levels have been related to several diseases
7,8
 or associated to 
neurotoxic compounds
9,10
. There has been an increasing interest in developing 
analytical methods for the simultaneous quantification of neurotransmitters, 
precursors and metabolites in biological matrices. 
Gas chromatography (GC) has been used to analyze neurotransmitters even though 
it involves long sample preparation and clean-up procedures as well as labor 
intense derivatization
11
. As a result of these disadvantages, liquid chromatography 
(LC) has been frequently preferred. High performance liquid chromatography 
(HPLC) interfaced to an electrochemical (EC) detection system is often employed 
for the analysis of monoamines
12
 but for the analysis of acetylcholine an enzymatic 
oxidative reaction is required prior to EC detection
13,14
.  
Due to the high polarity of these compounds reversed phase liquid chromatography 
(RPLC) can only be applied after a derivatization step in order to achieve retention 
and consequently increase the selectivity and sensitivity
15
. The RPLC separation 
can be improved by adding an ion-pair reagent
16
. However, when mass 
spectrometry (MS) is used, an ion-pair reagent is unfavorable because it often 
cause ion suppression and the MS interface clogging. Therefore, another 
instrumental configuration comprising an online elimination of the ion-pair reagent 
should be considered
17
. LC-MS/MS has the advantage to provide high analytical 
specificity. For cathecolamines a low MS ionization efficiency affecting the 
sensitivity has been previously shown
18
.  
In this context, hydrophilic interaction chromatography (HILIC) coupled to MS is a 
promising approach for neurotransmitter analysis, as shown by the increasing 
number of publications [19–25]. HILIC has the advantage to retain very polar 
compounds without the need to apply a derivatization step and MS detection allows 
a high selectivity. Nevertheless, the previous studies only focused on a small 
number of compounds, mainly monoamines
19
 and catecholamines
20,21
 whereas the 
method should preferably be extended to other neurotransmitters as well. Tang et 
al. (2014), recently proposed a method for the simultaneous determination of 
acetylcholine, serotonin, glutamate and dopamine, norepinephrine, GABA and 
glycine based on HILIC with a zwitterionic stationary phase
22
.  
Therefore, the aim of the present study is to develop a HILIC-MS/MS method 
capable of simultaneously detecting and quantifying a large series of compounds 
consisting of neurotransmitters, precursors and metabolites: 3-MT, 5-HIAA, 5-
hydroxy-L-tripthophan, acetylcholine, choline, L-DOPA, dopamine, epinephrine, 
GABA, glutamate, glutamine, histamine, histidine, L-tryptophan, L-tyrosine, 
norepinephrine, normetanephrine, phenylalanine, serotonin, tyramine. These 
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compounds are involved in a broad range of neurotransmitter synapses such as 
GABAergic, glutamatergic, serotonergic, dopaminergic, histaminergic and 
cholinergic pathways. The amino acid precursors have also been included, such as 
tryptophan as precursor for serotonin, and tyrosine as precursor for dopamine and 
epinephrine.  
In our study different HILIC stationary phases characterized by silica, amino, 
amide and two zwitterionic functionalities have been evaluated. The column 
retention behaviors have been investigated using the correlation coefficient R
2
 
between the distribution coefficient (Log D) and retention times, the separation 
factor k and the column resolution Rs. The column performances have been 
visualized with a heat map and hierarchical clustering analysis.  
To ensure the highest sensitivity and specificity, the mass spectrometer was 
operated in multiple reaction monitoring (MRM) mode and the most intense 
transition of each analyte was used for quantification. Stable isotope-labeled 
internal standards (IS) have been used for calibration and quantification. The 
method has been validated by assessing precision, accuracy, carry over, linearity 
and the limit of detection (LOD) and quantification (LOQ). 
The optimized methodology was applied to quantify the neurotransmitters of the 
CNS of the pond snail (Lymnaea stagnalis), which is a unique model organism in 
neurobiology because of the large and easily identifiable CNS neuronal nodes
23,24
.  
 
Meterial and Methods 
Reagents and Material 
Milli-Q water was obtained from a Millipore purification system (Waters-Millipore 
Corporation, Milford, MA, USA). HPLC grade acetonitrile (ACN) and methanol 
(MeOH) were from JT Baker Chemical (Phillipsburg, NJ, USA). MS grade formic 
acid (98% purity) and sodium formate salt (purity ≥ 99%) were obtained from 
Fluka (Steinheim, Germany). 
All the analytical standards of 3-MT, 5-HIAA, 5-hydroxy-L-tripthophan, 
acetylcholine, choline, L-DOPA, dopamine, epinephrine, GABA, glutamate, 
glutamine, histamine, histidine, L-tryptophan, L-tyrosine, norepinephrine, 
normetanephrine, phenylalanine, serotonin, tyramine were from Sigma-Aldrich 
(Schnelldorf, Germany). 
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The stable isotope-labeled internal standards of 3-MT-d4, acetylcholine-d4, 
serotonin-d4, 5-HIAA-d5, L-tryptophan-d3 and GABA-d6 were from CND Isotopes 
(Quebec, Canada). DOPA-d3, dopamine-d4, L-tyrosine-d4, epinephrine-
13
C2 
15
N, 
choline-d13 and glutamate-d5 were obtained from Cambridge Isotope Laboratories 
(Andover, MA). Glutamine-
13
C 
15
N, norepinephrine-d6 and 5-hydroxy-L-
tryptophan-d4 were from Toronto Research Chemicals (Ontario, Canada). 
Standard stock mixtures were prepared in milliQ water with 0.1% (v/v) formic acid 
for all individual compounds and stored in dark conditions at -20 ºC. The working 
solutions were obtained by dilution of the stock solutions in ACN:H2O 90:10 v/v.  
Chromatographic columns and tested conditions 
The selected columns (Table 2.1) have been tested by coupling a liquid 
chromatograph to a Time-of-Flight mass spectrometer (ToF-MS) with an isocratic 
elution for 25 min at 30 ºC with a flow rate of 0.2 ml/min with ACN:H2O 90:10 v/v 
10mM NH4COOH at pH 2.8. The ammonium formate concentration stated 
represents the overall concentration of the salt in the mobile phase not only in the 
water fraction. The aqueous buffer has been prepared by dissolving 0.63 g of 
ammonium formate in the water fraction. The pH has been measured in water using 
a pH-meter calibrated in aqueous buffers and then adjusted to reach pH 2.8 with 
formic acid (corresponding to 0.1% v/v in the final volume of the mobile phase).  
The mobile phase composition has been chosen based on previous research that has 
been conducted on the retention and selectivity of HILIC columns. The choice of 
the pH has been based on the pKa of the analytes and on previous study
19,25
. No 
significant differences have been observed by using ammonium formate instead of 
ammonium acetate
20
. Kumar et al. (2013), have shown that an increase in the 
buffer concentration led to a decreased retention of strongly basic and quaternary 
compounds on different HILIC stationary phases
26
. 
A standard solution of the compounds of interest (10 μg/mL) was injected (5 µL) to 
explore the HILIC column chemistry and retention behavior.  
Instrumental analysis 
For the column evaluation phase an Agilent 1200 HPLC system (Agilent, Palo 
Alto, USA) was coupled to a high resolution (HR) ToF- MS (MicroToF II, Bruker 
Daltonik, Bremen, Germany). The ESI source was operated in positive mode and 
the source parameters were set as follows: electrospray capillary voltage 2500 V, 
end set plate 500 V, nebulizer gas (N2) 4 bar and the drying gas 8 L/min at 200 ºC. 
The scanning range was between m/z 50 to 500 with a spectra rate of 1 Hz. The 
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HILIC-ToF chromatograms were analyzed with the instrument software 
DataAnalysis 4.0 (Bruker Daltonik, Bremen, Germany).  
The selected column was further investigated and the chromatographic conditions 
were optimized by coupling it to a triple quadrupole (QqQ) MS. For this purpose 
an Agilent (Palo Alto, USA) 1260 Infinity Binary LC System was coupled with an 
Agilent (Palo Alto, USA) 6410 Series Triple Quadrupole equipped with an ESI 
ionization source operating in positive mode. The MS data acquisition was carried 
out in MRM mode. Data acquisition and analysis of the HILIC-MS/MS 
chromatograms were performed with MassHunter Workstation by Agilent (Palo 
Alto, USA). All MRM chromatograms were processed using Agilent (Palo Alto, 
USA) MassHunter quantitative analysis software.  
Evaluation of HILIC column chemistry 
For each studied analytes the Log D and the percentages of the chemical species 
abundance were calculated with Marvin (ChemAxon, Budapest, Hungary) using 
the following options: weighted (VG=1, KLOP=1, PHYS=1) and electrolyte 
concentration 0.01 mol Na/dm
3
. The separation factor k was calculated following 
the equation: k = (tR – t0)/t0, where tR is the retention time and t0 correspond to the 
dead volume, calculated based on the column physical specification of the column 
used. The Log D values at pH 2.8 were consequently plotted against the separation 
factor (  ) and the linearity was assed considering the correlation coefficient R2. 
Since it has been previously shown that a particular group of analytes can induce a 
deviation in the linearity dependency
26
, the correlation coefficients have been 
calculated for all the analytes, as well as the positively charged and the zwitterionic 
analytes. 
Method Validation 
For the method validation several parameters were investigated: precision, 
accuracy, carry over, linearity, limit of detection (LOD) and limit of quantification 
(LOQ). The method precision has been assessed for both the method 
reproducibility (interday) and repeatability (intraday). The repeatability was 
evaluated by analyzing the calibration curves of all analytes and by calculating the 
relative standard deviation (RSD) of the retention times. The interday 
reproducibility expressed as the RSD of all the analytes has been investigated by 
injecting the same calibration standards at three different days. The accuracy of the 
method was investigated by performing experiments. Due to the the presence of 
endogenous compounds in biological matrices a spiking experiment was performed 
using stable-labeled compounds. The spiking experiment was performed in 5-fold 
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at a concentration level corresponding to 10 times the LOQ. Recoveries (R) have 
been calculated by comparing the results of the theoretical and measured peak 
areas.  
Calibration curves were prepared in 90:10 ACN:H2O (v/v) for each analyte starting 
from the LOQ level and the linearity has been assessed for each analyte by 
calculating the regression coefficient (R
2
). 
The characterization of the method was completed with the calculation of LODs 
and LOQs from the LC-MS/MS chromatograms. The peak height to the averaged 
background noise ratio was calculated, for which the background noise was 
estimated by three times the root mean square near the analyte peak. LODs and 
LOQs were then calculated as the signal-to-noise (S/N) ratio of 3 and 10. 
Application of the method to L. stagnalis: sample collection and preparation 
L. stagnalis specimens were taken from the culture maintained at the VU 
University, Amsterdam, The Netherlands. The snails were kept in the breeding 
facility under a circulation system of copper-free freshwater (averaged water 
characteristics: hardness 1.48 mmol/L, pH 8.12, total organic carbon 1.9 mg/L) at 
20 ± 1 ºC in a 12 h/12 h light-dark cycle and fed on lettuce leafs ad libitum. The 
snails were 16 weeks old and the average size was 2.7 ± 0.1 cm measured on the 
outer shell
27
. The snails were quickly sacrificed in liquid nitrogen for 15 sec. 
Subsequently, the shells were removed using tweezers and the snails CNS were 
removed and transferred to 0.5 mL Precellys vials with 1.4 mm ceramic beads 
(zirconium oxide) (CK 14, Bertin Technologies, France). The CNS samples were 
snap frozen in liquid nitrogen and kept on ice during the whole sample preparation 
procedure.  
A two-step extraction was carried out with the Precellys®24 Dual device (Bertin 
Technologies, France) operating at 6500 rpm for two cycles of 10 sec with a 15 s 
break between cycles. The first extraction step was performed with milli  water 
and    μL was withdrawn from the homogenate for the protein content 
measurement. These samples were collected in   mL  ppendorf tubes and stored at 
-8   C before performing the Bradford assay. The extraction was completed by 
adding a mixture of neurotransmitters stable isotope-labeled internal standards in 
MeOH in order to reach the final solvent composition of 1:1 v/v H2O:MeOH. The 
sample homogenates were transferred to 2 mL Eppendorf tubes and, after a vial 
rinsing step with 5  μL 7 :3  v/v MeOH:H2O, ice partitioning took place for 10 
min. All used solvents were kept on ice during the course of the sample 
preparation. Finally, the samples were centrifuged in a precooled centrifuge 
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(Heraeus Biofuge Stratos, Heraeus Instruments, Germany) at 4 ºC for 10 minutes at 
17,000 rpm and the supernatants were dried in a Centrivap Concentrator (Labconco 
Co., MO, USA) for 240 minutes at 20 ºC. The dried samples were then dissolved in 
100 μL of ACN:H2O 90:10 v/v and centrifuged for 5 min at 4 ºC at 17,000 rpm, 
and finally transferred to autosampler vials. 
Protein Content 
Neurotransmitters were normalized for the tissue protein content measured by the 
Bradford protein assay
28
. Bovine serum albumin (BSA), used as calibration 
standard, was obtained from Sigma–Aldrich, and the Protein Assay Dye Reagent 
was purchased from Bio-Rad Laboratories (Richmond, CA, USA). Absorbance and 
spectra were measured using 96 well-plate (Greiner Bio-One, Monroe, NC, USA) 
on a SPECTRAmax 340PC plate reader spectrophotometer (Molecular Devices). 
The absorbance readings were performed using software SoftmaxPro5.2 
(Molecular Devices, Sunnyvale, CA, USA). The sample homogenates in milliQ 
water were diluted 1:100 v/v with MilliQ water before following the Bradford 
assay procedure.  
 
Results and Discussion 
Method development 
HILIC column chemistry evaluation and selection 
Different HILIC stationary phases made either with silica or polymer-based have 
been evaluated for the separation of neurotransmitters, precursors and metabolites. 
Although the most frequently used HILIC stationary phases are amide and bare 
silica phases, we decided also to consider other column surface functionalities such 
as amino and zwitterionic phases
29
. The selection of HILIC columns for 
neurotransmitters analysis was studied but this was restricted to the class of 
catecholamines only
20
. Other column types were tested in that study, but the 
TSKgel Amide-80 column was similar as used in our study. For the analysis of 
neuroactive monoamines, Danaceau et al. (2012) have evaluated amide and HILIC 
stationary phase in comparison with RPLC
19
. Chirita et al. (2010), tested the 
behavior of zwitterionic stationary phases for the separation of polar compounds 
comprising many neurotransmitters and precursors
30
 In our study, we evaluated 
two other zwitterionic phases: the ZIC-cHILIC and the ZIC-pHILIC.  
An overview of the columns tested in the present study is given in Table 2.1.  
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Table 2.1 Physico-chemical parameters of the HILIC columns tested evaluated 
using a ToF-MS. 
Column 
Provide
r 
Functionality/Support 
Size 
(mm) 
Particle 
Size 
(µm) 
pH 
range 
XBridge HILIC Waters Silica/Silica 4.6x100 2.5 1-9 
XBridge Amide Waters Amide/Silica 2.1x100 3.5 2-11 
TSKgel Amide-80 Tosoh Amide/Silica 2.0x100 5 2-7.5 
Asahipak NH2P-50 
2D 
Shodex 
Amino/Polyvinyl alcohol 
Amino 
2.0x150 5 2-13 
ZIC-cHILIC 
Merck-
Sequant 
Zwitterionic/Silica 2.1x150 3 2-8 
ZIC-pHILIC 
Merck-
Sequant 
Zwitterionic/Polymeric 2.1x150 5 2-10 
The Bridge HILIC and XBridge Amide columns both have a hybrid support made 
of ethylene bridges in the silica matrix (BEH Technology): the HILIC column 
exerts unbound BEH particles while the Amide column has an amide ligand. The 
TSKgel Amide-80 stationary phase is an amide-bonded silica consisting of 
nonionic carbamoyl groups that are chemically bonded to the silica gel
31
. The 
Asahipak NH2P-50 2D is a polymer-based HILIC column of which the stationary 
phase shows an amino functionality. The zwitterionic columns tested are either 
based on silica gel (ZIC-cHILIC) or have a polymeric support (ZIC-pHILIC), and 
are characterized by a cholinate and a sulfoalkylbetaine stationary phase, 
respectively. The active surface of the stationary phase exhibits opposite charges: 
the ZIC-pHILIC column contains acidic sulfonic acid groups and strongly basic 
quaternary ammonium groups close to the polymeric support, whereas the ZIC-
cHILIC has positively charged quaternary ammonium groups and negatively 
charged phosphoric groups next to the silica gel surface
32
.  
To assess the retention behavior of the different phases, the correlation between 
retention and Log D of the analytes was investigated since in a previous study the 
distribution coefficient has been shown to effect the separation
26,30,33
. The 
structures of the analytes, abundance percentages and Log D values are shown in 
Table S2.1. The more abundant species of the selected compounds at the tested 
conditions are positively charged (3-MT, acetylcholine, choline, dopamine, 
epinephrine, GABA, histamine, histidine, norepinephrine, normetanephrine, 
serotonin, tyramine) or zwitterionic (5-HIAA, 5-hydroxy-L-trypthophan, L-DOPA, 
glutamate, glutamine, phenylalanine, tryptophan, tyrosine). As can be seen in Table 
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2.2, the correlation coefficients of the specific compound groups are higher 
compared to the group including all compounds. 
Table 2.2 Correlation coefficient (R
2
) of k plotted against Log D at pH 2.8 for 1) 
all analytes, 2) the positively charged analytes and 3) and the zwitterionic analytes. 
 
R
2
 all 
analytes 
R
2
 positively charged 
analytes 
R
2
 zwitterionic 
analytes 
XBridge HILIC 0.73 0.88 0.94 
Asahipak NH2P-50 
2D 
0.02 0.32 0.26 
XbridgeAmide 0.16 0.79 0.13 
TSKgel Amide-80 0.08 0.52 0.45 
ZIC-cHILIC 0.03 0.30 0.81 
ZIC-pHILIC 0.01 0.24 0.33 
The silica based XBridge HILIC column showed the highest correlation between 
retention and Log D of the analytes, demonstrating that for this phase hydrophilic 
partitioning is the main retention mechanism
34
. The partitioning of the solutes 
between the ACN rich mobile phase and the water layer on the stationary phase 
seems to be the main mechanism when a high content of water is reached, whereas, 
in a decreased water rich mobile phase other mechanisms such as adsorption, 
electrostatic interactions and hydrogen bonding are predominant
35
. Indeed, for 
zwitterionic stationary phases the ion-exchange interaction is the main retention 
mechanism
36
 that explains the increase in the ZIC-cHILIC column correlation 
coefficient when only the zwitterionic analytes where considered. Surprisingly, a 
different behavior was shown by the other zwitterionic column which was 
deviating from linearity in all investigated cases. This behavior might be due to the 
zwitterionic stationary phase differences since also the other polymer-based 
column (Asahipak NH2P-50 2D) showed low linear correlations for both positively 
charged and zwitterionic analytes. This behavior can be explained taking into 
consideration the net charge of the stationary phase. Since the amino stationary 
phase (Asahipak NH2P-50 2D) should be positively charged under the 
experimental condition, the retention is not only based on the partitioning 
mechanism but also on the electrostatic repulsion for the cationic analytes.  
The separation capability of the different phases was investigated by plotting the 
logarithmic transformation of the separation factor k of the studied compounds 
(Figure 2.1). 
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Figure 2.1 Distribution of the separation factor k (Log2) of the analytes for the 
tested HILIC columns. DOPA, histamine, and histidine show less data points due 
to their low signal response. The charge of the analytes has been shown: (n) = 
neutral analytes, (z) = zwitterionic analytes and (+) = postively charged analytes. 
The scattering of the k distribution represents a parameter to assess the separation 
power. The Log2k of the XBridge HILIC column has a small distribution as shown 
also by the separation factor k interval widths presented in Table 2.3, meaning that 
most of the peaks are co-eluting in a specific chromatographic region. The high 
values of Log2k for the XBridge HILIC column might indicate the strong affinity 
of the analytes for the stationary phase even though the column cannot discriminate 
them.  
Table 2.3 Separation factor k interval widths obtained on the tested HILIC 
columns. 
 
XBridg
e 
HILIC 
Asahipak 
NH2P-50 
2D 
TSKgel 
Amide-80 
Xbridge 
Amide 
ZIC-
cHILIC 
ZIC-pHILIC 
k interval 
widths 
6.18 13.25 13.42 16.99 19.20 20.02 
For the Asahipak NH2P-50 2D column, most analytes have low separation factors 
k demonstrating the low affinity for the amino stationary phase with the exception 
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of a few compounds that had a higher k value resulting in an increased k interval 
compared to the XBridge HILIC column. Although the columns with amide 
stationary phases have a wide distribution of Log2k values, their k interval width is 
smaller compared to the zwitterionic columns. Overall, the ZIC-cHILIC and the 
ZIC-pHILIC columns showed the most scattered distributions and this performance 
is also reflected in the largest k interval width among the tested columns. The 
slightly higher level of the ZIC-cHILIC k values implies a slightly better retention 
at the cholinate stationary phase column than provided by the ZIC-pHILIC betain 
sulfonated column. 
The full width half maximum (FWHM) obtained for neurotransmitters, precursors 
and metabolites on the tested HILIC columns has been evaluated (Figure S2.4). On 
average, the zwitterionic stationary phases (ZIC-cHILIC and ZIC-pHILIC) showed 
broader peaks, whereas the Asahipak NH2P-50 2D column showed the best 
performances in terms of narrow peaks, followed by the HILIC columns with the 
amide stationary phase (TSKgel Amide-80 and XBridge Amide).  
The resolution was measured by calculating the resolution factor Rs for two 
consecutive eluting peaks with the equation Rs = 1.18 ((tR1 - tR2)/(wh1 - wh2)). Since 
to achieve a baseline peak separation Rs must be equal to or higher than 1.5, we 
have calculated the percentages of resolution factors above 1.5 for every tested 
HILIC column (Table 2.4).  
Table 2.4 Percentages of the column resolution Rs above the baseline separation 
threshold of 1.5. 
Column % Rs above 1.5 
XBridge HILIC 18.8 
TSKgel Amide-80 31.6 
XbridgeAmide 36.8 
Asahipak NH2P-50 2D 38.9 
ZIC-cHILIC 52.9 
ZIC-pHILIC 58.8 
The XBridge HILIC column had the narrowest k interval width. Compared to the 
other columns, also the resolution is the lowest. The Asahipak NH2P-50 2D 
column showed a better resolution compared to its low performance in terms of k 
interval width and Log2k distribution. The resolution is particularly crucial in case 
of compounds with similar MRM transitions. In case of epinephrine, 
normetanephrine and phenylalanine, only zwitterionic based columns could 
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achieve their separation. Moreover, with the ZIC-cHILIC and ZIC-pHILIC 
columns more than 53% of the peaks were baseline separated.  
To visualize the normalized peak areas of the target analytes on all stationary 
phases, hierarchical clustering (HCA) was carried out using the Matlab R2014a 
algorithm clustergram where the linkage method was unweighted average distance 
and the metric was Euclidean distance. The HCA dendrogram shows the analytes 
in the rows and the stationary phases in the columns with the values shown in a 
color scale (Figure 2.2). 
 
Figure 2.2 Heat map and hierarchical clustering analysis of peak areas of the 
analytes for the HILIC columns. 
The differences shown in terms of normalized peak areas can be explained by 
different separation factors of the compounds on the tested columns, differential 
response factors and potential signal suppression during the electrospray ionization 
process.  
The HCA analysis showed that all the tested columns are arranged in two major 
clusters: one corresponding to the zwitterionic columns and the second cluster to 
the other phases. Therefore, the ZIC-cHILIC and ZIC-pHILIC columns show a 
similar performance and exhibit the highest peak area for the majority of 
compounds. This performance exemplifies the suitability of the separation 
mechanism of these two HILIC columns and indicates optimal retention behavior 
of small, polar analytes such as the neurotransmitters. Despite the weak separation 
power of the XBridge HILIC column, high peak areas were obtained proving the 
analytes’ high affinity for the silica stationary phase, which is also reflected by the 
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best correlation coefficient between retention and separation factor. The columns 
with the amide functionality clustered together, showing comparable performances. 
Even though these columns have a good selectivity for the analytes as shown by 
the k interval widths, the smaller peak areas make them less suitable for 
quantification purposes. In terms of separation factor distribution, column 
resolution and peak areas the zwitterionic columns clearly showed the best 
separation of the target analytes even though the chromatographic peaks were 
broader compared to the other columns. However, the ZIC-cHILIC column showed 
a better performance in respect to the linear correlation between retention time and 
k value than the ZIC-pHILIC column. Therefore, the ZIC-cHILIC column was the 
preferred column for further investigation and coupling to the QqQ. 
Chromatographic optimization 
The optimized HPLC conditions using ZIC-cHILIC column are given in Table 2.5 
and in Figure 2.3 a chromatogram is shown. 
Table 2.5 Optimal parameters and settings of the HILIC-MS/MS system. A HILIC 
(ZIC-cHILIC, 2.1x150) and a SeQuant ZIC-cHILIC guard column (20x2.1mm, 
5μm particle size) were used. 
HILIC 
Mobile phase 
composition 
A 100% MilliQ H2O
*
  
B 90:10 v/v 
ACN:H2O
*
 
Flow rate 0.3 mL/min 
Injection volume 5 µL 
Oven Temperature 3  ˚C 
Elution Gradient 
Time (min) A% 
0 0 
2 0 
10 40 
20 40 
MS ESI parameters 
Gas Temperature 350 °C 
Gas Flow 9 L/min 
Nebulizer pressure 40 PSI 
Electrospray capillary 
voltage 
4000 V 
*Both phases were buffered with 10 mM of HCOONH4 and the pH was adjusted at pH 2.8 with 
HCOOH. 
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Figure 2.3 HILIC-QqQ chromatogram of neurotransmitters, precursors and metabolites analysis. 1) Acetylcholine; 2) 5-HIAA; 
3) Choline;4) 3-MT; 5) Tyramine; 6) Phenylalanine; 7) Serotonin; 8) L-Tryptophan; 9) Normetanephrine; 10) Dopamine; 11) 
Epinephrine; 12) GABA; 13) L-Tyrosine; 14) 5-Hydroxy-L-tryptophan; 15) Norepinephrine; 16) L-DOPA; 17) Glutamine; 18) 
Glutamate; 19) Histidine; 20) Histamine. 
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Mass spectrometry optimization 
In order to maximize the sensitivity the quantification method was carried out on a 
QqQ MS operating in MRM mode. Optimization was carried out by direct infusion 
of standards and stable isotope-labeled internal standards (   μg/mL). The optimal 
MS source settings can be found in Table 2.5. 
Most of the compounds showed good fragmentation patterns with the exception of 
tyramine and epinephrine-
13
C2 
15
N, for which only one transition has been selected. 
For all analytes the most intense transitions were found and used to quantitate 
(labeled as “ uantifier”) and in the majority of cases a second characteristic 
transition was used for identification (labeled as “ ualifier”). For epinephrine and 
norepinephrine two fragments were selected as precursor ions of the quantifier 
transitions: respectively 166.1 was selected instead of 184.1 and 152.2 was chosen 
instead of 170.2.  
The m/z of the precursor and product ions and the corresponding voltage settings 
for the MRM transitions are shown in Table S2.2. The dwell time was set at 5 msec 
in order to increase the number of MRM transitions and to have enough data points 
per peak. 
Method validation 
An overview of the validation parameters is presented in Table 2.6. 
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Table 2.6 Validation parameters of the analytical method. 
Analyte Labelled IS RT 
RSD % 
RT Intraday 
RSD % 
RT Interday 
Linear range 
ng/mL 
R2 LOD ng/ml LOQ ng/mL R % 
RSD % 
Method 
3-MT 3-MT-d4 7.7 1.0 6.2 5-3000 0.996 1.11 3.3 95 2.2 
5-HIAA 5-HIAA-d5 3.4 1.6 4.1 10-2500 0.990 3.85 12 90 2.3 
5-Hydroxy-L-tryptophan 5-Hydroxy-L-tryptophan-d4 12.2 1.0 2.6 20-3000 0.975 3.68 11 73 6.8 
Acetylcholine Acetylcholine-d4 3.0 0.5 4.8 0.05-1000 0.998 0.02 0.1 92 1.1 
Choline Choline-d13 6.3 0.9 5.4 1-1000 0.990 0.35 1.0 85 2.1 
L-DOPA DOPA-d3 13.3 0.5 4.7 100-3000 0.902 19.5 58 84 9.4 
Dopamine Dopamine-d4 11.4 0.4 3.8 20-2500 0.995 5.50 17 86 2.7 
Epinephrine Epinephrine-13C2 
15N 11.6 0.3 4.4 20-2500 0.986 5.56 17 87 3.3 
GABA GABA-d6 12.1 0.3 3.5 40-3000 0.979 19.3 58 81 4.2 
Glutamate Glutamate-d5 13.6 0.8 2.2 20-3000 0.960 2.47 7.4 63 18 
Glutamine Glutamine-13C 15N 13.3 0.3 2.5 5-3000 0.942 1.51 4.5 79 1.7 
Histamine L-Tryptophan-d3 18.3 0.5 1.5 100-3000 0.973 25.2 76 89 1.7 
Histidine L-Tryptophan-d3 15.8 0.4 2.5 20-400 0.930 0.31 0.9 89 1.7 
L-Tryptophan L-Tryptophan-d3 10.7 0.4 3.2 5-2500 0.993 0.54 1.6 89 1.7 
L-Tyrosine L-Tyrosine-d4 12.1 0.5 3.2 40-3000 0.948 8.22 25 72 3.0 
Norepinephrine Norepinephrine-d6 12.7 0.5 4.2 40-2500 0.942 13.2 40 89 4.2 
Normetanephrine Norepinephrine-d6 10.7 0.2 3.6 1-1000 0.995 0.28 0.9 89 4.2 
Phenylalanine Epinephrine-13C2 
15N 10.3 1.0 3.2 0.1-1500 0.988 0.03 0.1 87 3.3 
Serotonin Serotonin-d4 10.5 0.8 3.9 0.5-2500 0.994 0.10 0.3 89 1.6 
Tyramine 3-MT-d4 9.7 0.5 4.8 1-1000 0.997 0.35 1.0 95 2.2 
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The software used for data quantification automatically calculated and checked the 
ion ratio between the qualifier ion and quantifier ion. Based on the retention time 
and the ion ratio, the software marks as outliers the analytes exceeding the 
accuracy maximum percent deviation level of 5%, so false positive results are 
prevented. 
The intraday precision of the retention time was lower than 1.6% whereas the 
interday precision was below 6%. The accuracy of the method defined as recovery 
varied from 63% to 95%, with 73% of the recoveries above 80%. The 
reproducibility of the recovery was below 10% for all analytes with the exception 
of glutamic acid. Carry-over effects were investigated by injecting a blank after the 
highest calibration standard or a sample, but no effects could be observed.  
The linear ranges of the calibration curves varied from six orders of magnitude for 
acetylcholine to two orders of magnitude for the less sensitive compounds since the 
highest calibration point used was 3000 ng/mL. The regression coefficient (R
2
) of 
linear regressions was above 0.9 for all analytes and higher than 0.99 for 55% of 
the studied analytes.  
Method sensitivity showed a broad range in concentrations since the lowest LOQs 
were 60 and 80 pg/mL for acetylcholine and phenylalanine, respectively and the 
highest LOQ was obtained for histamine (76 ng/mL). Most of the compounds 
(75%) had an LOQ below 20 ng/mL. The LOQ of acetylcholine was lower 
compared to several earlier published values (8 ng/g and 0.15nM)
37,38
. The LODs 
obtained for catecholamines using EC detection were 15, 20 and 25 pg on column 
for dopamine, epinephrine and norepinephrine, respectively
39
, whereas the LODs 
obtained with our method were 25, 28 and 66 pg on column, respectively. 
Although the LODs of the catecholamines are higher than those obtained using EC 
detection, our results are comparable to other studies in which the detection was 
carried out by tandem MS
40,41
.  
Application of the method: CNS of L. stagnalis  
The ZIC-cHILIC-MS/MS method was tested with the CNS of the freshwater snail 
L. stagnalis. The dissected CNS had an average weight of 7.9 mg and due to the 
high coefficient of variation (41%) normalization by protein content was used to 
minimize the biological variation. The concentrations of the quantified 
neurotransmitters, precursors and metabolites of L. stagnalis CNS (n=10) are 
shown in Table 2.7. Neurotransmitter concentrations in the CNS of L. stagnalis 
ranged over four orders of magnitude from 0.01 ng/mg (acetylcholine) to 131 
ng/mg (glutamine).  
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Table 2.7 Quantified neurotransmitters, precursors and metabolites in L. stagnalis 
CNS (n=10). 
Compound L. Stagnalis CNS ng/mg proteins 
3-MT <LOQ 
5-HIAA 1.66±0.12 
5-Hydroxy-L-Tryptophan <LOQ 
Acetylcholine 0.01±0.001 
Choline 1.84±0.19 
DOPA <LOQ 
Dopamine <LOQ 
Epinephrine <LOQ 
GABA 0.79±0.15 
Glutamate 94.12±18.58 
Glutamine 131.47±24.78 
Histamine 1.15±0.05 
Histidine 2.05±0.15 
L-Tryptophan 0.9±0.09 
L-Tyrosine 2.11±0.19 
Norepinephrine <LOQ 
Normetanephrine <LOQ 
Phenylalanine 3.38±0.73 
Serotonin 0.91±0.18 
Tyramine <LOQ 
 
Conclusions 
A novel HILIC-MS/MS method for the separation and quantification of the main 
neurotransmitters, precursors and metabolites was developed. A total of 20 analytes 
could be analysed within one chromatographic run of 20 min. This major 
achievement is the principal novelty of this study since currently published 
methods focus on a reduced number of neurotransmitters, mainly cathecolamines. 
Moreover, to obtain the best chromatographic separation for a broad range of 
compounds, different HILIC columns have been evaluated. Several parameters 
have been investigated, such as the linear correlation between retention and Log D, 
the capacity factor k, the column resolution Rs and the column performances have 
been visualized with a heat map and hierarchical clustering analysis. 
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The preferred method is based on a ZIC-cHILIC column coupled to a QqQ and is 
suitable for the simultaneous quantification of neuro-active metabolites and their 
precursors. The CNS of the freshwater pond snail L. Stagnalis was analysed to 
assess the method applicability although this biological matrix represents a 
challenge due to the small sample size. The presented results suggest that this 
method is useful to expand the knowledge of neuronal metabolism of different 
organisms and to explore the neurotransmitter profile changes caused by 
pathological states or neurotoxicant exposure.  
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Chapter 2 - Supporting Information 
Tables: 
Table S2.1 Chemical structures, Log D and macro species abundances at pH 2.8 of 
selected neurotransmitters, precursors and metabolites. 
Compound Log D (pH 2.8) Macro species abundance % at (pH 2.8)  
3-MT -5.38 100 
 
5-HIAA 1.39 96.3 
 
5-Hydroxy-L-Tripthophan -4.49 81.62 
 
Acetylcholine -8.12 100 
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Choline -8.56 100 
 
L-DOPA -5.32 93.4 
 
Dopamine -5.88 100 
 
Epinephrine -6.19 100 
 
GABA -7.42 98.1 
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Glutamate -6.61 86.2 
 
Glutamine -7 81.8 
 
Histamine -10.66 100 
 
Histidine -10.67 89.9 
 
L-Tryptophan -3.88 64.3 
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L-Tyrosine -4.75 90.9 
 
Norepinephrine -6.38 100 
 
Normetanephrine -6.23 100 
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Phenylalanine -4.08 77.2 
 
Serotonin -5.41 100 
 
Tyramine -5.59 100 
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Table S2.2 MRM transitions and MS/MS parameters of the compounds and stable isotope-labelled internal standards 
Compound Precursor Ion Product Ion Frag (V) CE (eV) Quantifier/Qualifier 
3-MT 
168.3 151.3 100 6 Quantifier 
168.3 119.1 100 6 Qualifier 
3-MT-d4 
172.1 155.1 50 20 Quantifier 
172.1 91.5 50 20 Qualifier 
5-HIAA 
192.2 146.1 100 9 Quantifier 
192.2 192.1 100 9 Qualifier 
5-HIAA-d5 
197.2 150.2 101 12 Quantifier 
197.2 67.6 101 56 Qualifier 
5-Hydroxy-L-tripthophan 
221.2 204.1 81 4 Quantifier 
221.2 134.1 81 4 Qualifier 
5-Hydroxy-L-tryptophan-d4 
225.2 207.1 91 8 Quantifier 
225.2 52.1 91 8 Qualifier 
Acetylcholine 
146.2 87.2 100 12 Quantifier 
146.2 60.2 100 12 Qualifier 
Acetylcholine-d4 
150.3 91.1 100 22 Quantifier 
150.3 43.1 100 22 Qualifier 
Choline 
104.1 60.1 86 16 Quantifier 
104.1 58.1 86 16 Qualifier 
Choline-d13 
117.1 49.1 100 25 Quantifier 
117.1 66.2 100 25 Qualifier 
L-DOPA 198.2 152.2 100 6 Quantifier 
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198.2 181.1 100 6 Qualifier 
DOPA-d3 
201.2 183.1 86 4 Quantifier 
201.2 108.7 86 28 Qualifier 
Dopamine 
154.1 137.2 100 12 Quantifier 
154.1 119.1 100 12 Qualifier 
Dopamine-d4 
158.2 95.2 81 28 Quantifier 
158.2 141.1 81 8 Qualifier 
Epinephrine 
184.1 166.1 75 13 Quantifier 
166.1 107.1 125 20 Qualifier 
Epinephrine-13C2 
15N 187.2 169.1 81 4 Quantifier 
GABA 
104.2 87.2 75 10 Quantifier 
104.2 69.2 75 10 Qualifier 
GABA-d6 
110.1 93.1 81 8 Quantifier 
110.1 49.1 81 20 Qualifier 
Glutamate 
148.1 84.1 100 5 Quantifier 
148.1 130.1 100 5 Qualifier 
Glutamate-d5 
153.1 135.1 76 4 Quantifier 
153.1 88.1 76 4 Qualifier 
Glutamine 
147.1 84.1 43 10 Quantifier 
147.1 130 43 10 Qualifier 
Glutamine-13C 15N 
149.1 85.1 75 5 Quantifier 
149.1 131.1 75 5 Qualifier 
Histamine 112.2 95.2 100 14 Quantifier 
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112.2 68.2 100 14 Qualifier 
Histidine 
156.2 110.2 100 8 Quantifier 
156.2 156.2 100 8 Qualifier 
L-Tryptophan 
205.1 188.2 100 6 Quantifier 
205.1 146.1 100 6 Qualifier 
L-Tryptophan-d3 
208.2 191.1 91 4 Quantifier 
208.2 147.1 91 4 Qualifier 
L-Tyrosine 
182.1 136.1 90 12 Quantifier 
182.1 165.1 90 12 Qualifier 
L-Tyrosine-d4 
186.2 169.1 86 4 Quantifier 
186.2 140.1 86 12 Qualifier 
Norepinephrine 
152.2 107.2 75 3 Quantifier 
170.2 135.2 75 3 Qualifier 
Norepinephrine-d6 
176.2 158.2 68 4 Quantifier 
176.2 111.1 68 20 Qualifier 
Normetanephrine 
166.1 134.1 125 20 Quantifier 
166.1 106.1 125 20 Qualifier 
Phenylalanine 
166.2 120.1 75 20 Quantifier 
166.2 103.1 75 20 Qualifier 
Serotonin 
177.2 160.2 75 0 Quantifier 
177.2 177.2 75 0 Qualifier 
Serotonine-d4 181.2 164.1 76 8 Quantifier 
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181.2 136.1 76 24 Qualifier 
Tyramine 138.1 121.2 76 6 Quantifier 
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Figures: 
Figure S2.1 Correlation coefficient (R
2
) of separation factor k plotted against LogD calculated at pH 2.8 for all the studied 
analytes. 
 
Figure S2.2 Correlation coefficient (R
2
) of separation factor k plotted against Log D calculated at pH 2.8 for the positively 
charged analytes. 
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Figure S2.3 Correlation coefficient (R
2
) of separation factor k plotted against Log D calculated at pH 2.8 for the zwitterionic 
analytes. 
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Figure S2.4. Full width half maximum (FWHM) for neurotransmitters, precursors and metabolites obtained with the tested 
HILIC columns. 
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Abstract 
During early development, neurotransmitters are important stimulants for the 
development of the central nervous system and normal neurological functionality. 
Although the development of different neuronal cell types during early zebrafish 
(Danio rerio) development is well studied, little is known of the levels of 
neurotransmitters, their precursors and metabolites during development and how 
these levels are affected by exposure to environmental contaminants. A HILIC-
MS/MS method has been applied for the first time to zebrafish embryos and larvae 
to study five neurotransmitter systems in parallel, including the 
dopaminergic/andrenergic, serotoninergic, histaminergic, cholinergic, and 
glutaminergic/GABAnergic systems.). Our method enables the quantification of 
neurotransmitters, their precursors and metabolites in whole zebrafish embryos and 
larvae from the period of zygote to free swimming larvae (6 days post fertilization 
(dpf)). We observed a developmental stage-dependent pattern, with clear 
differences between the first two days of development and the following days. 
Whereas the neurotransmitter levels steadily increased, the precursors showed a 
peak at 3 dpf. After exposure to several pesticides, significant differences in 
concentrations of neurotransmitters and precursors were observed. Our study 
revealed new insights about neurotransmitter systems during the early zebrafish 
development and showed the usefulness of our approach for environmental 
neurotoxicity studies.  
 
Introduction 
Neurotransmitters are endogenous metabolites that act as messengers in 
intracellular signalling across synapses in the central nervous system (CNS). They 
are released by vesicular fusion from the presynaptic cell of a neuron and diffuse 
across the synaptic cleft where they bind to their specific receptor-binding site. 
Many neurotransmitters are synthesized from simple precursors like amino acids.
1
 
Their metabolic rate and release is directly modified by the concentrations of their 
precursors
1
. During early development neurotransmitters are important stimulants 
for the proper development of the CNS. In the developing organism, 
neurotransmitters are produced at different levels, which can affect the modulation 
and formation of synapses. These transient changes are mostly limited to a few 
synapses at a specific time point during development
2
. Changes in the 
neurotransmitter levels during development might lead to improper development of 
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the CNS and impair normal neurological functionality. Neurotransmitters are 
known to be altered in a variety of different neurological diseases like Alzheimer 
and ADHD
3,4
. Exposure to environmental contaminants like organophosphate (OP) 
pesticides can induce behavioural changes via alteration of neurotransmitter 
systems
5
. The potency of contaminants to alter neurotransmitter systems is mostly 
assessed using in vitro assays that lack the capability to deal with uptake and 
metabolism and fail to assess interactions between neurotransmitter systems. It is 
not clear to what extent the (developing) neurotransmitter systems need to be 
altered to cause whole organism effects like altered behaviour, which would be 
important to for risk assessment. Commonly used in vivo tests can give this 
information but are time consuming and expensive. Currently, neurotoxicity testing 
is not performed in chemical risk assessment e.g. within the European Commission 
legislation concerning registration, evaluation and authorisation of chemicals 
(REACH). 
The zebrafish (Danio rerio) is one of the most important model species for 
studying vertebrate development and genetics
6
. The development of zebrafish is 
well characterized and shows high similarity to other vertebrates including humans. 
Development is rapid; within the first day all major organs are formed. Two to 
three days after fertilization, a free swimming larvae hatches. The small size, 
comparatively low maintenance costs and their high reproduction rate makes them 
well suited for high-throughput screenings
7
. Zebrafish are widely used in 
toxicology and recently they became popular as an new alternative animal model to 
study neurotoxicity in vivo
8
. The embryos and early larvae are transparent, which 
allows the monitoring of changes in morphology under the microscope, making 
them well suited for toxicology and neurogenesis studies
9
. Although the 
proliferation and differentiation of the different neuronal cell types has been 
extensively studied, knowledge about changes in neurotransmitter level during 
early development and in response to environmental contaminants is very limited. 
To further establish zebrafish as a potential model for neurotoxicity testing, more 
fundamental knowledge in the regulation of neurotransmitters is needed.  
In this study we present the neurotransmitter profile during the early zebrafish 
neurodevelopment from four hours post fertilization (hpf) to six days post 
fertilization (dpf). An analytical method, based on hydrophilic interaction liquid 
chromatography (HILIC) coupled to tandem mass spectrometry (MS/MS), was 
applied to quantify the main neurotransmitters, their precursors and their 
metabolites in whole zebrafish embryos and larvae. Six different developmental 
time points were analysed, starting with the onset of neurodevelopment up to a 
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swimming larvae, with a nearly fully developed nervous system. Statistical data 
analysis was performed to gain new insights into the relationships between 
different neurotransmitter systems during the early development. Furthermore, 
altered neurotransmitter levels were measured in zebrafish larvae exposed to eight 
different pesticides at concentrations where no phenotypical malformations were 
observed but alterations in swimming behaviour could be detected.  
 
Materials and methods 
Chemicals and Materials 
The Millipore purification system was used to obtain Milli-Q water (Waters-
Millipore Corporation, Milford, MA, USA). HPLC grade acetonitrile (ACN) and 
methanol (MeOH) were from JT Baker Chemical (Phillipsburg, NJ, USA). Mass 
spectrometry grade formic acid (98% purity) and sodium formate salt (purity ≥ 
99%) were obtained from Fluka (Steinheim, Germany). 
All the analytical standards of 3-methoxy tyramine (3-MT), 5-hydroxyindoleacetic 
acid (5-HIAA), 5-hydroxy-L-tryptophan, acetylcholine, choline, L-3,4-
dihydroxyphenylalanine (L-DOPA), dopamine, epinephrine, γ-aminobutyric acid 
(GABA), glutamic acid, glutamine, histamine, histidine, L-tryptophan, L-tyrosine, 
norepinephrine, normetanephrine, phenylalanine, serotonin, tyramine were from 
Sigma-Aldrich (Schnelldorf, Germany). 
The stable isotope-labeled internal standards of 3-MT-d4, acetylcholine-d4, 
serotonin-d4, 5-HIAA-d5, L- tryptophan-d3 and GABA-d6 were purchased from 
CND Isotopes (Quebec, Canada). DOPA-d3, dopamine-d4, L-tyrosine-d4, 
epinephrine-
13
C2 
15
N, choline-d13 and glutamic acid-d5 were obtained from 
Cambridge Isotope Laboratories (Andover, MA). Glutamine-
13
C 
15
N, 
norepinephrine-d6 and 5-hydroxy-L-tryptophan-d4 were bought from Toronto 
Research Chemicals (Toronto, Ontario, Canada). 
For each compound a stock solution was prepared in milliQ water with 0.1% of 
formic acid. Mixture solutions were made by proper dilution in ACN:H2O 90:10 
v/v. All solutions were stored in dark conditions at -20 ºC.  
The pesticides aldicarb, carbaryl, chlorpyrifos, dichlorfos, imidacloprid, permethrin 
and pirimicarb were purchased from (Schnelldorf, Germany) in analytical standard 
quality. Diazinin-O-analog (oxon van diazinon) was ordered from AccuStandard 
(New Haven, CT, USA) in highest purity. All compounds were dissolved in 
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dimethyl sulfoxide (DMSO, Arcos Organics, Geel, Belgium) at 100mM 
concentrations and stored in darkness at -20 ºC. 
Sample collection of zebrafish development 
Wild type zebrafish originally obtained from Ruinemans (Montfoort, The 
Netherlands) have been bred for many generations in our lab and were maintained 
under standard conditions
10
. Spawning was induced by separating male and female 
fish overnight and joining them together in a breeding cage within a mesh net the 
next morning. Eggs from several clutches were mixed and fertilization and quality 
were assessed under a stereo microscope (M7.5, Leica, Eindhoven, The 
Netherlands). Within 4 hpf, eggs were transferred in Petri dishes filled with 
Embryo Standard Water (ESW: 100 mgL
-1
 NaHCO3, 20 mgL
-1
 KHCO3, 180 mgL
-1
 
MgSO4 and 200 mgL
-1
 CaCl2) at 26 ºC. On the different days of development, 
samples were checked for their quality and collected and pooled in a 2mL Precellys 
tubes with 1.4 mm ceramic beads (zirconium oxide) (CK 14, Bertin Technologies, 
France). Thee batches of twenty larvae/embyos each were collected at the same 
developmental time points, at 4 hpf (0 dpf) and every 24 hours of development dpf 
1, 2, 3, 4, 5 till 6 days. Water was removed and the samples snap frozen and stored 
at -80 ºC until analysis.  
Zebrafish exposure 
Zebrafish eggs were exposed to pesticide concentrations that did not cause 
phenotypic malformations (No Effect Concentration (NOEC)) but showed 
behavioural changes using the light-dark transition test, startle reflex, and baseline 
activity test. Within 4 hpf, eggs were exposed to the diluted pesticides in 15 mL of 
Embryo Standard Water at 26 ºC in an 6 well-plate, fifty eggs per well. During the 
experiment the exposure medium was not refreshed. For every compound, three 
different wells (replicates) were included. In all experiments solvent control 
(DMSO, 0.1%) and negative control (ESW) were incorporated. The exposures 
where checked every day. After 5 dpf, twenty larvae per well were pooled for 
neurotransmitter measurements and the rest was used to measure behavioural 
effects. Samples were collected in a 2mL Precellys tube with 1.4 mm ceramic 
beads (zirconium oxide) (CK 14, Bertin Technologies, Montigny-le-Bretonneux, 
France) and snap frozen and stored at -80 ºC until analysis. 
Sample preparation 
The metabolite extraction was carried out with the tissue homogenizer 
Precellys
®
24 Dual device (Bertin Technologies, France) operating at 6500 rpm for 
two cycles of 10 sec with a 15 s break between cycles. The first homogenization 
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was performed with 4   μL of refrigerated (4 ºC) milliQ water. An aliquot of 10 
μL was taken and collected in   mL  ppendorf tubes and stored in the -80 ºC 
freezer before performing a protein content measurement by the Bradford assay
11
 
using the BioRad protein assay reagent (BioRad, Hercules, CA, USA). The 
remaining milliQ water extract in the Precellys vials was extracted by adding 400 
μL of neurotransmitters stable isotope-labelled internal standards prepared in ice 
cold MeOH. The sample homogenates were transferred to 2 mL Eppendorf tubes 
and the Precellys tube were rinsed with 5  μL 7 :3  v/v MeOH:H2O. To facilitate 
the protein precipitation, an ice partitioning step was added for 10 min. Finally, the 
sample homogenates were centrifuged in a precooled (4 ºC) centrifuge (Heraeus 
Biofuge stratos, Heraeus Instruments, Germany) for 10 minutes at 17000 rpm and 
the supernatants were dried in a Centrivap Concentrator (Labconco Co., MO, USA) 
for 240 minutes at 20 ºC. The dried samples were then dissolved in 100 μL of 
ACN:H2O 90:10 v/v and centrifuged for 5 minutes at 4 ºC at 17000 rpm before 
their final transfer in the autosampler vials. 
Instrumentation and data acquisition 
The neurotransmitters analysis was carried out on a 1260 Infinity Binary liquid 
chromatography (LC) system from Agilent Technologies (Palo Alto, USA) coupled 
to a 6400 series triple quadrupole by Agilent (Palo Alto, USA) equipped with an 
electrospray ionization source. The chromatographic separation was achieved using 
the zwitterionic ZIC-cHILIC column ( . x 5 mm, 3μm particle size) and a ZIC-
cHILIC guard column (20 x 2.1 mm, 5 μm particle size) obtained from Merck-
Sequant (Darmstadt, Germany). The mobile phase composition consisted of 
solvent A 100% MilliQ H2O and solvent B 90:10 v/v ACN:H2O, both buffered 
with 10 mM of ammonium formate adjusted at pH 2.8 with formic acid. The mass 
spectrometry (MS) electrospray source was operated in positive mode. The MS 
acquisition was carried out in multi reaction monitoring (MRM) mode and the data 
acquisition was performed with MassHunter Workstation by Agilent Technologies 
(Palo Alto, CA, USA). Quantitative data analysis was executed using MassHunter 
Quantitative analysis software by Agilent Technologies. More methodological 
details are described in (Tufi et al. 2015). An overview of the neurotransmitters, 
precursors and metabolites analyzed is found in Table 3.1. 
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Table 3.1 Overview of the neurotransmitters, precursors, and metabolites analysed and their function in the different 
neurotransmitter systems. The color highlights the neurotransmitter system in which the neurotransmitters, precursors and 
metabolites are involved. Histaminergic = Orange, glutaminergic/GABAnergic = Pink, cholinergic = Green, serotoninergic = 
Purple, dopaminergic/andrenergic= Blue. 
Neurotransmitter system Compound Acronym Function LOQ (ng/mL) 
Histaminergic 
Histamine  Neurotransmitter 76 
Histidine  Precursor 0.9 
Glutaminergic/ GABAnergic 
γ-aminobutyric acid GABA Neurotransmitter 58 
Glutamic acid  Neurotransmitter 7.4 
Glutamine  Precursor/Metabolite 4.5 
Cholinergic 
Acetylcholine  Neurotransmitter 0.1 
Choline  Precursor/Metabolite 1 
Serotoninergic 
Serotonin  Neurotransmitter 0.3 
5-hydroxy-L-tryptophan  Precursor 11 
Tryptophan  Precursor 1.6 
5-hydroxyindoleacetic acid 5-HIAA Metabolite 12 
Dopaminergic/ andrenergic 
Norepinephrine  Neurotransmitter 40 
Normetanephrine  Metabolite norepinephrine 0.9 
Epinephrine  Neurotransmitter 17 
Dopamine  Neurotransmitter 17 
3,4-dihydroxyphenylalanine DOPA Precursor dopamine, norepinephrine epinephrine 58 
Phenylalanine  Precursor dopamine, norepinephrine epinephrine 0.1 
Tyrosine  Precursor dopamine, norepinephrine epinephrine 25 
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Data Analysis 
Neurotransmitter levels were normalized according to the number of embryos/ 
larvae per sample. Data interpretation was performed by generating heat maps and 
performing hierarchical clustering analysis (HCA). The one-way HCA was 
performed in Matlab (version R2014a, The MathWorks, Natrick, MA, USA) using 
the algorithm clustergram where the pair wise distance between columns was 
Euclidean and the linkage function was set as default to average.  
A t-test was calculated on neurotransmitters concentrations between control group 
and exposure groups. Fold changes were calculated by dividing the average of 
metabolites in exposed groups by the control group.  
 
Results 
A novel method able to analyse neurotransmitters, precursors and metabolites 
belonging to five different neurotransmitter systems (Table 3.1) in parallel was 
applied for the first time to developing zebrafish. We analysed samples from 4 hpf, 
every 24 hours, up to 6 dpf, thereby covering all important stages of zebrafish early 
neurodevelopment. Concentrations of twelve compounds could be quantified in 
samples (n=20) from zebrafish embryos and larvae, during the period of early 
neurodevelopment. Eight compounds could not be accurately measured as their 
levels were below the limit of quantification (LOQ) (Table 3.1).  
Neurotransmitter profile during early development  
Temporal changes in levels of metabolites were observed during the early 
development. Concentrations of neurotransmitters, precursors and metabolites in 
all development stages expressed in ng/embryo is reported in Table S3.1. 
Interestingly, neurotransmitter levels (epinephrine, serotonin, acetylcholine) stay 
relatively constant during the whole early neurodevelopmental period (Table S3.1). 
This might indicate that they also have an important function in the growth of an 
embryo.  
Hierarchical cluster analysis is usually applied for the visualization of large data set 
such as microarray data originating from transcriptomic experiments in order to 
explore the (dis)similarity among different sample treatments
12
. Recently, this 
technique has been applied to other “omics” discipline like proteomics13,14 and 
metabolomics
15,16
. A hierarchically clustered heat map was used to identify 
neurotransmitter, precursor and metabolite profiles during early zebrafish 
development (Figure 3.1). 
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Figure 3.1 Heat map and HCA of measured neurotransmitters, precursors and 
metabolites during early zebrafish development. Data represents averaged 
concentrations normalized to the highest concentration (ng/embryo) of each 
measured compound (scale from 0 to 1 coloured accordingly from blue to dark 
red). 
The hierarchical clustering shows the average concentrations which were 
normalized according to the maximum abundance of each neurotransmitter. The 
horizontal dendrogram shows the clustering of the developmental days and the 
vertical dendrogram presents the clustering of the different compounds. Clustering 
of the developmental stages shows a clear distinction between two major groups: 
one group comprising the first two days of development and the second group for 
the stages from 3 to 6 dpf. The clustering of the compounds shows several smaller 
groups. The compounds with constant levels (serotonin, epinephrine and histidine) 
cluster together as well as the compounds showing an increased level during early 
development (acetylcholine, GABA, glutamic acid and glutamine). The 
compounds choline, tyrosine, tryptophan and phenylalanine cluster together and 
showed a Gaussian like pattern, with a peak in the middle of the early development 
(3dpf). It is particularly interesting to note that most of the amino acid precursors 
followed this Gaussian distribution. The metabolite 3-MT is separated from the 
other clusters, likely due to the extremely low, non-detectable levels prior to 2 dpf. 
After 3 dpf an increase in 3-MT could be observed.  
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Neurotransmitter profile after pesticides exposure 
Zebrafish embryos were exposed the first five days of development to eight 
neurotoxic pesticides. The studied pesticides were: pirimicarb, aldicarb and 
carbaryl (carbamates), permethrin (pyrethroids), dichlorfos, chlorpyrifos and 
diazinon-O-analog (OP pesticides) and the neonicotinoid pesticide, imidacloprid. 
Regarding their mode of action (MoA), carbamates and organoposphate pesticide 
share the same MoA by inhibiting the enzyme acetylcholinesterase (AChE). 
Permethrin interferes with the sodium channels of insects nervous system and 
imidacloprid is an agonist of the nicotinic acetylcholine receptors (nAChRs). 
The exposure concentrations corresponded to the no observed effect concentration 
(NOEC) which were determined by assessing phenotypic malformations based on a 
zebrafish embryo toxicity test. The NOEC concentrations of the tested pesticides 
were: aldicarb 0.5 µM, carbaryl 9 µM, chlorpyrifos 11 µM, diazinin-O-analog 1 
µM, dichlorfos 29 µM, imidacloprid 100 µM, permethrin 2 µM and pirimicarb 100 
µM. The concentration of imidacloprid and pirimicarb (100 µM) correspond to the 
highest concentration tested. All concentrations induced behavioral changes at 
5dpf.  
To visualize neurotransmitter, precursor and metabolite profile after pesticide 
exposure a heat map was made and clustering analysis was executed (Figure 3.2). 
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Figure 3.2 Heat map and HCA of measured neurotransmitters, precursors and metabolites after five days exposure to eight 
pesticides at NOEC concentrations. Data represent averaged concentrations normalized to the highest concentration (ng/embryo) 
from each measured compound (scale from 0 to 1 coloured accordingly from blue to dark red).
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The hierarchical clustering is made using averaged levels, which were normalized 
according to the maximum abundance of each metabolite. The horizontal 
dendrogram shows the clustering for the compounds and the vertical dendrogram 
that for the different pesticides. Each pesticide shows a specific neurotransmitter 
pattern. Pesticides cluster based on the toxic potency (NOEC concentrations) 
instead of the pesticide class or the mode of action. The less potent pesticides 
imidacloprid, pirimicarb and carbaryl clustered together as well as the most potent 
pesticides aldicarb, diazinon-O-analog and permethrin. The most potent group 
clustered also with the control group, indicating a similar profile of 
neurotransmitters as the control group. This can be explained by the altered levels 
of only a few compounds: permethrin and aldicarb affected only tyrosine whereas 
diazinon-o-analog changed only the levels of tryptophan and phenylalanine. 
Chlorpyrifos and dichlorvos showed very distinct profiles although they show a 
similar toxic potency and act via the same mode of action (AChE inhibition).  
Each tested pesticide significantly affected at least one neurotransmitter system. 
Acetylcholine, GABA, choline, tryptophan and phenylalanine were altered by at 
least one pesticide. Acetylcholine and tryptophan were significantly altered by four 
and five pesticide, respectively (Figure 3.3).  
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Figure 3.3 Effects (fold change relative to control) of pesticide exposure on 
neurotransmitter levels in zebrafish after five days exposure to eight pesticides at 
NOEC concentrations. (*significantly different from control, p-values < 0.05) 
Most neurotransmitters levels are down-regulated after exposure, with chlorpyrifos 
being the only exception, inducing an increased level of phenylalanine and 
tryptophan. Carbaryl reduced the levels of the highest numbers of compounds 
(acetylcholine, GABA, choline, tryptophan, phenylanaline). Acetylcholine was 
down-regulated by pesticides acting via different modes of action, like pirimicarb 
(AChE inhibition), carbaryl (AChE inhibition), chlorpyrifos (AChE inhibition) and 
imidacloprid (nAChRs).  
Discussion 
Rapid zebrafish neurotransmitter profiling 
This is the first time neurotransmitter levels were measured comparatively during 
early zebrafish development, covering six developmental time points. A novel, 
rapid and high throughput method for neurotransmitter profiling of a wide range of 
synaptic pathways was applied to generate these data. The method based on HILIC 
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coupled to MS has been developed for the simultaneous quantification of 20 
compounds, comprising neurotransmitters, precursors and metabolites. By using 
only twenty embryos or larvae, we could quantify the levels of 12 compounds 
during early zebrafish development: histidine, glutamine, glutamic acid, GABA, 
acetylcholine, choline, tryptophan, serotonin, phenylalanine, tyrosine, 3-MT and 
epinephrine. The levels of histamine, 5-hydroxy-tryptophan, 5-HIAA, L-DOPA, 
dopamine, norepinephrine and normetanephrine were below the detection limit of 
the method. For each developmental stage and exposure group we analyzed three 
biological replicates, each consisting of a pool of twenty larvae or embryos. Even 
though we used only three biological replicates per developmental stage and 
exposure group, the high reproducibility of the method provided a low variability. 
An increase in the number of larvae or embryos could overcome the lack of 
sensitivity for some of the compounds that were below the LOQ. Nevertheless, for 
higher-throughput applications, the number of larvae and embryos should be 
reduced. For this reason, we used only twenty embryos/ larvae per replicate to 
show the applicability in high throughput screening.  
A comparison with available literature revealed the absence of studies measuring 
levels from neurotransmitters, their precursors and metabolites in zebrafish. Only 
two studies have been published which show the screening of different 
developmental stages and are limited to only two compounds involved in 
neurotransmitter pathways
17,18
. An overview of the published studies on 
neurotransmitter determination in zebrafish is given in Table 3.2. Sampling age and 
tissue varied between studies, as well as the number of larvae pooled per sample, 
which ranged from 10 to 200 larvae. The amount of larvae needed depends on the 
sensitivity of the analytical technique. Enzymatic or colorimetric assays require a 
larger amount of sample material due to their low sensitivity compared to 
chromatographic methods
19,20
. The most widely applied technique to quantify 
neurotransmitters is LC based on reverse phase separation followed by 
electrochemical detection (ED)
18,21–25
. This method is particularly suited to analyze 
catecholamines such as dopamine, epinephrine and serotonin whereas it is not 
applicable for the determination of other neurotransmitters as choline, 
acetylcholine, GABA and glutamine. Accordingly, the majority of publications 
focus on catecholamine determination only. For the quantification of acetylcholine, 
colorimetric assays were applied
20
. The methodological differences between 
studies make it difficult to compare concentrations of neurotransmitters with those 
found here. Divergences exist in the sampling age, the amount of larvae, but also 
the normalization procedure and the unit used to express the concentration levels 
was found.  
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Table 3.2 Overview of publications exploring neurotransmitter levels in zebrafish. The sample type, the development stages, the 
applied analytical method and the concentrations when available have been reported. 
Sample 
Development 
Stage 
Analytical 
Methodology 
Neurotransmitters Levels Neurotransmitters Analysed Reference 
Adult brain 90 days old HPLC-ED 
Dopamine = 4.18 ± 0.28 ng/mg of 
protein 
3,4-Dihydroxyphenylacetic acid 
(DOPAC) < 4 ng/mg of brain protein 
Serotonin < 0.8 ng/mg of protein 
5-HIAA < 0.5 ng/mg of protein 
Dopamine, DOPAC, serotonin and 5-
HIAA 
21
 
Larvae (n=30) 5 dpf HPLC-ED 
Serotonin = ± 0.15 pmol/g fish 
Epinephrine = ± 1.25 pmol/g fish 
Serotonin and epinephrine 
23
 
Adult brain 9±1 months old HPLC-ED Dopamine = 1.5 ng/mg protein  
22
 
Larvae (n =10-20) 7 dpf HPLC-ED NA* 
Dopamine, DOPAC, homovanillic 
acid, noradrenaline and histamine 
26
 
Larvae (n=15-20) 5 dpf HPLC-ED NA* 
Dopamine, DOPAC, noradrenaline, 
epinephrine, 5-HIAA and 3-MT 
25
 
8 Embryos (n=8) 
1 hpf, 2 hpf, 3 
hpf, 5 hpf and 
18 hpf 
Direct Infusion 
FTMS 
NA* Tyrosine and phenylalanine 
17
 
50 larvae 5 dpf ELISA assay Dopamine = ± 20 pg/mL Dopamine 
19
 
30-40 larvae 
1 hpf, 1 dpf, 2 
dpf, 3 dpf, 4 
dpf, 5 dpf 
HPLC-ED 
Epinephrine = ± 0.5 nmoL/g at 5 dpf 
Norepinephrine = ± 1.5 nmoL/g at 5 
dpf 
Epinephrine and norepinephrine 
18
 
200 larvae 120 hpf Colorimetric assay 
Acetylcholine = ± 600 nmoL/mg 
protein 
Acetylcholine 
20
 
* NA: Not available. Absolute concentrations are not reported. HPLC (high-performance liquid chromatography), ED (electrochemical detection), FTMS (Fourier transform 
mass spectrometry), ELISA (enzyme-linked immunosorbent assay). 
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Neurotransmitter profile during development 
The hierarchical clustering shows that there is a developmental stage specific 
neurotransmitter profile. The clustering of the developmental stages shows a clear 
distinction between two major groups: one group comprising the first two days of 
development and the second group for the stages from 3 dpf to 6 dpf. The total 
levels of all measured neurotransmitters increased throughout the early 
neurodevelopment. Interestingly, the precursors tyrosine, tryptophan, 
phenylalanine and choline show a peak at 3 dpf. We hypothesize that this peak 
might be related to the hatching of the embryo and the onset of swimming and the 
switch of anabolism to catabolism as the precursor molecules are also the 
substrates for lipids and proteins.  
The cholinergic system is one of the most studied neurotransmitter systems in 
zebrafish. Nevertheless only little data exists on the absolute levels of acetylcholine 
and choline itself during zebrafish neurodevelopment. In our study acetylcholine 
could be detected from the early segmentation phase (9 hpf) up to the swimming 
larvae in increasing levels, similar to acetylcholine esterase (AChE)
27
. Choline 
showed a Gaussian trend with an increase until 3 dpf and a small decrease during 
the larva stages.  
The neurotransmitters of the GABAergic and glutaminergic system where the most 
abundant to be detected. Measured levels were on average ten times higher for 
GABA and thousand times higher for glutamic acid then for the other 
neurotransmitters (acetylcholine, serotonin, epinephrine). The GABAergic and 
glutaminergic nervous system is one of the first neurotransmitter systems 
established in the developing zebrafish. At 24 hpf the early brain neurons contains 
GABA or at least GABA-positive cells. At 2dpf an increased number of GABA 
cells is observed in most parts of the early zebrafish brain
28
. Accordingly, Mueller 
et al. (2006) showed a numeric dominance of early GABA positive cells compared 
to cholinergic, serotoninergic, dopaminergic and noradrenergic cells at 1-2 dpf. 
This together with our findings indicate that GABA and glutamic acid might be 
involved in early brain development
28
. 
Although histidine could be detected at every studied stage, the levels of histamine 
were below our limit of detection, which is in line with Eriksson et al. (1998) who 
could only detect low levels of histamine in the brain after 4 dpf with 
immunocytochemistry
29
. Histamine appears to be produced only in small amounts 
during early zebrafish neurodevelopment. 
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We quantified the levels of the precursor tryptophan and serotonin during zebrafish 
early development for the first time. Tryptophan showed a Gaussian distribution 
with a peak at 3 dpf. Serotonin levels were stable and only minor changes were 
visible during development. Previous immunohistochemistry studies have shown 
that serotonin can be detected in the brain area starting at 1 dpf (29). At 2 dpf, it is 
detected in the hindbrain and the spinal cord. Functional serotonin only is playing a 
role after 4 dpf
30
. We could not detect 5-Hydroxytryptophan, however, which is an 
intermediate metabolite which is rapidly further metabolized to serotonin in rat 
brains
31
. We assume that 5-Hydroxytryptophan is also quickly metabolized to 
serotonin in the zebrafish, which explains why we could not detect it. We could 
also not detect 5-HIAA, a metabolite of serotonin. Both Sallinen et al. (2009) and 
Chatterjee et al. (2009), however, could measure 5-HIAA, a metabolite of 
serotonin, in zebrafish larvae and adult brains. Tryptophan and phenylalanine 
showed similar patterns and levels as the other neurotransmitter precursors (tyrosin 
and choline). Their highest levels were around 3 dpf. Similar to 5-
hydroxytryptophan, it is assumed that DOPA, a direct dopamine precursor, is 
rapidly metabolized into dopamine
31
. This might explain why we could not detect 
DOPA. Although we were also not able to measure dopamine itself we could detect 
3-MT and epinephrine that are metabolized from dopamine. Other studies that 
could measure dopamine levels mostly used higher amounts of sample material or 
later stages (Table 3.2). In zebrafish, dopaminergic neurons have been observed at 
24hpf and functional dopamine activity could be seen starting at 3dpf
32
. We could 
detect epinephrine during the entire period of early neurodevelopment but 3-MT 
only after 3 dpf. It is not known if catechol-O-methyltransferase, the enzyme 
metabolizing dopamine into 3-MT, exists in zebrafish, although the existence of 3-
MT would suggests this.  
We were able to measure epinephrine but not norepinephrine. Steele et al. (2011) 
found higher levels of norepinephrine than epinephrine, both detectable in embryos 
at 1 hpf. Levels of each increased gradually from 1 hpf to 5 dpf
18
. In our study 
epinephrine was detected at constant levels during early neurodevelopment. We 
could also not detect normetanephrine, the metabolite produced from 
norepinephrine degradation. Catecholamines are electroactive and most studies that 
successfully measured catecholamines use HPLC with electrochemical detection 
(HPLC-ED). The disadvantage of HPLC-ED is that it does not allow to measure 
non-electroactive compounds like amino acids, acetylcholine and GABA
33
. 
Although we were not able to measure all compounds involved in the 
dopaminergic and andrenergic neurotransmitter system we could measure the main 
precursors and two metabolites of dopamine which still allows us to monitor the 
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dopaminergic and andrenergic neurotransmitter system during early zebrafish 
development. 
Neurotransmitter profile after exposure to pesticides 
In order to evaluate if our approach can be used to study effects of a variety of 
different substances we selected known neurotoxic pesticides that cover a variety 
of different toxic modes of action, ranging from carbamate pesticides, as 
pirimicarb, aldicarb and carbaryl, pyrethroids as permethrin, OP pesticides like 
dichlorfos, chlorpyrifos and diazinon-O-analog and the neonicotinoid pesticide, 
imidacloprid. Each pesticide was tested at one concentration that induced no 
phenotypic malformations but altered behaviour, to ensure neurotoxic relevance. 
All tested pesticides induced changes in neurotransmitter systems, showing the 
usefulness of our approach for neurotoxicity testing.  
On the basis of standard safety approaches and due to its low binding potential 
observed for the mammalian nAChRs
34
, imidacloprid is thought to have low toxic 
potency in vertebrates
35
. Imidacloprid is extensively used in agriculture as 
substitute of carbamate and organophosphate pesticides. Imidacloprid binds to the 
post synaptic nicotinic acetylcholine receptors (nAChRs) of insects neuronal 
cells
36
. It has been linked to the decline in honey bee colonies
37
 and aquatic 
invertebrates
38
. In this study we have observed behavioural-induced effect of 
imidacloprid in zebrafish, a non-target species, as also shown before
39
, 
demonstrating adverse effects related to imidacloprid exposure in non-target 
species. Moreover, we have found a decrease in acetylcholine levels, a trend that 
was also observed after exposure to other pesticides, like pirimicarb, carbaryl and 
chlorpyrifos. This effect is particularly interesting since it was shown for pesticides 
belonging to different classes and with different modes of action. The AChE 
inhibitors block the enzyme activity to hydrolyse acetylcholine to choline. 
Therefore, for this type of pesticides, an increase of acetylcholine would be 
expected to be found in the synaptic cleft. Imidacloprid replaces acetylcholine 
binding site in the nAChRs, inducing as a consequence an accumulation of 
acetylcholine in the neuronal cleft. Our finding suggests an opposite mechanism in 
which acetylcholine decreases due to a possible increase in AChE. This is in 
accordance with previous research that showed a correlation between the exposure 
to AChE inhibitors in mice and feedback pathways associated to an increase in 
cholinergic gene expression
40
.  
In this study we have chosen to use a relatively small number of larvae in order to 
have an experimental method comparable to the zebrafish embryo toxicity test 
(ZFET) and to show high throughput applicability. Our method applying zebrafish 
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embryos combined with MS analysis of neutronsmitters is promising as an 
alternative animal test to investigate the toxicity of chemicals on whole organisms, 
since it is rapid, high-throughput and more sensitive than the standard ZFET. In 
fact, alteration of neuronal metabolism has been found for all the tested pesticides 
at ZFET based NOECs. The newly applied method is able to monitor five 
neurotransmitter systems and uses only a small amount of larvae per sample (20 
larvae) to enable an high-throughput comparative approach. The unique 
combination of our method with zebrafish gave us the opportunity to quantify 
neurotransmitter levels during early development and its alteration caused by 
exposure to eight different pesticides. This is not feasible in other model organisms 
like mice and rats, where mostly specific tissues (brain slices) at very limited 
number of time points are analyzed. Being able to monitor developmental changes 
in neurotransmitter levels will help better understand the impact of these molecules 
on neurodevelopment and disease onset. Due to the high sensitivity, our approach 
may be also suited for environmental samples with low concentrations of 
contaminants. Our method shows the usefulness of zebrafish as a potential model 
for studying neurodevelopment and neurological changes after pesticide exposure 
and future research will focus on deepening mechanistic insights in the role of 
altered NTs in the development and impairment of the nervous system.  
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Chapter 3 - Supporting Information 
Table S3.1 Levels of neurotransmitters, precursors and metabolites expressed in ng/embryo or pg/embryo in different zebrafish 
developmental stages. The color highlights the neurotransmitter system in which the neurotransmitters, precursors and 
metabolites are involved. Histaminergic = Orange, glutaminergic/GABAnergic = Pink, cholinergic = Green, serotoninergic = 
Purple, dopaminergic/andrenergic= Blue. 
Normalization 
Developmental 
Stage 
Histidine GABA Glutamic acid Glutamine Acetylcholine Choline 
Average ± SD Average ± SD Average ± SD Average ± SD Average ± SD Average ± SD 
ng/embryo 
or 
pg/embryo 
0 dpf 2.0 0.01 1.7 0.02 < LOQ < LOQ 7.6 0.1 2.1 0.2 0.1 0.01 
1 dpf 2.0 0.04 1.7 0.01 5.5 1.5 9.5 0.3 2.6 0.6 1.6 0.01 
2 dpf 2.0 0.07 1.8 0.03 6.9 1.9 9.1 0.5 3.0 0.1 1.5 0.1 
3 dpf 2.1 0.07 2.2 0.1 4.7 0.3 12 0.3 4.0 0.1 2.8 0.1 
4 dpf 2.4 0.30 2.9 0.6 8.6 2.9 14.9 2.9 2.9 0.2 1.5 0.01 
5 dpf 2.2 0.03 2.9 0.7 9.4 2.9 13.7 2.6 3.7 0.3 1.7 0.1 
6 dpf 2.3 0.04 3.4 0.1 9.1 5.3 16.9 1.5 4.1 0.03 1.2 0.1 
Normalization 
Developmental 
Stage 
Serotonin Tryptophan Epinephrine Phenylalanine Tyrosine 3-MT 
Average ± SD Average ± SD Average ± SD Average ± SD Average ± SD Average ± SD 
g/embryo 
or 
pg/embryo 
0 dpf 7.6 0.1 0.4 0.01 37.5 0.1 1.1 0.04 3.2 0.1 < LOQ < LOQ 
1 dpf 7.2 0.1 1.5 0.02 37.5 0.1 4.1 0.1 6.4 0.4 < LOQ < LOQ 
2 dpf 7.2 0.01 3.4 0.3 37.4 0.5 9.7 1.3 10.7 1.1 < LOQ < LOQ 
3 dpf 7.1 0.1 4.5 0.2 37.1 0.1 11.2 1.8 12.7 1.5 47.8 0.3 
4 dpf 7.3 0.3 4.5 0.1 37.2 0.2 10.8 0.2 13.7 0.7 47.9 0.6 
5 dpf 7.5 0.3 3.8 1.0 37.4 0.4 7.0 0.7 10.8 1.8 48.7 0.8 
6 dpf 8.1 0.2 2.0 0.2 37.7 0.2 5.2 0.7 4.4 0.3 50.4 0.4 
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Abstract 
The freshwater pond snail Lymnaea stagnalis is used in several studies on 
molecular and behavioural neurobiology and eco-toxicology showing its successful 
application as model organism. In the present study a cross-platform metabolomic 
approach has been evaluated to characterize L. stagnalis central nervous system 
(CNS), digestive gland (DG) and albumen gland (AG) organs molecular 
phenotypes. Two types of tissue disruption methods were evaluated of which beads 
beating was the preferred method. To obtain a broad picture of the hydrophilic and 
lipophilic metabolome, two complementary analytical platforms have been 
employed: liquid chromatography (LC) and gas chromatography (GC) coupled to 
high resolution mass spectrometry. Furthermore, to increase the power to separate 
small polar metabolites, hydrophilic interaction liquid chromatography (HILIC) 
was applied. The analytical platform performances have been evaluated based on 
the metabolome coverage, number of molecular features, reproducibility and 
multivariate data analysis (MVDA) clustering. This multi-platform approach is a 
starting point for future global metabolic profiling applications on L. stagnalis. 
 
Introduction 
Metabolomics is the final biochemical downstream of the system biology omics 
cascade and since the metabolome is not affected by post-translational 
modifications and regulatory epigenetic processes, like proteomics and 
transcriptomics respectively, it is capable to capture an instant picture of a certain 
biological status. Changes in the metabolome reflect modifications in organ 
functions within an organism
1
 and for this reason metabolomics is a rapidly 
growing field in system biology
2
. Metabolomics has already been applied in many 
research areas, e.g. clinical disease diagnostics
3
, plant chemistry
4
, human nutrition
5
, 
food quality
6
 and environmental sciences
7
.  
The freshwater snail L. stagnalis is a widely used model organism in 
environmental toxicology 
8
. It has been used for bioaccumulation and toxicity 
studies using the digestive gland (DG)
9,10
 and effects on the reproductive system 
have been studied in the albumen gland (AG)
11
. Moreover, this invertebrate species 
is a unique model in neurobiology
12
 since the central nervous system (CNS) is 
easily accessible as well as relatively simple to dissect. Additionally, it is possible 
to recognize many neurons
13
. As a result of the growing interest in this aquatic 
species in many research fields, transcriptomic studies have been carried out to 
increase L. stagnalis annotated genes. The transcriptomic expression of different 
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organs has been explored and the genomic response to a pesticide exposure has 
been investigated
14
. The neuronal transcriptome sequencing has been interest of 
several recent studies on L. stagnalis CNS
15,16
. The increasing number of 
publications is promoting L. stagnalis as model organism in the omics field
17,18
. 
The definition of metabolomics was introduced by O. Fiehn referring to a 
comprehensive analytical approach aiming at identifying the whole metabolome of 
a biological sample
19
. Considering that cells and tissues of an organism contain 
thousands of metabolites, which are heterogeneous and have a wide range in 
concentration, it has been argued that it is not feasible to comprehensively analyse 
the metabolome
20
. From this point of view the metabolic profile is tightly related to 
the selected analytical technique or platform and since the main goal of 
metabolomics studies is to reveal up or down-regulated metabolites it is crucial to 
expand the metabolome coverage by combing data of complementary platforms.  
The literature is scattered with platform specific oriented strategies
21–23
 and, among 
the chromatographic techniques, liquid chromatography (LC) is commonly 
employed. In particular, reverse phase liquid chromatography (RPLC) is the most 
applied technique
24
. However, the application of only one platform would imply 
the inevitable loss of information in terms of detected metabolites and biological 
information. As a consequence, cross-platform approaches in metabolomics have 
been applied and the recent trend is to move towards the combination of more than 
one analytical platform
25,26
. Nevertheless, the scientific literature is limited in 
studies that compare cross-platform methodologies. Moreover, even though L. 
stagnalis is often regarded as model organism, until now this is the first 
metabolomics study on this species and a starting point for underlying organ 
specific effects by an untargeted metabolomics approach.  
Therefore, the aim of this study is to apply and evaluate a cross-platform strategy 
for the characterization of different organ molecular phenotypes (or metabotypes) 
of the aquatic model organism L. stagnalis. Based on this knowledge, future eco-
toxicological research will be carried out on L. stagnalis although this is outside the 
scope of the present study.  
For the cross-platform strategy, complementary analytical techniques have been 
combined. Liquid chromatography and gas chromatography (GC) were coupled to 
mass spectrometry (MS) and to further increase the metabolome coverage, besides 
RPLC, hydrophilic interaction liquid chromatography (HILIC) has also been 
applied. Concerning sample preparation, two widespread tissue disruption methods 
have been evaluated: ultrasound assisted extraction and beads beating 
homogenization. In order to reduce the analysis time and increase the throughput 
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simultaneous extraction of hydrophilic and lipophilic metabolites was carried out. 
With this multi-platform approach, the CNS, DG and AG of L. stagnalis have been 
profiled and the performances of each technique have been evaluated based on the 
metabolome coverage, number of detected metabolites features and reproducibility. 
By properly selecting HILIC chromatographic conditions we have tried to 
maximize the coverage of important metabolites classes that are unretained by 
RPLC. By applying a supervised MVDA method, platform discrimination and 
classification capabilities were assessed for organ metabotype characterization. 
 
Material and Methods 
Snail selection and treatment 
L. stagnalis specimen was taken from the culture maintained at the VU University, 
Amsterdam, The Netherlands. In the breeding facility the snails were kept in a 
circulation system of copper-free fresh water (averaged water characteristics: 
hardness 1.48 mmol/L, pH 8.12, total organic carbon 1.9 mg/L) at 20 ± 1 ºC in a 12 
h/12 h light-dark cycle and fed on lettuce leafs ad libitum. For this study snails 
were collected from the same experimental tank consisting of 800 snails of the 
same generation. The snails used in the metabolomic study were 16 weeks old and 
the average size was 2.85 ± 0.08 cm, measured on the outer shell
27
. 
Since a stress factor can produce quick changes at the metabolic level of an 
organism it is good practice to reduce every external stress source that differs from 
the induced stress of interest. When working with animals, particular care should 
be taken during their treatment in order not to influence the results of the study. 
Common practice during snail handling consist of a magnesium chloride solution 
injection in the snails body prior to sacrifice and dissection
28
. This procedure is 
impracticable for a metabolomics study because this procedure anesthetizes the 
animal and doesn’t quench the metabolic activity. Therefore, we have chosen to 
sacrifice the snails by snap freezing in liquid nitrogen in order to instantaneously 
quench the metabolome. Another crucial factor when working with animals is their 
collection to reduce the biological variability. In this study we have worked with a 
synchronized population and for this reason age and size have been the selection 
parameters considered during snail picking. The snails were sacrificed by snap 
freezing in liquid nitrogen for 10 s followed by dissection of organs. The different 
organs were weighed and immediately snap frozen in liquid nitrogen and stored at -
80 °C until extraction. 
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Chemicals and Materials 
Both hydrophilic standards (amino acid, sugars, organic acid and nucleotides) and 
hydrophobic standard mixture, consisting of 37 fatty acid methyl esters fatty acid 
methyl esters, were purchased from Sigma-Aldrich (See supplementary material, 
Table S4.1). The hydrophilic metabolites were mixed in acetonitrile (ACN):H2O 
90:10 v/v at a concentration of 1 mg/L and the fatty acid mixture was diluted to 1 
mg/L. These standards were respectively used as quality control (QC) for the LC-
MS and GC-MS analysis. The GC derivatization solution of boron trifluoride 
(BF3)-Methanol (MeOH) (10% w/w) was obtained from Sigma-Aldrich. 
Milli-Q water was generated by Millipore purification system (Waters-Millipore 
Corporation, Milford, MA, USA). ACN and MeOH were HPLC grade (JT Baker 
Chemical Co., Phillipsburg, NJ, USA) and chloroform, hexane and isooctane 
CHROMASOLV® from Sigma-Aldrich. Formic acid was mass spectrometry grade 
with a 98% purity and sodium formate salt with a purity ≥ 99% were obtained from 
Fluka.  
Sample Preparation 
For the sample preparation step we compared two common applied tissue 
disruption methodologies: ultrasound assisted extraction (US) and beads beating 
(BB) using a Precellys®24 Dual (Bertin Technologies, France) with 1.4 mm 
ceramic (zirconium oxide) in 0.5 mL and 2 mL (CK 14, Bertin Technologies, 
France). For both methods we carried out a two-steps extraction starting with 
water, followed by the addition of MeOH:CHCl3. From the water extract a  5 μL 
aliquot was withdrawn in order to perform protein quantification (see below). The 
final solvent composition for the CNS metabolite extraction was 45  μL of  : :  
v/v/v H2O:MeOH:CHCl3, and for AG and DG      μL of  : :  v/v/v 
H2O:MeOH:CHCl3 due to the higher amount of sample. The BB extraction 
occurred in a 0.5 mL vial for the CNS organs and in a 2 mL vial for the AG and 
DG organs and consisted of two cycles of 10 s at 6500 rpm with a 15 s break 
between the cycles, whereas the ultrasound (US) extraction was 15 s per step. The 
homogenates were removed and transferred to vials. The final step of both 
extraction procedures consisted of rinsing respectively the ultrasound tip and the 
ceramic beads by adding twice 5  μL (CNS) and     μL (AG and DG) of MeOH: 
H2O 70:30 v/v. 
The metabolite partitioning in the biphasic mixture was performed by keeping the 
homogenate in ice for 10 min. Then, the homogenate was centrifuged for 5 min at 
4 ℃ at 17000 rpm and the hydrophilic fraction was removed and transferred to a 
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vial. The remaining extract was finally transferred into a Corning® Costar® Spin-
X® centrifuge tube filters (Nylon membrane, pore size  .   μm) and was 
centrifuged for 5 min at 4 ℃ at 17000 rpm (Heraeus Biofuge Stratos). The 
hydrophilic fractions were concentrated in a CentriVap Cold Trap with CentriVap 
Concentrator (Labconco Co., MO, USA). The residues were reconstituted in 100 
μL of mobile phase, vortexed and centrifuged again. The clear solutions were 
transferred to autosampler vials for analysis. 
The chloroform fractions containing the lipophilic metabolites were dried under a 
gentle flow of N2 and then derivatized with 500 µL of boron fluoride (BF3) 
methanolic solution kept for 30 min at the temperature of 80 °C. After cooling, a 
liquid-liquid extraction was performed three times with 500 µL of hexane. The 
hexane fractions were reconstituted in an autosampler vial and evaporated till 
dryness with nitrogen and finally, 200 µL of isooctane was added. 
Protein content 
The protein content was determined according to Bradford
29
.This assay is a 
colorimetric protein assay based on an absorbance shift of the complex formed by 
protein assayed and dye Coomassie Brilliant Blue G-250 from red to blue 
occurring under acidic conditions. Bovine serum albumin (BSA) was obtained 
from Sigma–Aldrich and the Protein Assay Dye Reagent was purchased from Bio-
Rad Laboratories (Richmond, CA, USA). Absorbance and spectra were measured 
using 96 well-plate (Greiner Bio-One, Monroe, NC, USA) on a SPECTRAmax 
340PC plate reader spectrophotometer (Molecular Devices).  
Instrumentation and Data Acquisition 
LC-MS 
The profile of the hydrophilic fraction was analyzed with an Agilent 1200 HPLC 
system (Agilent, Palo Alto, USA) coupled to a high resolution time of flight MS 
(HR ToF MS, MicroToF II, Bruker Daltonik, Bremen, Germany). The HPLC 
system consisted of a quaternary pump, a vacuum degasser, an autosampler with a 
cooling unit (4 °C) and a heated column compartment. Both RP and HILIC 
chromatography were applied for the hydrophilic metabolite separation. 
The RPLC was achieved on a C18 Waters symmetry column (150 x 2.1 mm, 3.5 µm 
particle size) connected to a guard column (10 x 2.1 mm, 3.5 µm particle size). The 
mobile phase was as follows: eluent A was H2O:ACN 95:5 v/v and eluent B was 
ACN. Formic acid 0.1% was added to eluent A. Gradient elution was applied for 
the separation increasing the percentage of B in 45 min from 5 to 90%. 
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The HILIC separation was performed using a Waters XBridge Amide column (150 
x 2.1 mm, 3.5µm particle size) equipped with a XBridge Amide guard column (10 
x 2.1 mm, 3.5µm particle size). Different mobile phases were used consisting of 
ACN:H2O 30:70 v/v NH4HCOOH 10mM (A) and ACN:H2O 95:5 v/v 
NH4HCOOH 10mM (B) both adjusted to pH 9 with NH4OH and with HCOOH to 
pH 2.8. A gradient elution was used by increasing B from 0 to 100% in 25 min. 
For both LC approaches, the separation occurred at 30 °C, the flow rate was set to 
0.25 mL min
− 
 and the injection volume was 5 µL.  
The MS source was an electrospray ionization (ESI) operating in positive and 
negative mode scanning in the range of 50 to 1000 m/z with a spectra rate of 1 Hz. 
The capillary was set at ±2500 V, the end set plate was set to ± 500 V, the 
nebulizer gas (N2) at 4 bar and the drying gas at 8 L/min at 200 °C. Internal 
calibration was performed using sodium formate cluster by infusing a solution 
containing 5 mM sodium hydroxide in the sheath liquid of 0.2% formic acid in 
water/isopropanol 1:1 (v/v). The same calibration solution was injected at the 
beginning of each run so that in each chromatogram the mass could be recalibrated 
providing an accurate mass acquisition. In order to assess stability of the 
instrumental performances, QC injection of hydrophilic metabolite standards was 
executed every ten samples injections. 
GC-MS 
An Agilent Technologies 5975C GC (Agilent, Palo Alto, USA) was interfaced to a 
high resolution time of flight MS (HR ToF MS, MicroToF II, Bruker Daltonik, 
Bremen, Germany) equipped with an APCI source for the analysis of the 
hydrophobic metabolites. 
All injections were performed in splitless mode with   μL volume injected using a 
25 m BPX5 (5% phenyl-methylpolysilphenylene-siloxane) column, internal 
diameter  5  μm, film thickness  . 5 μm (SG  International, Ringwood, 
Australia). The injector temperature was 275 °C and pressure 100 kPa. Helium was 
used as carrier gas with a ﬂow rate of   mL min-1. The initial oven temperature was 
set at 90 °C for 2 min, followed by a linear ramp to 260 °C at 6 °C min
-1
. 
Subsequently, the temperature was raised to 325 °C with a ramp rate of 20 °C min
-
1
and a hold time of 20 min, leading to a total run time of 58.6 min.  
The mass spectrometer was coupled to an atmospheric pressure chemical ionization 
source (APCI) operating in the positive ionization mode. The APCI vaporizer 
temperature was 400 °C, the capillary voltage was + 2500 V, the voltage of the 
corona discharge needle was + 5000 nA and end set plate was set to + 500. The 
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pressure of the nebulizer gas was 4 Bar and temperature and flow rate of the dry 
gas were 200 °C and 2 L min
-1
, respectively. A mass range from 50 to 1000 m/z at 
spectra rate of 1 Hz was used. The mass accuracy was assured calibrating the 
instrument before every chromatographic run by infusing a 1:1 v/v fatty acid APCI 
Tuning Mix (Agilent, Palo Alto, USA). In order to control the chromatographic 
performance QC injections of a fatty acid mixture were executed after every 10 
samples.  
Data Analysis 
Data Pretreatment 
The chromatograms were analysed through the software DataAnalysis 4.0 (Bruker 
Daltonik, Bremen, Germany). The first treatment step consisted of the spectra 
internal calibration using the enhanced quadratic mode. All chromatograms were 
processed with the Find Molecular Features (FMF) algorithm that combines 
isotopes, charge state, adducts and neutral losses belonging to the same compound 
into one feature. The selected settings were: S/N = 5, correlation coefficient 
threshold = 0.8, minimum compound length = 10 spectra. Each feature is defined 
by retention time, m/z value and intensity. The detected molecular features were 
analysed to assess the capability of each platform for every selected organ to 
extract metabolite features. ANOVA testing with Post hoc Tukey's HSD (honestly 
significant difference) (IBM SPSS software) was used to test if the mean 
concentrations were significantly different (p-value <0.05). 
The molecular features were processed with the software ProfileAnalysis 2.1 
(Bruker Daltonik, Bremen, Germany) to perform retention time alignment using a 
nonlinear retention time shift algorithm, bucketing and normalization. The intensity 
values were normalised to the largest bucket value in each sample in order to 
compare different samples.  
The variables of each bucket table were normalized according to the organ protein 
content using Microsoft Excel. The generated data matrix or bucket table was 
exported and imported to SIMCA-P+ 13.0 (Umetrics, Umeå, Sweden) for 
multivariate data analysis (MVDA). 
Multivariate data analysis (MVDA) 
All multivariate statistical analyses were performed with SIMCA-P+ 13.0 software 
(Umetrics, Umeå, Sweden). Hierarchical cluster analysis (HCA) is a statistical 
method useful for finding clusters on measured variables and visualizing intrinsic 
structure of the data set without a priori assumption about the origin of the samples. 
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For HCA analysis, the  uclidean distance and Ward’s linkage type to calculate the 
distance between the different generated clusters
30
. Principal component analysis 
(PCA), Partial Least Squares Discriminant Analysis (PLS-DA) and Orthogonal 
Partial Least Squares Discriminant Analysis (OPLS-DA) were performed using 
Pareto scaling where the intensity of each variable was scaled by the square root of 
that variable's standard deviation. The PLS and OPLS models were validated with 
a 7-round cross-validation procedure with exclusion of 1/7
th
 of the samples from 
the model in each round in order to avoid the model overfitting. The first two 
components were used and to study the reliability of the models a cross validation 
was carried out using CV-ANOVA (cross validated analysis of variance). The 
validation is based on an ANOVA assessment of the cross-validation (CV) 
predictive residuals of an OPLS model
31
. 
 
Results and Discussion 
Sample disruption methods 
Two different tissue disruption techniques have been compared: ultrasound assisted 
extraction (US) and bead beating using a Precellys Dual bead-beater with 1.4 mm 
ceramic (zirconium oxide) beads (BB). 
HCA has been applied to the HILIC ESI (+) metabolomic profile data to 
discriminate between the two selected tissue disruption techniques: US and BB. 
The samples could be separated into two distinct groups based on the performed 
sample preparation methods. Furthermore, the distance within the samples of the 
US group is 36.4%, and indicates more variability than the BB cluster (10.9%), 
implying a better reproducibility of the BB method (See supplementary material, 
Figure S4.1). 
The extraction yield of the tissue disruption method was also included in the 
evaluation of the method. Box plot diagrams were used to compare the differences 
in peak intensity of L. stagnalis CNS metabolites extracted either with the BB or 
US tissue disruption method. The significance difference has been calculated by a 
t-test using SPSS as shown in supplementary material, Figure S4.2. The extraction 
yield was for most of the metabolites higher for the BB tissue disruption technique. 
Guanosine, uridine, inosine and xanthine showed a significantly higher extraction 
yield with beads beating than with US. However, for adenine the yield was higher 
with the ultrasounds assisted extraction and for the three metabolites (adenosine, 
carnitine and choline) there were no significant differences between the two 
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extraction methods. US had a higher variability in results than BB. Another 
advantage of the BB method is the high-throughput because of the simultaneous 
extraction of 12 samples and its speed. In addition, the high intensity energy used 
during the ultra sound assisted extraction can breakdown some sensitive metabolite 
and eventually introduce a source of metabolome alteration
32–34
. Consequently, the 
BB technique was chosen to carry out the sample preparation extraction. 
Analytical platform comparison 
To date, few studies have examined cross-platform metabolomic approaches in 
terms of their performances and they have mainly focused on the sample 
preparation evaluation. Multi-platform approaches have been used to assess the 
solvent capability to gain the best metabolic extraction information from the 
studied tissues
35,36
. The present work extends the cross-platform metabolomics 
evaluation to its analytical platform performances in terms of platform specific 
metabolome coverage, molecular features and reproducibility.  
Platform specific metabolome coverage 
The analytical platform performances have been evaluated by their metabolome 
coverage. For this purpose, different metabolite classes have been selected ranging 
from amino acid, their derivatives cathecholamines, nucleotides involved in purine 
and pirimidine metabolism, organic acid involved in glycolysis/gluconeogenesis, 
pyruvate metabolism, tricarboxylic acid (TCA) cycle, and fatty acid taking part in 
the lipid metabolism (n=73) (See supplementary material, Table S4.1). Those 
compounds have been selected because of their broad range of physical-chemical 
properties that is commonly reflected in organ metabolite composition and due to 
their important biological roles. 
To evaluate the LC platform coverage in order to drive the optimal 
chromatographic conditions, different pHs of the mobile phase and ionization 
polarities of the detector source have been compared in triplicate. The HILIC 
platform was tested at pH 2.8 and pH 5.5 in the positive mode and at pH 5.5 and 
pH 9 in the negative mode. The buffer of choice was found to be relevant for the 
metabolome coverage, reflected in the specific selectivity of the metabolite classes, 
as is shown in Figure 4.1.   
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Figure 4.3 Analytical platform specific coverage of different hydrophilic 
metabolite classes. *1 91% of the peaks has a RT < 1.5 min; *2 88% of the peaks 
has a RT < 1.5 min. 
An overview of the detected metabolite with the different chromatographic 
condition is provided in supplementary material, Table S4.2. 
Although there were no differences among HILIC platform conditions on the total 
metabolome coverage (except for pH 5.5 in negative mode), there are differences 
between the coverage of specific metabolic classes. The ionization polarity of the 
detector has a large influence on the metabolome coverage, as expected. 
Metabolites involved in carbohydrate metabolisms showed a coverage above 80% 
using HILIC pH 9 and RP negative mode conditions, whereas they were not 
detected in the positive mode. Using the HILIC platform in ESI negative mode at 
pH 5 it was not possible to detect L-ascorbic acid and lactic acid. This is in 
accordance with previous studies and it is due to the fact that a hydroxyl group 
needs very basic conditions to be hydrolysed
37
. In fact using the HILIC-ESI(-) at 
pH 5 only pyruvic acid, succinic acid and fumaric acid could be detected because 
the hydroxy group of these metabolites are deprotonated at pH 5 due to the low 
pKa values. The nucleotide metabolites, adenine, adenosine, guanine and 
thymidine were detected across all the different platforms. The majority of the 
nucleotides were mainly detected in MS operating in negative mode with the 
exception of 2-deoxyadenosine that was detected only in ESI(+). This might be due 
to the fact that at pH lower than 5 this metabolite is protonate and the ionization is 
increased. Metabolites taking part in amino acid have been detected mainly when a 
positive ionization has been used and most of them showed the highest coverage 
with HILIC at pH 2.8. The metabolite biotin has been detected across all the 
chromatographic conditions, and carnitine has been detected only in positive mode 
due to the positive charge on the quaternary ammonium group.  
Moreover, it is interesting to notice that, although in both polarity modes the RP 
platform showed a high coverage, the chromatographic retention is poor. More 
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than 91% of the peaks had a retention time lower than 1.5 min in the positive 
mode, and >89% of the peaks in the negative mode. Therefore, most of the selected 
metabolites showed overlapping peaks in the first minute of the RP chromatogram. 
This result confirms that the RP platform is not a suitable choice for the separation 
of small polar metabolites as previously described
38,39
. By properly selecting 
HILIC chromatographic conditions it was possible therefore to increase the 
metabolome coverage for the selected metabolites. The chosen HILIC conditions 
used in this study for L. Stagnalis tissue metabotyping were HILIC-ESI(-) with a 
buffer at pH 9 since it showed the highest coverage of carbohydrates metabolites 
and HILIC-ESI(+) with a buffer at pH 2.8 to increase the coverage of amino acid 
and nucleotides. As expected, the GC-APCI(+) platform has a 100% coverage of 
the 37 analysed fatty acid. 
Molecular features 
To evaluate the analytical performances of the platforms the number of molecular 
features of the different organs was assessed. The average detected molecular 
features for each organ were compared between the analytical platforms using 
ANOVA with Tukey’s test (Figure 4.2a).  
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Figure 4.2 a) Average number of detected molecular features extracted for each 
chromatographic condition for three snail (L. stagnalis) tissue types (n=7, seven 
independent biological replicates). Platforms with different letters are significantly 
different (ANOVA Tukey’s test, p<0.05) within an organ. b) average number of 
detected molecular features for each chromatographic platform in three organs of 
L. stagnalis normalized by the analyzed tissue amount (n=7, seven independent 
biological replicates). Organs with different simbols are significantly different 
(ANOVA Tukey’s test, p<0.05) within a platform. (CNS: Central nervous system; 
AG: albumen gland; DG: digestive gland.) 
For all three organs (AG, CNS, DG) the highest significant number of molecular 
features were found with GC-APCI(+). On the other hand, for the LC platforms 
there is no significant difference between RPLC and HILIC for AG. However, for 
CNS there is a significant difference between HILIC-ESI(+) and RPLC-ESI(+), 
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and in the negative mode between HILIC-ESI(-) and RPLC-ESI(-). Although 
significant higher molecular features were found for HILIC-ESI(+) compared to 
HILIC-ESI(-) the RPLC platforms didn’t show a significant difference between the 
ionization modes. For DG the GC-APCI(+), HILIC-ESI(+) and HILIC-ESI(-) were 
significantly different in number of molecular features. The RPLC platforms were 
not significantly different compared to the other platforms, except GC-APCI. 
To make a comparison between the organs, the number of detected metabolite 
features has been normalized by the weight of the samples processed (Figure 4.2b). 
The CNS showed the highest average number of detected metabolite features in all 
the platforms whereas there was no significance difference between AG and DG 
with the exception of the GC-APCI(+) platform.  
The overall conclusion is that for the three organs investigated the ability to extract 
molecular features is GC-APCI(+) > HILIC-ESI(+) > RPLC-ESI(+). This results 
suggest that the GC-APCI(+) platform provides the most biological information for 
the hydrophobic metabolite fraction, and for the hydrophilic fraction HILIC 
provides more information than RPLC from a probabilistic point of view.  
The higher number of molecular features detected by HILIC-ESI(+) than by 
RPLC-ESI(+) can be explained by the higher number of retained metabolites with 
HILIC and the higher MS detection sensitivity
40
. In RPLC the organic solvent 
content (acetonitrile) of the mobile phase increased during the run time, in HILIC 
the opposite process occurs. In ESI MS the response depends on the organic 
solvent content of the mobile phase because in positive ionization mode cationic 
droplets dissociate only when the electric field intensity is strong enough to 
overcome the surface tension of the solvent. As acetonitrile has a lower surface 
tension than water, the higher proportion of organic solvents present in HILIC 
mobile phase enhanced the achieved MS response and as a direct consequence the 
number of detected metabolite features. 
Analytical platform reproducibility  
Reproducibility has been evaluated in terms of retention times (RT), full width at 
half maximum (FWHM), and peak intensity (I) for a selected group of metabolites 
found in seven independent snail replicates and in three organs (CNS, AG and DG) 
with the different analytical platforms. Peak intensity data were normalized using 
the organ protein content measured with the Bradford assay. 
The relative standard deviations (RSD) of the retention times were < 4% for all the 
platforms (Table 4.1). 
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Table 4.1 Analytical platform performances evaluated in terms of retention times (RT), full width at half maximum (FWHM) 
and peak intensity (I) on seven independent snail organ replicates. 
Chromatography Metabolite Organ 
RT [min] FWHM [min] I 
Average RSD% (n=7) Average 
RSD% 
(n=7) 
RSD% 
(n=7) 
HILIC-ESI(+) 
Choline 
CNS 6.07 0.12 0.13 3.56 26.5 
AG 6.07 0.21 0.14 11.6 25.1 
DG 6.05 0.15 0.20 9.62 17.4 
Inosine 
CNS 6.53 0.20 0.14 12.9 19.9 
AG 6.54 0.17 0.14 30.7 17.9 
DG 6.53 0.08 0.14 3.91 17.1 
Carnitine 
CNS 10.1 0.04 0.12 5.89 16.8 
AG 10.1 0.14 0.11 4.69 5.86 
DG 10.1 0.04 0.11 0.01 8.67 
HILIC-ESI(-) 
Xanthine 
CNS 1.81 6.03 0.07 33.1 18.1 
AG 1.80 2.87 0.10 0.01 20.2 
DG 1.80 2.87 0.10 0.01 40.2 
Adenine 
CNS 3.48 0.35 0.08 13.4 31.8 
AG 3.50 1.48 0.10 0.01 35.7 
DG 3.50 0.01 0.10 0.01 41.1 
Uridine 
CNS 3.65 18.7 0.08 28.7 17.4 
AG 3.70 1.40 0.10 0.01 20.1 
DG 3.70 0.01 0.10 0.01 37.3 
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RP-ESI(+) 
Aspartic acid 
CNS 1.04 1.21 0.15 50.9 17.6 
AG 1.11 2.78 0.12 48.7 19.1 
DG 1.03 0.73 0.09 14.1 23.1 
Guanosine 
CNS 1.13 0.33 0.06 8.13 19.8 
AG 1.13 0.51 0.06 8.33 30.4 
DG 1.13 27.9 0.06 40.1 24.4 
Phenylalanine 
CNS 1.27 0.01 0.06 6.30 18.4 
AG 1.27 0.01 0.06 10.5 37.7 
DG 1.27 0.35 0.06 0.01 26.7 
GC-APCI(+) 
Myristic acid 
CNS 11.4 0.17 0.15 32.8 23.8 
AG 11.4 0.16 0.10 19.1 38.7 
DG 11.4 0.05 0.09 25.4 35.5 
Palmitic acid 
CNS 13.5 0.04 0.08 10.2 32.3 
AG 13.6 0.17 0.07 35.9 21.8 
DG 13.6 0.12 0.11 27.3 2.96 
Stearic acid 
CNS 16.2 0.05 0.08 32.4 33.6 
AG 16.2 0.29 0.09 19.9 14.5 
DG 16.3 0.16 0.10 8.94 12.1 
Arachidonic 
acid 
CNS 18.4 0.05 0.09 9.30 26.6 
AG 18.5 0.38 0.12 31.5 36.2 
DG 18.5 0.17 0.08 19.7 23.8 
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Although HILIC retention times are more affected by the column conditioning
41,42
, 
HILIC-ESI(+) showed the best performances with an average RSD of 0.12%, 
followed by GC-APCI(+) with 0.15%. The HILIC platforms showed 49% better 
reproducibility than RPLC. 
Considering the FWHM, HILIC platforms had the lowest average relative standard 
deviation (RSD) of 8.8% and a range of 0.01-28.7% , whereas the RP and GC-
APCI platforms showed average RSDs of 21% and 23%, respectively. Therefore, 
the HILIC platforms provided 62% higher overall reproducibility for peak width. 
This data is in contrast with the fact that HILIC peak shapes are often distorted 
compared to RPLC
43
. 
The variation in peak intensities was always below 26% for all the 
chromatographic platforms. Thus, the intensity reproducibility is neither influenced 
by the chosen platform or by the analysed organs. Considering that the relatively 
high variability also includes the biological variability within snail individuals, as 
seven independent snail replicates were analysed, these results are acceptable.  
These results showed that the HILIC platforms had the best performances in terms 
of RT, FWHM and peak intensity reproducibility. 
Organ specific metabolome 
Organ metabotypes 
In order to define the organ metabotypes we have searched for 73 target 
metabolites across the different chromatographic platforms. The albumen and 
digestive gland organs yielded the highest number of detected and shared 
metabolites compared to the CNS. Nonetheless those organs showed unique 
metabolites. In particular the AG organs were more abundant in fatty acid whereas 
the DG organs were richer in unique polar metabolites (Table 4.2).  
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Table 4.2 Target metabolites detected in each L. stagnalis organs. 
 
 
 
 
 
 
 
 
 
 
 
  
POLAR METABOLITES 
UNPOLAR 
METABOLITES 
Total Metabolites 
AMINOACI
DMetabolism 
NUCLEOTIDES 
Metabolism 
CARBOHYDRATES 
Metabolism 
Total 
Polar 
FATTY 
ACID 
AG 43 7 7 2 16 27 
DG 40 7 8 1 16 24 
CNS 30 7 7 0 14 15 
Shared Metabolites  
AG and DG 
AG and CNS 
CNS and DG 
5 7 2 14 21 
5 7 0 12 15 
5 7 0 12 15 
Unique Metabolites 
AG 
 
0 0 1 1 4 
DG 
 
1 1 0 2 2 
CNS 
 
0 0 0 0 0 
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This evidence is in accordance with the number of metabolite features extracted by 
the GC-APCI(+) platform where AG organs have shown to be significantly 
different from the other organs, and by the HILIC-ESI(+) platform where a 
significant difference has been shown between AG and DG (Figure 4.2). 
The different organ metabolome compositions allow the characterization of 
specific and peculiar metabolic patterns for both hydrophilic (See supplementary 
material, Figure S4.3) and hydrophobic metabolites (See supplementary material, 
Figure S4.4). 
Since the L. stagnalis metabolome has not been characterized before, this number 
of detected metabolites in the different studied organs represents an important 
baseline of metabolic data for this model organism. 
Clustering performances 
For each tested chromatographic platform, PLS-DA models have been built to 
evaluate, classify and cluster the snail different organs. The PLS-DA score plots 
were investigated to evaluate the ability of the different platforms to differentiate 
the organs of L. stagnalis. The PLS-DA score plot of the HILIC-ESI(+) platform 
showed the highest clustering of the three organs of the tested platforms (Figure 
4.3).  
 
 
Figure 4.3 PLS-DA score plot of L. stagnalis albumen gland (AG), digestive gland 
(DG) and central nervous system (CNS) organ clustering. These data were obtained 
from the chromatographic runs of HILIC-ESI(+) platform. 
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The distance between CNS and DG using HILIC-ESI(+) is higher than for the 
other platforms, and the difference between these organs is mainly due to polar 
metabolites detected with this platform. 
The clustering performances have been investigated further by applying the 
Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA). This method 
is used to find correlations between two organs and the predictive value 
representing the correlated variation between X and Y is given by R
2
Y (cum). The 
advantage of this method is its ability to calculate other types of uncorrelated 
variation between two organs that is given by the parameter R
2
X (cum) 
orthogonal
44
. This source of variability doesn’t comprise random variation, which 
is not considered in the model, but is a systematic variation associated with the 
experiment. This systematic variability can come from two sources; an unknown 
source like the instrumental variability and a known source such as the biological 
variability of the samples set. In fact, this value should be as low as possible 
especially in comparison to the R
2
Y predictive. Therefore, in the metabolomic 
experimental design the orthogonal R
2
X (cum) value is crucial in order to decrease 
the uncorrelated variability that doesn’t provide relevant information to 
discriminate the samples. For this purpose, normalization and standardization 
improvements should be achieved and the biological variability should be reduced 
by including a higher number of biological replicates or by selecting a more 
homogenous group of individuals.  
For this reason, OPLS-DA models were assessed with each platform for each pair 
of organs (AG / DG, CNS / AG and CNS / DG). The model statistic parameters 
R
2
X (cum) predictive and orthogonal were calculated in order to evaluate the 
cluster performances and the intra cluster variability. Moreover, to assess the 
statistical significance of the models the cross-validated residuals ANOVA (CV-
ANOVA) p values were used to compare the platform performances for each pair 
of organs. The calculated parameters of the OPLS-DA models are shown in Table 
4.3. 
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Table 4.3 OPLS-DA model calculations to evaluate the analytical platform 
clustering performances of L. stagnalis organ specific metabolomics. 
The OPLS-DA model for the RPLC-ESI(+) platform was unable to separate the 
organs. In case of the RPLC-ESI(-) platform, there was no statistical difference 
between the CNS and AG. However, the PLS-DA and OPLS-DA score plots 
showed a high specificity for DG. Moreover, the intergroup variation from the 
R
2
X(cum) orthogonal values of the AG / DG model and CNS / DG model was 
high, contributing only 6% and 9%, respectively, to the model predictions of the 
organs. The HILIC-ESI(+) platform was the only selected platform able to 
discriminate the three L. stagnalis organs and, consequently, provide an organ 
specific metabolome. The only statistically significant OPLS-DA model for the 
HILIC-ESI(-) platform was the AG / DG and, in fact, from the interpretation of the 
PLS-DA score plot there was no specificity for the CNS organ. Finally, OPLS-DA 
showed that GC APCI (+) was able to separate CNS from AG and DG, but this 
platform was not able to separate AG from DG. This indicates that only small 
differences in the hydrophobic metabolite profiles between the organs were found. 
Another issue is the high intra- variability of the CNS/AG and CNS/DG models 
Analytical 
condition 
OPLS-DA Model 
Classes 
CV 
ANOVA 
p value 
R
2
X(cum) 
Predictive 
R
2
X(cum) 
Orthogonal 
RP ESI (+) AG / DG >0.05 - - 
RP ESI (+) CNS / AG >0.05 - - 
RP ESI (+) CNS / DG >0.05 - - 
RP ESI (-) AG / DG 2.3e
-5
 0.36 0.06 
RP ESI (-) CNS / AG >0.05 - - 
RP ESI (-) CNS / DG 2.8e
-2
 0.35 0.09 
HILIC ESI (+) AG / DG 8.1e
-5
 0.38 0.14 
HILIC ESI (+) CNS / AG 1.1e
-6
 0.50 0.13 
HILIC ESI (+) CNS / DG 3.0e
-5
 0.37 0.14 
HILIC ESI (-) AG / DG 3.8e
-04
 0.43 0.20 
HILIC ESI (-) CNS / AG >0.05 - - 
HILIC ESI (-) CNS / DG >0.05 - - 
GC APCI (+) AG / DG >0.05 - - 
GC APCI (+) CNS / AG 9.9e
-04
 0.25 0.23 
GC APCI (+) CNS / DG 2.7e
-02
 0.22 0.27 
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where the variation between the groups is similar to the variation inside the groups. 
This large variability results in a poor reproducibility of the GC platform. 
 
Conclusions 
A cross-platform metabolomics study and a systematic evaluation of the different 
platform performances is presented. The HILIC-ESI(+) showed the best 
performance in terms of reproducibility of retention times, FWHM and peak 
intensity. Moreover, in terms of detected molecular features this platform showed 
the highest number of molecular features (CNS n=493; AG n=414; DG n=628) 
confirming its ability to be a more informative platform compared to reverse phase 
LC. Furthermore, the clustering performance of the HILIC-ESI(+) was the only 
platform able to distinguish different organs, suggesting that the hydrophilic 
metabolome has the highest contribution to the organ discrimination. 
Organ specific metabotypes of L. stagnalis were found. To our knowledge, this is 
the first study carrying out a metabolomics study on the freshwater snail L. 
stagnalis. The different organ profiles provide the metabolome basis of L. stagnalis 
and open the way for future metabolomics applications with this model organism. 
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Chapter 4 - Supporting Information 
Tables: 
Table S4.1. Metabolite standard compounds 
Metabolite Standard Mixture 
Butyric Acid Hydrophobic mixture 
Hexanoic Acid Hydrophobic mixture 
Octanoic Acid Hydrophobic mixture 
Decanoic Acid Hydrophobic mixture 
Undecanoic Acid Hydrophobic mixture 
Dodecanoic Acid Hydrophobic mixture 
Tridecanoic Acid Hydrophobic mixture 
Myristoleic Acid Hydrophobic mixture 
Myristic Acid Hydrophobic mixture 
cis-10-Pentadecenoic Acid Hydrophobic mixture 
Pentadecanoic Acid Hydrophobic mixture 
Palmitoleic Acid Hydrophobic mixture 
Palmitic Acid Hydrophobic mixture 
cis-10-Heptadecenoic Acid Hydrophobic mixture 
Heptadecanoic Acid Hydrophobic mixture 
γ-Linolenic Acid Hydrophobic mixture 
α-Linolenic Acid Hydrophobic mixture 
Linoleic Acid Hydrophobic mixture 
Linolelaidic Acid Hydrophobic mixture 
Elaidic Acid Hydrophobic mixture 
Oleic Acid Hydrophobic mixture 
Stearic Acid Hydrophobic mixture 
cis-5,8,11,14,17-Eicosapentaenoic Acid Hydrophobic mixture 
Arachidonic Acid Hydrophobic mixture 
cis-11,14,17-Eicosatrienoic Acid Hydrophobic mixture 
cis-8,11,14-Eicosatrienoic Acid Hydrophobic mixture 
cis-11,14-Eicosadienoic Acid Hydrophobic mixture 
cis-11-Eicosenoic Acid Hydrophobic mixture 
Arachic Acid Hydrophobic mixture 
Henicosanoic Acid Hydrophobic mixture 
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cis-4,7,10,13,16,19-Docosahexaenoic Acid Hydrophobic mixture 
cis-13,16-Docosadienoic Acid Hydrophobic mixture 
Erucic Acid Hydrophobic mixture 
Docosanoic Acid Hydrophobic mixture 
Tricosanoic Acid Hydrophobic mixture 
cis-15-Tetracosenoic Acid Hydrophobic mixture 
Tetracosanoic Acid Hydrophobic mixture 
Pyruvic Acid Hydrophilic mixture 
Fumaric Acid Hydrophilic mixture 
Lactic Acid Hydrophilic mixture 
Succinic Acid Hydrophilic mixture 
L-Ascorbic Acid Hydrophilic mixture 
Malonic Acid Hydrophilic mixture 
Adenine Hydrophilic mixture 
2-Deoxyadenosine Hydrophilic mixture 
Adenosine Hydrophilic mixture 
Thymidine Hydrophilic mixture 
Guanine Hydrophilic mixture 
Xanthine Hydrophilic mixture 
Cytidine Hydrophilic mixture 
Uridine Hydrophilic mixture 
2-Deoxyguanosine Hydrophilic mixture 
Inosine Hydrophilic mixture 
Guanosine Hydrophilic mixture 
Acetylcholine Hydrophilic mixture 
3-Methoxytyramine Hydrophilic mixture 
Tyramine Hydrophilic mixture 
Histamine Hydrophilic mixture 
Choline Hydrophilic mixture 
GABA Hydrophilic mixture 
Homovanillyl alcohol Hydrophilic mixture 
3,4-Dihydroxyphenylacetic Acid Hydrophilic mixture 
Serotonin Hydrophilic mixture 
5-Hydroxyindoleacetic Acid Hydrophilic mixture 
Tryptophan Hydrophilic mixture 
Phenylalanine Hydrophilic mixture 
Epinephrine Hydrophilic mixture 
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Aspartic Acid Hydrophilic mixture 
Norepinephrine Hydrophilic mixture 
Dopamine Hydrophilic mixture 
Tyrosine Hydrophilic mixture 
5-Hydroxy-L-Tryptophan Hydrophilic mixture 
Carnitine Hydrophilic mixture 
Biotin Hydrophilic mixture 
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Table S4.2. List of detected metabolites in the different chromagraphic runs (n=3). 
Metabolite Class 
Chromatographic condition tested 
HILIC pH 2.8 - ESI (+) HILIC ph 5.5 - ESI (+) RP - ESI (+) HILIC pH 5.5 - ESI (-) HILIC pH 9.0 - ESI (-) RP - ESI (-) 
3-Methoxytyramine Amino acid  √ √ √ √ x x 
5-Hydroxyindoleacetic Acid Amino acid  √ √ √ √ x √ 
5-Hydroxy-L-Tryptophan Amino acid  √ x √ √ x x 
Acetylcholine Amino acid  √ √ √ x x x 
Choline Amino acid  √ √ √ x x x 
3,4-Dihydroxyphenylacetic Acid Amino acid  √ x x x x x 
Dopamine Amino acid  √ x √ √ x x 
Epinephrine Amino acid  √ √ √ √ x x 
GABA Amino acid  √ √ x x x x 
Histamine Amino acid  √ √ √ x x x 
Homovanillyl alcohol Amino acid  √ √ x x x x 
Norepinephrine Amino acid x x √ √ x x 
Phenylalanine Amino acid √ √ √ x x x 
Serotonin Amino acid √ √ x x x x 
Tryptophan Amino acid √ √ √ √ x x 
Tyramine Amino acid √ √ √ x x √ 
Tyrosine Amino acid √ √ √ x x √ 
Fumaric acid Carbohydrate x x x √ √ √ 
Lactic Acid Carbohydrate x x x x √ √ 
L-Ascorbic acid Carbohydrate x x x x √ x 
Pyruvic acid Carbohydrate x x x √ √ √ 
Succinic acid Carbohydrate x x x √ √ √ 
2-Deoxyadenosine Nucleotide √ √ √ x x x 
2-Deoxyguanosine Nucleotide x √ √ √ √ √ 
Adenine Nucleotide √ √ √ √ √ √ 
Adenosine Nucleotide √ √ √ √ √ √ 
Cytidine Nucleotide √ √ √ √ √ x 
Guanine Nucleotide √ √ √ √ √ √ 
Guanosine Nucleotide x x √ √ √ √ 
Inosine Nucleotide x √ x √ √ √ 
Thymidine Nucleotide √ √ √ √ √ √ 
Uridine Nucleotide x √ x √ √ √ 
Xanthine Nucleotide x x x √ √ √ 
Biotin Others √ √ √ √ √ √ 
Carnitine Others √ √ √ x x x 
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Figures: 
Figure S4.1 A HCA dendrogram (Ward’s linkage and sorted by size) based on the 
HILIC ESI (+) platform data of tissue disruption sample preparation. The right blue 
branch corresponds to the ultrasound assisted extraction method and the left green 
branch represents the beads beating extraction procedure. BB: beads beating; US: 
ultrasonic. 
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Figure S4.2 Box plot diagrams analyzing the differences in peak intensity 
(logarithmic scale, base 10) of L. Stagnalis CNS metabolites extracted either with 
the beads beating (BB) or ultrasound assisted (US) tissue disruption method.  
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Figure S4.3 Metabolic profiles of polar metabolites detected in L. stagnalis central nervous system (CNS), albumen gland (AG) 
and digestive gland (DG). The peak intensity of each metabolite has been normalized for the sum of peak intensities of detected 
metabolites in the sample. This figure is shown in logarithmic scale. 
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Figure S4.4 Metabolic profiles of fatty acids detected in L. stagnalis central nervous system (CNS), albumen gland (AG) and 
digestive gland (DG). The peak intensity of each metabolite has been normalized for the sum of peak intensities of detected 
metabolites in the sample. This figure is shown in logarithmic scale. 
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Abstract 
Modern toxicology is seeking new testing methods to better understand 
toxicological effects. One of the most concerning chemicals is the neonicotinoid 
pesticide imidacloprid. Although imidacloprid is designed to target insects, recent 
studies have shown adverse effects on non-target species. Metabolomics was 
applied to investigate imidacloprid-induced sublethal toxicity in the CNS of the 
freshwater snail Lymnaea stagnalis. The snails (n=10 snails) were exposed for 10 
days to increasing imidacloprid concentrations (0.1, 1, 10 and 100 µg/L).  
The comparison between control and exposure groups highlighted the involvement 
and perturbation of many biological pathways. The levels of several metabolites 
belonging to different metabolite classes were significantly changed by 
imidacloprid exposure. A change in the amino acids and nucleotide metabolites 
like tryptophan, proline, phenylalanine, uridine and guanosine was found. Many 
fatty acids were down-regulated and the levels of the polyamines, spermidine and 
putrescine, were found to be increased which is an indication of neuron cell injury. 
A turnover increase between choline and acetylcholine led us to hypothesize an 
increase in cholinergic gene expression to overcome imidacloprid binding to the 
nicotinic acetylcholine receptors. Metabolomics revealed imidacloprid induced 
metabolic changes at low and environmentally relevant concentration in a non-
target species and generated a novel mechanistic hypothesis.  
 
Introduction 
Over the past decades, the presence of manufactured chemicals in the environment 
has raised concerns because of their potential lethal as well as sublethal effects on 
organisms, resulting in ecosystem functionality damages
1
. The environmental risk 
assessment guidelines (e.g. Water Framework Directive, 2000) are currently based 
on phenotypical endpoint effects, measured by acute and chronic lethal 
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concentrations and with experiments focusing on effects such as mobility, 
ventilation and reproduction (www.OECD.org). These types of toxicity testing are 
Should say incapable of mimicking a realistic environmental exposure scenario and 
are failing to predict effects in anything other than the target species
2
.  
To test the possible sublethal toxic effects of environmental pollutants in the past 
decades several biochemical biomarkers have been developed
3
. Among these, 
enzymatic assays indicate toxic effects because the activity of these biomarker 
enzymes has been linked to oxidative stress
4
. One of these enzymatic tools is the 
 llman’s cholinesterase assay, which provides a simple colorimetric determination 
of acetylcholinesterase (AChE) activity. To investigate toxic effects induced by 
pesticides, the AChE bioassay is commonly applied and is especially effective in 
determining the toxicity of organophosphate and carbamate pesticides, because 
these compounds directly block AChE
5
. 
Nowadays, after the introduction on the market of the neonicotinoid pesticide 
imidacloprid in 1991 by Bayer CropScience, the global insecticides market is 
dominated by this new class of pesticides
6,7
. Due to its extensive application and 
combined with the high persistency and leaching potential
8,9
, imidacloprid 
concentrations in water bodies have been found to exceed the regulatory norms in 
several countries
10–13
. Recently, this compound gained attention due to its 
significant ecotoxicological effects
14
. The pesticide is considered to be insect-
specific, as it acts mainly as an agonist of the nicotinic acetylcholine receptors 
(nAChRs) on the post-synaptic membrane of neuronal cells of insects
15,16
. 
However, recent reports indicate a decline in non-target species in surface waters 
contaminated with imidacloprid, demonstrating serious cascading effects of 
imidacloprid on aquatic and terrestrial ecosystem functionality
10,17,18
.  
Due to the different mode of action of imidacloprid, an alternative strategy to the 
AchE bioassay should be found to warrant the investigation of imidacloprid-
induced toxicity in non-target species. To this extent, promising alternatives to 
traditional toxicity testing are found in the “omics” field19. Transcriptomics, 
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proteomics and metabolomics can measure changes in intracellular functioning 
upon exposure to toxicants at lower concentrations than traditional toxicity testing 
methods and can focus on numerous endpoints (genes, proteins and metabolites) 
simultaneously 
20. The combination of these “omics” techniques in a system 
biology approach will enable a more accurate determination of the mechanism of 
action of toxicants, which may improve environmental risk assessment
21,22
. 
Compared to the other omics, metabolomics has the advantage that metabolites are 
more conserved across species and therefore this approach is more suited to 
determine conserved endpoints
23
. Metabolomics is adding to the base of knowledge 
on the ecotoxicological effects of compounds that are of immediate concern to 
environmental health
22–24
. 
To further improve the base of evidence of imidacloprid toxicity the effect of 
imidacloprid on non-target species should be more thoroughly investigated. A 
promising species to study imidacloprid-induced sublethal effects is the freshwater 
snail Lymnaea stagnalis. This species is a globally distributed inhabitant of 
freshwater ecosystems and a model organism in environmental toxicology and 
neurobiology
25,26
. L. stagnalis has been applied as a model organism in the omics 
field, as shown by the increasing number of recent publications
25,27–30
. 
In this study, a ten day exposure to imidacloprid at environmentally relevant 
concentrations (0.1 µg/L and 1.0 µg/L) and higher concentrations (10 and 100 
µg/L) was carried with L. stagnalis. Each exposure group comprised 10 snails and 
along the exposure experiment a control group with 10 snails not exposed to 
imidacloprid was used. Effects on reproduction and on the activity of acetylcholine 
esterase (ACh ) of the snails’ central nervous systems (CNSs) were examined. To 
assess the toxicity of imidacloprid at the molecular level, multiple metabolomics 
approaches were applied and compared to traditional toxicity assessment methods. 
A metabolomics targeted approach based on hydrophilic interaction liquid 
chromatography (HILIC) coupled to tandem mass spectrometry (MS) was 
performed to profile neurotransmitters in the CNSs of the exposed L. stagnalis. A 
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non-targeted metabolomics strategy based on liquid chromatography (LC) and gas 
chromatography (GC) coupled to high accuracy MS was used to investigate 
changes in hydrophilic and hydrophobic metabolites after imidacloprid exposure. 
Multivariate data analysis (MVDA) and multiple t-test with false discovery rate 
(FDR) correction was employed to determine the metabolites contributing to the 
differences between the control group and exposed groups and potential 
biomarkers of exposure were identified. Biochemical networks were created to 
provide mechanistic insights into the metabolic pathways associated with 
imidacloprid toxicity. 
 
Materials and Methods 
Reagents and Materials 
Milli-Q water was obtained from a Millipore purification system (Waters-Millipore 
Corporation, Milford, MA, USA). HPLC grade acetonitrile (ACN) and methanol 
(MeOH) were from JT Baker Chemical (Phillipsburg, NJ, USA). MS grade formic 
acid (98% purity) and sodium formate salt (purity ≥ 99%) were obtained from 
Fluka (Steinheim, Germany). Chloroform, hexane and isooctane were obtained 
from Sigma-Aldrich (Schnelldorf, Germany).  
Hydrophilic standards (amino acids, sugars, organic acids, neurotransmitters and 
nucleotides) and the hydrophobic standard mixture, consisting of 37 fatty acid 
methyl esters, were purchased from Sigma-Aldrich. The hydrophilic metabolites 
were mixed in ACN:H2O 90:10 v/v at a concentration of 1 mg/L and the fatty acid 
methyl esters mixture was diluted to 1 mg/L in isooctane. These standards were 
used as quality control (QC) for the LC-MS and GC-MS analysis, respectively. The 
MS metabolite library of standards (MSMLS) was obtained from IROA 
Technologies (Ann Arbor, Michigan, USA) and the mixtures of metabolites were 
prepared as described by the manufacturer. A list of all the analytical standards 
used can be found in supporting information, Table S5.1. The stable isotope-
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labeled internal standards of 3-MT-d4, acetylcholine-d4, serotonin-d4, 5-HIAA-d5, 
L-tryptophan-d3 and GABA-d6 were from CND Isotopes (Quebec, Canada). 
DOPA-d3, dopamine-d4, L-tyrosine-d4, epinephrine-
13
C2 
15
N, choline-d
13
 and 
glutamate-d5 were obtained from Cambridge Isotope Laboratories (Andover, MA, 
USA). Glutamine-
13
C 
15
N, norepinephrine-d6 and 5-hydroxy-L-tryptophan-d4 were 
bought from Toronto Research Chemicals (Toronto, Ontario, Canada). 
Imidacloprid analytical standard (99.9%) and imidacloprid-d4 were purchased from 
Sigma-Aldrich.  
L. stagnalis selection and exposure 
L. stagnalis snails used in our study were sixteen weeks old, with an average shell 
length of 26.14 ± 0.69 mm, and from a synchronized population, cultured at the 
VU University Amsterdam, The Netherlands. In the breeding facility the snails 
were kept in a circulation system of copper-free fresh water (averaged water 
characteristics: hardness 1.48 mmol/L, pH 8.12, total organic carbon 1.9 mg/L) at 
20 ± 1ºC in a 12 h/12 h light-dark cycle and fed on lettuce leaves ad libitum. 
The snails were individually exposed for ten days to different concentrations of 
imidacloprid (control, 0.1 µg/L, 1.0 µg/L, 10 µg/L and 100 µg/L). The control and 
exposure groups were composed by 10 snails each. Two days prior to the exposure 
the snails were acclimatized in glass beakers with copper-free water. Afterwards, 
the glass beakers were filled with 150 mL of copper-free water spiked with 
different concentrations of imidacloprid, previously dissolved in cupper free water. 
The beakers were placed in a climate room at 20 °C in a 8:16-h light:dark cycle. A 
suspension of  5  μL TetraPhyll fish feed in copper-free water (133 g/L) was 
added daily. 
Effects on reproduction were assessed by measuring the number of laid eggs and 
the dry weight of the egg clutches. Every other day, egg clutches were collected 
and the eggs were counted using the cell counter plug-in of the image analysis 
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software, ImageJ. The egg clutches were dried at 50 °C for 12 hours and weighed 
(see supporting information).  
Imidaclopid exposure concentrations 
The exposure media solutions were refreshed every second day. Samples of the 
exposure solutions were collected and analyzed with LC triple quadrupole (QqQ) 
mass spectrometer (QqQ) to determine actual exposure concentrations. The internal 
standard was added to the water samples in a final concentration of 5 ng/mL. 
Analysis were carried out with a Agilent (Palo Alto, USA) 1260 infinity binary 
liquid chromatography system coupled to an Agilent (Palo Alto, USA) QqQ 6410 
series. A pentafluorophenyl column (100 x 2.1 mm 3.5 µm particle size) from 
Phenomenex was used at a flow rate of 0.2 mL/min. The mobile phase composition 
was H2O 0,1% formic acid and MeOH and the elution was achieved with a gradient 
from 20% to 90% of MeOH in six minutes. The electrospray source (ESI) was 
operated in positive mode and the following parameters were set: gas temperature, 
350 °C; gas flow 6 L/min; nebulizer pressure, 40 PSI and ESI capillary voltage, 
3000 V. The MS data acquisition was carried out in multiple reaction monitoring 
(MRM) mode. The calibration line ranged from 0.05 µg/L (LOQ) to 1000 µg/L and 
was linear with a correlation coefficient (R
2
) of > 0.98. The MRM transitions 
monitored for imidacloprid were  56.  →  75.  (identification) and  56.  → 
209.1 (quantification) and for imidacloprid-d4 were  6 .  →   3.  (identification) 
and  6 .  →  79.  (quantification). The fragmentor was set to 9  V, the collision 
energy at 30 eV and the dwell time was set at 50 ms for all transitions. Data 
acquisition and analysis using the QqQ was performed with a MassHunter 
Workstation by Agilent. The actual concentrations of the 0.1 and 1 µg/L) groups 
were in the range of the nominal concentrations, see supporting information Figure 
S5.3. The actual concentrations of the 10 and 100 µg/L groups were about three 
times lower than the nominal concentrations. The stability of imidacloprid 
concentrations in the exposure media were assessed before carrying out the 
exposure experiment (see Supporting Information).  
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Sample preparation 
After the exposure experiment, the snails were sacrificed by snap freezing in liquid 
nitrogen. The CNSs were dissected and the sample preparation was carried out 
following a two-step extraction with the Precellys®24 Dual device (Bertin 
Technologies, France) operating at 6500 rpm for two cycles of 10 sec with a 15 s 
break between cycles. The first extraction step was performed with milliQ water. 
From the aqueous homogenate 10 µL and 15 µL were withdrawn from the 
homogenate to perform the Bradford and Ellman assays, respectively. Chloroform 
and a mixture of neurotransmitters stable isotope-labelled internal standards in 
MeOH was added to the homogenate and in order to reach the final solvent 
composition of 1:1:1 v/v/v H2O:MeOH:CHCl3 in the final volume of 5   μL. The 
homogenates were kept in ice for 10 min to allow the metabolite partitioning in the 
biphasic mixture. The samples were centrifuged in a precooled centrifuge (Heraeus 
Biofuge Stratos, Heraeus Instruments, Germany) at 4 °C for 10 minutes at 17,000 
rpm and the hydrophilic fractions were dried in a Centrivap Concentrator 
(Labconco Co., MO, USA) for 240 minutes at 20 ºC. The residues were 
reconstituted in     μL of mobile phase, vortexed and centrifuged again. The clear 
solutions were transferred to autosampler vials for analysis. The chloroform 
fractions containing the lipophilic metabolites were dried under a gentle flow of N2 
and then derivatized with 500 µL of BF3 methanolic solution kept for 30 min at the 
temperature of 80 °C. After cooling, a liquid-liquid extraction was performed three 
times with 500 µL of hexane. The hexane fractions were reconstituted in an 
autosampler vial and evaporated till dryness with nitrogen and finally, 200 µL of 
isooctane was added. 
Acetylcholinesterase activity assay 
The experimental setup of the AChE bioassay has is described in the Supporting 
information. 
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Metabolomics 
A targeted metabolomics analysis of neurotransmitters, precursors and metabolites 
was performed with MS/MS based on the method by Tufi et al.
31
. A cross-platform 
non-targeted metabolomics approach, based on HILIC high resolution Time of 
Flight (ToF) and GC-HRToF coupled to atmospheric pressure chemical ionization 
(APCI), was used to profile the hydrophilic metabolites and the chloroform fraction 
respectively according to Tufi et al.
28
.  
Data analysis 
The data were normalized for the CNS protein content and outliers were removed 
using the Dixon’s   test. The analysis of variance (ANOVA) with post hoc 
Tukey's honestly significant difference (HSD) was performed with the software 
SPSS (IBM).  
The high-resolution (HR)-ToF chromatograms were analyzed with Compass 
DataAnalysis software (Bruker Daltonik, Bremen, Germany) where a mass 
accuracy below 5 ppm was assured by calibrating chromatograms using sodium 
nitrate calibration curves. The chromatograms were analysed with the software 
DataAnalysis 4.0 (Bruker Daltonik, Bremen, Germany). The first data treatment 
step consisted of a internal calibration of the spectra using the enhanced quadratic 
mode. The peak intensities of the detected metabolites in all HILIC-ToF and GC-
ToF data were normalized for the CNS protein content. 
Based on the MSMLS, a target list was created and with the software 
PathwayScreener (Bruker Daltonik, Bremen, Germany) a batch targeted analysis 
was performed. The acquired LC and GC HR-MS chromatograms were then 
automatically screened for the accurate masses of metabolites in the target list. The 
results were exported to ProfileAnalysis 2.1 (Bruker Daltonik) that performs 
exclusion of outliers based on the interquartile  
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Results and Discussion 
Neuronal metabolism disruption 
On the basis of imidacloprid mode of action, a biologically driven targeted 
metabolomics analysis was carried out. Since imidacloprid binds to the ACh 
receptor on the post-synaptic membrane of neuronal cells, the neuronal metabolism 
was investigated by quantifying the levels of the main neurotransmitters, their 
metabolites and precursors. Of the twelve quantified neurotransmitters, metabolites 
and precursors, the levels of eight metabolites were significantly (p-value < 0.05, t-
test) changed by imidacloprid, Figure S5.4. These metabolites are: choline, 
acetylcholine, glutamate, glutamine, serotonin, tryptophan, phenylalanine and 
histidine. Four of these metabolites were significantly different at more than two 
exposure concentrations: choline, acetylcholine, phenylalanine and histidine. 
Most of the changes appear indeed to be implicated with the cholinergic system in 
accordance with the mode of action of imidacloprid. Acetylcholine decreases and 
the observed increase of the choline/acetylcholine ratio (Figure 5.1) might indicate 
a possible increase in the cholinergic gene expression. 
 
Figure 5.1 Choline (Ch)/ acetylcholine (ACh) ratio in L. stagnalis CNS exposed to 
increasing concentration of imidacloprid (IMI). Statistical significance (n=10; error 
bars = SD; * = p-value < 0.05, t-test).  
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This mechanism might take place in the synaptic cleft to enhance the clearance of 
acetylcholine, which accumulates because of the binding of imidacloprid to the 
nACh receptors. This compensatory strategy would then lead to a feedback 
increase of acetylcholine esterase (AChE) that has been previously observed in 
association with acute stress and AChE inhibitors
35
. The CNS extracts of the 
exposed snails were tested in the AChE activity assay. A slight increase in the 
AChE activity related to increased exposure concentrations was observed (Figure 
S5.5). The group exposed to the highest imidacloprid concentration showed an 
average AChE activity of 156.2 ± 33.6 % compared to the control group (unpaired 
t-test, confidence interval 90%). Despite the large number of biological replicates, 
the coefficients of variation (CV%) in the exposed groups were above 30%. The 
incubation period of 10 days may have been too short to show any significant 
effects on AChE activity. However, a significant reduction of AChE activity after 
only 7 days of exposure at 25 µg/snail was previously reported in the land snail 
(Helix aspera)
36
. A significant inhibition of AChE activity was observed at 0.1 
mg/L and 1.0 mg/L in exposed mussels gills
37
. In blood and brain of rats exposed 
to imidacloprid an enzyme inhibition was shown as well
38,39
. Phenotypical 
endpoints like locomotion and ventilation of Chironomus riparius Meigen larvae 
showed to be more sensitive to imidacloprid exposure than AChE activity
40
. On the 
contrary an increase in AChE activity was observed in caged bees in response to 
imidacloprid exposure
41
. Even though AChE has been suggested as potential 
biomarker of imidacloprid exposure
38,41
 the effect of imidacloprid on AChE 
activity appears to be species-specific or not significant. On the basis of these 
results, AChE cannot be used to assess imidacloprid-induced sublethal effects and 
is not suitable as biomarker for imidacloprid exposure. 
Metabolome perturbation 
To further explore what metabolite levels were altered due to exposure of 
imidacloprid, the HILIC and GC chromatograms were screened for a larger number 
of metabolites. This approach allowed increasing the number of detected 
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metabolites and in combination with statistics, it enhanced the chances to discover 
exposure biomarkers. Many metabolites in our standard library (Table S5.1) were 
accurately identified on the basis of three quality parameters (mass accuracy, 
retention time and isotopic pattern) and were found to be statistically significant (p-
value < 0.05, t-test FDR). For the exposure at environmental concentrations of 0.1 
μg/L and   μg/L we have identified    and  5 significant metabolites, respectively. 
At    μg/L and     μg/L,  7 and 3  identified metabolites, respectively were 
significantly different (Table 5.1). The fold changes and p-values of all the 
identified metabolites in the different exposure groups are given in Table S5.2.  
Table 5.1 Number of metabolites identified in the different exposure groups, 
number of significantly different metabolites based on p-values corrected by false 
discovery rate and percentage of significantly different metabolites of the identified 
metabolites. 
Exposure 
group 
# identified 
metabolites 
# of significant 
metabolites 
% of significant 
metabolites of identified 
metabolites 
Ctrl vs 0.1 
µg/L 
71 22 31 
Ctrl vs 1.0 
µg/L 
56 25 45 
Ctrl vs 10 
µg/L 
61 27 44 
Ctrl vs 100 
µg/L 
68 30 44 
The fold changes for metabolites which were significantly changed in at least two 
exposure concentrations are shown in Figure 5.2. 
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Figure 5.2 Fold changes of the significantly different metabolites (* p-value < 
0.05, t-test FDR) for two or more imidacloprid (IMI) exposure concentrations. 
Decreased levels were found for tryptophan, linolelaidic acid, linoleic acid, cis-10-
heptadecenoic acid, 3-methoxy-4-hydroxymandalate, uridine, stearic acid, oleic 
acid, inosine, heptadecanoic acid, guanosine, γ-linolenic acid, elaidic acid, 
acetylcholine and 3-methyl-2-oxovaleric acid. An increase in the level of 
spermidine, proline, leucine, histidine, betaine, 5-methylthioadenosine, putrescine, 
4-methyl-2-oxovaleric acid, valine, creatinine, 4-guanidino-butanoate, 
phenylalanine, choline and carnitine was observed.  
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The significant biomarkers can be used as biomarkers of exposure. Several 
biomarkers for imidacloprid exposure have been determined and their accuracy 
assessed by the receiver-operating characteristic (ROC) curve analysis. Of the 
twenty-nine metabolites that showed a statistically significant change at least at 
two exposure concentrations (shown in Figure 5.2), twelve showed an area under 
the curve (AUC) above 0.8 (Table S5.3 and Figure S5.8). These metabolites are: 
carnitine, elaidic acid, γ-linolenic acid, linolelaidic acid, stearic acid, 3-methyl-2-
oxovaleric acid, acetylcholine, creatinine, guanosine, inosine, phenylalanine and 
tryptophan. Among these metabolites, acetylcholine is directly related to mode of 
action of imidacloprid. The profile of these metabolites can be used as a biomarker 
of imidacloprid exposure. 
Biochemical networks were built to provide information on the mechanism of 
toxicity and the metabolic pathways affected. The networks were based on p-values 
and fold changes between the control group and exposed groups (Figure 5.3).  
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Figure 5.3 Biochemical network mapping for the comparison between control and exposed groups to increasing concentrations 
of imidacloprid (IMI). In the networks, the size of the nodes (metabolites) depends on the p-values. Statistically significant 
metabolites (p-value < 0.05, t-test FDR) are shown by bigger nodes, whereas not significant metabolites are represented by 
smaller nodes. The color of the node represents the fold change: red = down-regulated, green = up-regulated and gray = not 
detected metabolites. The clusters of the fatty acids metabolite class is shown in blue, the nucleotides are clustered within the 
red circle and in green the cluster comprising amino acids and derivatives is shown. 
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Using biochemical network maps, the biological interpretation is facilitated since it 1 
allows the visualization of consistent changes among the exposure concentrations. 2 
Pathway over-represented analysis was performed with the web-tool IMPaLA on 3 
the list of significantly changed metabolites. This tool analyzes whether these 4 
metabolites are significantly associated with a particular pathway or set of 5 
pathways. In table 5.2 the metabolic pathways in which significantly changed 6 
metabolites are involved are reported. In this table the pathway name, the database 7 
source, the pathway size and the number of metabolites overlapping to the 8 
metabolic pathway and the percentage of the pathway coverage are provided. In 9 
addition, the p-value and q-value corrected by FDR for each pathway are reported. 10 
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Table 5.2 Pathway over-represented analysis of the significantly changed metabolites at more than two concentration exposure 11 
of imidacloprid. P value and Q value (FDR) for the pathways are given. 12 
Pathway name 
Pathway 
source 
# of overlapping 
metabolites 
# of all pathway 
metabolites 
% of pathway 
coverage 
P value 
Q value 
(FDR) 
Metabolism of amino acids and derivatives Reactome 12 181 6.6 6.70E-11 5.90E-08 
Metabolic disorders of biological oxidation 
enzymes 
Reactome 11 305 3.6 3.40E-07 7.20E-05 
Biological oxidations Reactome 7 220 3.2 1.90E-04 6.80E-03 
Immune System Reactome 6 87 6.9 7.70E-06 3.70E-04 
Urea cycle and metabolism of arginine, 
proline, glutamate, aspartate and asparagine 
EHMN 6 125 4.8 6.20E-05 2.50E-03 
Adaptive Immune System Reactome 5 48 10.4 6.50E-06 3.30E-04 
Antigen processing-Cross presentation Reactome 5 29 17.2 4.80E-07 9.10E-05 
Arginine and proline metabolism KEGG 5 91 5.5 1.50E-04 5.50E-03 
Glutathione conjugation Reactome 5 38 13.2 2.00E-06 2.20E-04 
Glutathione synthesis and recycling Reactome 5 30 16.7 5.80E-07 1.00E-04 
Leukotriene biosynthesis HumanCyc 5 29 17.2 4.80E-07 9.10E-05 
Methionine Metabolism SMPDB 5 41 12.2 2.90E-06 2.20E-04 
Biosynthesis of unsaturated fatty acids KEGG 4 54 7.4 2.40E-04 8.30E-03 
Valine, leucine and isoleucine biosynthesis KEGG 4 23 17.4 7.50E-06 3.70E-04 
Valine, leucine and isoleucine degradation KEGG 4 40 10 7.20E-05 2.80E-03 
β-Alanine metabolism KEGG 3 31 9.7 7.20E-04 2.10E-02 
Biogenic Amine Synthesis Wikipathways 3 17 17.6 1.10E-04 4.30E-03 
Branched-chain amino acid catabolism Reactome 3 36 8.3 1.10E-03 3.20E-02 
Metabolism of polyamines Reactome 3 30 10 6.50E-04 2.00E-02 
Nucleotide Metabolism Wikipathways 3 17 17.6 1.10E-04 4.30E-03 
Spermidine and Spermine Biosynthesis SMPDB 3 17 17.6 1.10E-04 4.30E-03 
 13 
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With an increase in the exposure concentration, a down-regulation was found for 
the fatty acids biosynthesis and the cholinergic system, whereas an increase was 
observed for many amino acids for which several amino acid biosynthesis 
pathways were involved. 
The decrease in the levels of many fatty acids indicates a down-regulation of fatty 
acid biosynthesis and up-regulation of fatty acids degradation through the 
mechanism of β-oxidation. In this metabolic breakdown of long chain fatty acids, 
carnitine and acylcarnitines play the key role of carriers that assist the 
transportation across the inner mitochondrial membrane. The acetyl-CoA generated 
in the β-oxidation enters the TCA cycle, where it is further oxidized to CO2, 
producing more reduced energy carriers, NADH and FADH2. Another destination 
of acetyl-CoA is the production of ketone bodies by the liver that are transported to 
tissues like heart and brain for energy. The observed increase in carnitine and 
acetyl-carnitine associated with the decrease in fatty acid levels suggest a possible 
alteration in mitochondrial metabolism, energy production and/or acute oxidative 
stress
42
. 
Pathway analysis revealed the involvement of metabolic pathways associated with 
biological oxidation, immune system and inflammation process. Glutathione 
metabolism is usually correlated to oxidative stress
43
 and leukotriene biosynthesis 
is related to the occurrence of an inflammatory reaction in tissue injuries caused by 
xenobiotic
44
. A significant difference was found in the biogenic amine synthesis in 
which the main neurotransmitters are synthesized starting from their amino acid 
precursors, confirming the involvement of the neuronal metabolism.  
An alteration in many amino acids was observed, such as arginine and proline 
metabolism, methionine metabolism and β-alanine metabolism. Branched chained 
amino acids like valine, leucine and isoleucine metabolism were also affected by 
imidacloprid exposure. Pathways of valine, leucine and isoleucine biosynthesis and 
degradation and branched-chain amino acid catabolism appear to be involved. The 
levels of the 3-methyl-2-oxovaleric acid, isoleucine alpha-keto acid and precursor 
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were decreased whereas the levels of valine and leucine were enhanced, suggesting 
an increasing turnover of these amino acids biosynthesis. The levels of other amino 
acids like phenylalanine and proline were found to be increased whereas a decrease 
in tryptophan was found.  
Nucleotides were involved as well showing a decrease in the levels of inosine, 
uridine and guanosine.  
Polyamine levels were also significantly changed and, as a consequence, the 
polyamine metabolism and spermidine levels and spermine biosynthesis were 
dysregulated by imidacloprid exposure. Putrescine and spermidine had increased, 
showing an up-regulation in polyamine metabolism. The enzymatic reaction of 
spermidine synthetase catalyzes the production of spermidine from putrescine that 
is involved in the amino acid pathways such as arginine and proline metabolism, β-
alanine metabolism, cysteine and methionine metabolism and glutathione 
metabolism. Increases in putrescine levels have been related to cell injuries in the 
CNS associated to pathological conditions and neurotoxin exposure
45,46
.  
To our knowledge, this is the first time a metabolomics study has been applied to 
investigate the metabolic alterations in the CNSs of the freshwater snail L. 
stagnalis. With this approach, the molecular mechanism of imidacloprid toxicity in 
a non-target species was investigated. This quantitative and biologically-driven 
approach was effective to single out metabolites whose levels were affected by the 
exposure of the snails to different levels of imidacloprid, showing the importance 
of the followed strategy. Since metabolomics focuses simultaneously on multiple 
endopoints our study found indications that, besides the binding of imidaclorpid to 
the AChE, this neonicotinoid can probably cause inflammation and neuron cell 
injury. This should be further investigated. Metabolomics resulted to be more 
sensitive than tradition toxicity testing since it enabled to determine metabolic 
alterations at low and environmentally relevant concentrations. The combination of 
metabolomics with statistical and visualization tools, such as biochemical networks 
and pathway analysis, facilitated the biological interpretation of the results and a 
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better understanding of the undergoing toxicity mechanism. However, the proposed 
hypothesis of an increase in the cholinergic gene expression should be further 
studied by applying gene expression techniques and future research should 
investigate the validity of the exposure biomarkers also in other species.  
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Chapter 5 - Supporting Information 
Material and Methods 
Protein content measurement 
The protein content was determined by the Bradford colorimetric protein assay. For 
the calibration, bovine serum albumin (BSA) was used (Sigma-Aldrich). The Dye 
Reagent was purchased from Bio-Rad Laboratories (Richmond, CA, USA). The 
absorbance was measured with the SPECTRAmax 340PC 96 well-plate reader 
spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).  
Acetylcholinesterase activity assay 
A potassium-phosphate buffer (0.1M KH2PO4/K2HPO4) (Sigma-Aldrich), 5mM 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) (99%, Sigma-Aldrich), and 0.8 mM S-
acetylthiocholine-iodide (ATC) (98%, Sigma-Aldrich) were prepared. The samples 
were prepared by mixing 15 μL of the CNS homogenate with 135 μL of MilliQ 
water. Subsequently, a 96-well plate was filled with 50 μL of 5 μM DTNB and 50 
μL of 0.8 mM ATC. After 5 minutes of incubation, 50 μL of the CNS sample was 
added in triplicate to the 96-well plate. The plate was placed in a SPECTRAmax 
340PC Spectrophotometer, where the absorbance of the wells was measured at 412 
nm for 30 minutes with 20 second intervals. Finally, the maximum rate of change 
in absorbance (Vmax) was analyzed with SoftmaxPro5.2. As positive control the 
AChE-inhibiting organophosphate pesticide chlorpyrifos (Sigma-Aldrich) was 
used. 
Results and Discussion 
Imidaclopid exposure concentrations 
Before the exposure experiment, we have tested if imidacloprid concentrations 
were stable in cupper-free water under the experimental condition of the sequent 
exposure experiment.  
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The beakers were filled with 150mL of cupper-free water which were spiked with 
imidacloprid to reach the final concentration of 10 µg/L and 1000 µg/L. The 
experiment was carried out in triplicate and before injecting to the LC-MS/MS 
system, the IS was added to the samples. To test if there was a significant decline 
in imidacloprid concentrations the analysis of variance (ANOVA) with post hoc 
Tukey's honestly significant difference (HSD) was performed with the software 
SPSS (IBM). No significant variations in imidacloprid concentrations were 
observed at both concentration of 10 µg/L (Figure S5.1) and 1000 µg/L (Figure 
S5.2). 
The concentration of imidacloprid in the exposure media were measured at two 
subsequent days of incubation (0, 24 and 48 h). The results are shown in Figure 
S5.3.  
The averaged actual concentrations of imidacloprid over 0, 24 and 48 hours of 
exposure were 0.10 ± 0.01 μg/L, 0.7 μg/ ± 0.09 μg/L, 3.6 ± 0.43 μg/L and 34.4 ± 
5.6 μg/L for the exposure groups of 0.1 μg/L, 1 μg/L, 10 μg/L and 100 μg/L, 
respectively. The actual imidacloprid concentrations were in the range of the 
nominal concentration for the 0.1 and 1 μg/L groups. However for the higher dose 
groups (10 and 100 μg/L) the concentrations were about 3 times lower than the 
nominal concentration. For all exposure concentrations there was a significant 
decrease in imidacloprid concentration after 48 hours (ANOVA, p-value < 0.01). 
The deviation of the nominal concentrations for the two high dose groups could be 
due to bioaccumulation of imidacloprid in L. stagnalis which is also indicated by 
the decline of the concentrations in time. It has been found that the 
bioaccumulation factor of imidacloprid in snails is high
2
.  
Traditional toxicological endpoints 
The AChE activity of L. stagnalis CNS exposed to different imidacloprid 
concentrations was tested. The average of Vmax compared to the control group was 
calculated for all exposure groups (Figure S5.5).  
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The applicability of AChE bioassay to determine imidacloprid-induced toxic 
effects has been tested. The reliability was tested by incubating L. stagnalis CNS 
homogenate of unexposed snails with low concentrations of chlorpyrifos. 
Imidacloprid was tested to determine any intrinsic inhibiting effects on AChE. The 
protein contents, determined with the Bradford assay, were use to normalize for the 
heterogeneity in CNS sample sizes. The positive control chlorpyrifos showed a 
significantly lowered enzyme activity compared to the controls. This result 
confirmed the applicability of this assay to determine AChE activity in CNS 
samples of imidacloprid-exposed snails. Imidacloprid did, however, not 
significantly reduce the enzyme activity (Figure S5.6). 
No significant effects were observed on phenotypical endpoint of mortality and 
reproduction. L.stagnalis is able to reproduce through parthenogenesis and for this 
reason it is a well-suited species for isolated reproduction experiments
3
. Effects on 
the reproduction of L. stagnalis were tested by measuring the number of laid eggs 
and the dried weight of the egg clutches. The ANOVA performed on the egg count 
(Figure S5.7 (A)) and measurements of the dry weight of the egg clutches (Figure 
S5.7 (B)) of snails exposed to imidacloprid did not show significant differences 
between the exposure groups and the control. Even though reproductive outputs 
have been shown before to be a sensitive endpoint in L. stagnalis, the incubation 
time used in this study was probably too short to induce a significant effect on the 
snail reproduction
3
. Nevertheless, these results indicate that the lowest effect 
concentration (LOEC) for the analysed sublethal endpoints in L. stagnalis is higher 
than 34 μg/L for    days of exposure. This is in agreement with a high LO C for 
imidacloprid found in another aquatic snail species: 25,000 µg/L caused heart rate 
effects in embryos of Marisa cornuarietis after 10 days of exposure
4
. Furthermore, 
Nyman et al.
2
 found that the LC50 of L. stagnalis was about 50,000 µg/L with 4 
days of exposure. 
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Tables: 
Table S5.1 Metabolite standards of the IROA MSMLS library detected in the samples.  
METABOLITE NAME Supplier Analytical Platform 
Detected 
in 
sample 
m/z 
Molecular 
Formula 
RT 
Mass 
Error 
(ppm) 
3-METHYL-2-OXOVALERIC ACID IROA MSMLS Non-targeted (ToF) √ 130.0630 C6H10O3 2.1 <2ppm 
4-GUANIDINO-BUTANOATE IROA MSMLS Non-targeted (ToF) √ 145.0851 C5H11N3O2 8.7 <2ppm 
4-METHYL-2-OXOVALERIC ACID IROA MSMLS Non-targeted (ToF) √ 130.0630 C6H10O3 2.1 <2ppm 
5-HIAA Sigma-Aldrich Targeted (QqQ) √ 191.0582 C10H9NO3 3.4 <2ppm 
5'-METHYLTHIOADENOSINE IROA MSMLS Non-targeted (ToF) √ 297.0896 C11H15N5O3S 14.1 <2ppm 
ACETYLCHOLINE Sigma-Aldrich Targeted (QqQ) √ 146.1176 C7H16NO2 3.0 <2ppm 
ADENINE IROA MSMLS Non-targeted (ToF) √ 135.0545 C5H5N5 5.8 <2ppm 
ALPHALINOLENIC ACID Sigma-Aldrich Non-targeted (ToF) √ 292.2402 C19H32O2 21.4 <2ppm 
ARACHIDIC ACID IROA MSMLS Non-targeted (ToF) √ 326.3185 C21H42O2 25.1 <2ppm 
ARACHIDONIC ACID Sigma-Aldrich Non-targeted (ToF) √ 318.2559 C21H34O2 24.1 <2ppm 
BETAINE IROA MSMLS Non-targeted (ToF) √ 117.0790 C5H11NO2 9.2 <2ppm 
CARNITINE IROA MSMLS Non-targeted (ToF) √ 161.1052 C7H15NO3 9.8 <2ppm 
CHOLINE Sigma-Aldrich Targeted (QqQ) √ 104.1075 C5H14NO 6.3 <2ppm 
CIS10HEPTADECENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 282.2560 C18H34O2 20.2 <2ppm 
CIS1114EICOSADIENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 322.2872 C21H38O2 24.7 <2ppm 
CIS1117EICOSATRIENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 320.2715 C21H36O2 24.3 <2ppm 
CIS11EICOSENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 324.3028 C21H40O2 24.7 <2ppm 
CIS1316DOCOSADIENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 350.3185 C23H42O2 27.4 <2ppm 
CIS15TETRACOSENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 380.3654 C25H48O2 29.9 <2ppm 
CIS517EICOSAPENTAENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 316.2402 C21H32O2 24.1 <2ppm 
CIS814EICOSATRIENOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 320.2715 C21H36O2 24.7 <2ppm 
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CREATININE IROA MSMLS Non-targeted (ToF) √ 113.0589 C4H7N3O 6.0 <2ppm 
DIETHANOLAMINE IROA MSMLS Non-targeted (ToF) √ 105.0790 C4H11NO2 9.3 <2ppm 
DIMETHYLBENZIMIDAZOLE IROA MSMLS Non-targeted (ToF) √ 146.0844 C9H10N2 8.9 <2ppm 
DOCOSAHEXAENOIC ACID IROA MSMLS Non-targeted (ToF) √ 328.2402 C22H32O2 1.9 <2ppm 
ELAIDIC ACID Sigma-Aldrich Non-targeted (ToF) √ 296.2715 C19H36O2 21.8 <2ppm 
ELAIDIC ACID IROA MSMLS Non-targeted (ToF) √ 296.2715 C19H36O2 21.8 <2ppm 
GABA Sigma-Aldrich Targeted (QqQ) √ 103.0633 C4H9NO2 12.1 <2ppm 
GAMMALINOLENIC ACID Sigma-Aldrich Non-targeted (ToF) √ 292.2402 C19H32O2 21.7 <2ppm 
GLUTAMATE Sigma-Aldrich Targeted (QqQ) √ 147.0532 C5H9NO4 13.6 <2ppm 
GLUTAMINE Sigma-Aldrich Targeted (QqQ) √ 146.0691 C5H10N2O3 13.3 <2ppm 
GUANINE IROA MSMLS Non-targeted (ToF) √ 151.0494 C5H5N5O 7.7 <2ppm 
GUANOSINE IROA MSMLS Non-targeted (ToF) √ 283.0917 C10H13N5O5 9.0 <2ppm 
HENICOSANOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 340.3341 C22H44O2 26.5 <2ppm 
HEPTADECANOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 284.2715 C18H36O2 20.6 <2ppm 
HISTAMINE Sigma-Aldrich Targeted (QqQ) √ 111.0797 C5H9N3 18.3 <2ppm 
HISTIDINE Sigma-Aldrich Targeted (QqQ) √ 155.0695 C6H9N3O2 15.8 <2ppm 
HYPOXANTHINE IROA MSMLS Non-targeted (ToF) √ 136.0385 C5H4N4O 6.0 <2ppm 
INDOLE-3-ACETALDEHYDE IROA MSMLS Non-targeted (ToF) √ 175.0633 C10H9NO2 6.4 <2ppm 
INOSINE IROA MSMLS Non-targeted (ToF) √ 268.0808 C10H12N4O5 8.3 <2ppm 
LEUCINE IROA MSMLS Non-targeted (ToF) √ 131.0946 C6H13NO2 8.6 <2ppm 
LINOLEIC ACID Sigma-Aldrich Non-targeted (ToF) √ 294.2559 C19H34O2 21.6 <2ppm 
LINOLELAIDIC ACID Sigma-Aldrich Non-targeted (ToF) √ 294.2559 C19H34O2 21.8 <2ppm 
L-TRYPTHOPHAN Sigma-Aldrich Targeted (QqQ) √ 204.0899 C11H12N2O2 10.7 <2ppm 
L-TYROSINE Sigma-Aldrich Targeted (QqQ) √ 181.0739 C9H11NO3 12.1 <2ppm 
N6-(DELTA2-ISOPENTENYL)-
ADENINE 
IROA MSMLS Non-targeted (ToF) √ 203.1171 C10H13N5 8.8 <2ppm 
N-ACETYL-L-LEUCINE IROA MSMLS Non-targeted (ToF) √ 173.1052 C8H15NO3 1.4 <2ppm 
N-ACETYLPUTRESCINE IROA MSMLS Non-targeted (ToF) √ 130.1106 C6H14N2O 8.8 <2ppm 
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N-ACETYLSEROTONIN IROA MSMLS Non-targeted (ToF) √ 218.1055 C12H14N2O2 5.0 <2ppm 
NE,NE,NE-TRIMETHYLLYSINE IROA MSMLS Non-targeted (ToF) √ 188.1525 C9H20N2O2 12.7 <2ppm 
NICOTINAMIDE IROA MSMLS Non-targeted (ToF) √ 122.0480 C6H6N2O 3.0 <2ppm 
O-ACETYL-L-CARNITINE IROA MSMLS Non-targeted (ToF) √ 203.1158 C9H17NO4 8.8 <2ppm 
OLEIC ACID Sigma-Aldrich Non-targeted (ToF) √ 296.2715 C19H36O2 21.6 <2ppm 
PALMITOLEIC ACID Sigma-Aldrich Non-targeted (ToF) √ 268.2402 C17H32O2 18.6 <2ppm 
PHENYLALANINE Sigma-Aldrich Targeted (QqQ) √ 165.0790 C9H11NO2 10.3 <2ppm 
PICOLINIC ACID IROA MSMLS Non-targeted (ToF) √ 123.0320 C6H5NO2 5.0 <2ppm 
PIPECOLINIC ACID IROA MSMLS Non-targeted (ToF) √ 129.0790 C6H11NO2 10.4 <2ppm 
PROLINE IROA MSMLS Non-targeted (ToF) √ 115.0633 C5H9NO2 9.8 <2ppm 
PUTRESCINE IROA MSMLS Non-targeted (ToF) √ 88.1001 C4H12N2 12.6 <2ppm 
SEROTONIN Sigma-Aldrich Targeted (QqQ) √ 176.0950 C10H12N2O 10.5 <2ppm 
SPERMIDINE IROA MSMLS Non-targeted (ToF) √ 145.1579 C7H19N3 15.2 <2ppm 
STEARIC ACID Sigma-Aldrich Non-targeted (ToF) √ 298.2872 C19H38O2 22.2 <2ppm 
TETRACOSANOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 382.3811 C25H50O2 30.3 <2ppm 
THIOPURINE S-METHYLESTER IROA MSMLS Non-targeted (ToF) √ 166.0313 C6H6N4S 1.5 <2ppm 
TRICOSANOIC ACID Sigma-Aldrich Non-targeted (ToF) √ 368.3654 C24H48O2 29.1 <2ppm 
TRYPTOPHANAMIDE IROA MSMLS Non-targeted (ToF) √ 203.1059 C11H13N3O 5.8 <2ppm 
URACIL IROA MSMLS Non-targeted (ToF) √ 112.0273 C4H4N2O2 10.6 <2ppm 
URIDINE IROA MSMLS Non-targeted (ToF) √ 244.0695 C9H12N2O6 6.0 <2ppm 
URIDINE-5-MONOPHOSPHATE IROA MSMLS Non-targeted (ToF) √ 324.0359 C9H13N2O9P 9.2 <2ppm 
UROCANATE IROA MSMLS Non-targeted (ToF) √ 138.0429 C6H6N2O2 3.3 <2ppm 
VALINE IROA MSMLS Non-targeted (ToF) √ 117.0790 C5H11NO2 3.1 <2ppm 
XANTHINE IROA MSMLS Non-targeted (ToF) √ 152.0334 C5H4N4O2 15.0 <2ppm 
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Table S5.2 Metabolite identified in the different exposure groups. Fold change and p-values correc QC LC-ToF and Targeted 
QqQ analysis ted by false discovery rate (FDR) are reported. Marked in red the metabolites significantly different for more than 
three exposure concentrations and in gree QC LC-ToF and Targeted QqQ analysis n the p-values below 0.05 are marked. 
METABOLITE 
Fold 
chang
e 
p-value 
(FDR) 
Fold 
change  
p-value 
(FDR) 
Fold 
change 
p-value 
(FDR) 
Fold 
change 
p-value 
(FDR) 
ctrl vs 0.1 μg/L Ctrl vs 1.0 μg/L ctrl vs 10 μg/L ctrl vs 100 μg/L 
3-methyl-2-oxovaleric acid -1.81 0.028 -2.85 0.001 -3.31 0.000 -2.70 0.000 
4-guanidino-butanoate 1.44 0.320 4.08 0.002 2.92 0.012 4.06 0.002 
4-methyl-2-oxovaleric acid 2.86 0.074 3.09 0.049 4.91 0.022 2.09 0.127 
5-HIAA 1.19 0.651 1.29 0.755 1.00 0.620 1.33 0.552 
5-methylthioadenosine -1.57 0.044 1.45 0.193 1.18 0.529 2.44 0.008 
Acetylcholine -1.66 0.026 -2.24 0.013 -1.75 0.043 -1.58 0.008 
Adenine 1.11 0.807 1.39 0.259 1.15 0.572 2.07 0.012 
Arachidic acid -2.83 0.382 nd nd nd nd -6.04 0.063 
Arachidonic acid 1.32 0.491 nd nd -1.40 0.216 -1.35 0.113 
Betaine 1.42 0.009 1.18 0.136 1.18 0.114 1.45 0.002 
Carnitine 2.10 0.000 1.47 0.002 1.76 0.000 1.61 0.003 
Choline -1.19 0.026 2.24 0.005 2.01 0.022 1.36 0.008 
cis-10-heptadecenoic acid -30.73 0.019 -25.19 0.007 -1.78 0.559 -14.95 0.099 
cis-11,14-eicosadienoic acid -1.43 0.138 nd nd -1.00 0.000 -1.34 0.262 
cis-11,17-eicosatrienoic acid -1.27 0.195 nd nd nd nd -1.02 0.988 
cis-11-eicosenoic acid -12.12 0.000 nd nd -1.00 0.000 -5.26 0.079 
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cis-13,16-docosadienoic 
acid 1.00 0.998 nd nd nd nd -1.07 0.926 
cis-15-tetracosenoic acid -1.03 0.983 nd nd nd nd 1.32 0.429 
cis-5,17-eicosapentaenoic 
acid 1.16 0.664 nd nd -1.00 0.000 -1.01 0.988 
cis-8,14-eicosatrienoic acid -2.76 0.071 nd nd nd nd -2.51 0.260 
Creatinine 1.17 0.418 1.70 0.014 1.74 0.013 1.80 0.003 
Diethanolamine -1.89 0.053 -1.24 0.261 1.07 0.775 1.17 0.643 
Dimethylbenzimidazole nd nd 5.25 0.002 nd nd nd nd 
Docosahexanoic acid -2.39 0.005 nd nd nd nd 1.06 0.843 
Elaidic acid -9.73 0.000 -8.68 0.000 -6.75 0.006 -7.61 0.001 
Erucic acid -1.01 0.998 nd nd nd nd -1.00 0.988 
GABA 1.26 0.262 3.28 0.245 4.44 0.624 5.38 0.036 
Glutamate -2.72 0.041 1.35 0.442 -1.71 0.389 1.95 0.131 
Glutamine -2.06 0.078 8.36 0.023 2.04 0.143 -2.47 0.079 
Guanine 1.10 0.807 1.60 0.293 1.16 0.756 -1.05 0.893 
Guanosine -2.92 0.002 -2.46 0.001 -1.94 0.020 -1.46 0.003 
Henicosanoic acid -1.26 0.195 nd nd nd nd -1.13 0.592 
Heptadecanoic acid -26.11 0.004 -29.01 0.000 -35.44 0.011 -28.48 0.000 
Hexadecanol -1.13 0.962 1.13 0.801 1.13 0.801 1.75 0.503 
Histamine -1.05 0.651 1.03 0.755 -1.09 0.620 -1.07 0.552 
Histidine 4.34 0.761 1.37 0.685 -1.07 0.000 -1.19 0.001 
Hypoxanthine -1.90 0.011 -1.05 0.805 -1.73 0.097 -1.10 0.702 
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Indole-3-acetaldehyde -1.14 0.807 nd nd 1.39 0.475 nd nd 
Inosine -2.33 0.004 -1.95 0.011 -1.93 0.011 -1.46 0.017 
Leucine 1.31 0.145 1.52 0.001 1.31 0.174 1.67 0.002 
Linoleic acid -1.32 0.244 -9.13 0.000 -3.18 0.216 -6.89 0.049 
Linolelaidic acid -1.88 0.117 -10.94 0.005 -3.84 0.216 -12.04 0.012 
L-proline 1.12 0.540 1.58 0.008 1.14 0.615 1.46 0.024 
N6-(delta2-isopentenyl)-
adenine 1.09 0.807 1.05 0.911 2.39 0.048 1.05 0.893 
N6,N6,N6-trimethyl-L-
lysine 1.75 0.222 2.16 0.067 1.89 0.123 1.91 0.090 
N-acetyl-L-leucine 1.20 0.778 2.36 0.080 2.19 0.117 2.36 0.090 
N-acetylputrescine 1.35 0.156 1.24 0.109 1.31 0.141 1.11 0.680 
N-acetylserotonin 1.44 0.666 1.20 0.764 1.06 0.883 1.20 0.716 
Nicotinamide 1.53 0.456 -1.04 0.956 5.29 0.048 nd nd 
O-acetyl-L-carnitine 1.27 0.540 1.06 0.911 2.37 0.040 1.20 0.680 
Oleic acid -14.94 0.000 -14.40 0.000 -4.06 0.005 -14.12 0.000 
Palmitoleic acid nd nd nd nd -1.47 0.028 nd nd 
Phenylalanine 4.17 0.005 4.27 0.002 2.01 0.005 1.93 0.018 
Picolinic acid 1.20 0.456 1.21 0.342 1.16 0.484 1.40 0.085 
Pipecolinic acid 1.22 0.415 1.25 0.293 1.34 0.114 1.94 0.006 
Putrescine 1.43 0.105 1.47 0.067 1.85 0.022 1.84 0.008 
Serotonin -1.63 0.177 -2.29 0.103 -2.58 0.173 -6.28 0.036 
Spermidine 1.28 0.136 1.03 0.911 1.55 0.022 1.54 0.024 
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Stearic acid -42.80 0.000 -40.42 0.000 -31.92 0.001 -37.25 0.000 
Tetracosanoic acid -1.37 0.094 nd nd nd nd -1.02 0.988 
Thiopurine S-methylester 1.08 0.807 1.03 0.931 1.04 0.846 1.04 0.893 
Tricosanoic acid -1.13 0.558 nd nd nd nd -1.00 0.000 
Tryptophan -1.18 0.446 -1.62 0.025 -1.81 0.094 -1.75 0.020 
Tryptophanamide 1.36 0.412 nd nd nd nd nd nd 
Tyrosine 1.08 0.761 -1.13 0.521 -1.44 0.303 1.17 0.521 
Uracil -1.37 0.023 -1.20 0.081 1.15 0.550 1.11 0.680 
Uridine -1.78 0.002 -1.98 0.000 -1.42 0.011 -1.25 0.138 
Uridine-5-monoposphate -1.19 0.778 -2.25 0.062 -2.00 0.070 -1.51 0.552 
Urocanate -3.17 0.157 1.13 0.470 -2.63 0.080 1.10 0.684 
Valine 1.39 0.016 1.60 0.049 1.18 0.146 1.52 0.002 
Xanthine -1.26 0.462 -1.10 0.291 1.08 0.608 1.15 0.371 
α-linolenic acid -1.97 0.162 nd nd -2.50 0.039 -1.84 0.072 
γ-linolenic acid -8.51 0.015 -13.73 0.005 -9.72 0.033 -14.38 0.000 
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Table S5.3 Area under the ROC curve (AUC ± Std. error) for metabolites > 0.8 in more than three exposure concentrations. 
Metabolite 
Imidacloprid exposure concentration (μg/L) 
0.1 1.0 10 100 
Carnitine 0.89 ± 0.07 0.86 ± 0.09 0.84 ± 0.11 0.90  ± 0.07 
Elaidic acid 0.93 ± 0.07 1 ± 0.01 1 ± 0.01 0.86 ± 0.10 
γ-linolenic acid 0.86 ± 0.10 1 ± 0.01 1 ± 0.01 0.83 ± 0.11 
Linolelaidic acid 0.8 ± 0.15 0.94 ± 0.07 0.88 ± 0.12 0.9 ± 0.10 
Stearic acid 0.93 ± 0.07 0.88 ± 0.12 0.88 ± 0.12 0.86 ±  0.12 
3-methyl-2-oxovaleric acid 0.7 ± 0.12 0.97 ± 0.03 0.9 ± 0.08 1 ± 0.01 
Acetylcholine 0.86 ± 0.11 0.96 ± 0.05 1 ± 0.00 0.7 ± 0.19 
Creatinine 0.65 ± 0.12 0.88 ± 0.07 0.91 ± 0.06 0.95 ± 0.05 
Guanosine 0.85 ± 0.10 0.95 ± 0.04 0.83 ± 0.09 0.79 ± 0.11 
Inosine 0.81 ± 0.10 0.85 ± 0.08 0.84 ± 0.90 0.77 ± 0.11 
Phenylalanine 0.59 ± 0.14 0.88 ± 0.07 0.84 ± 0.09 0.96 ± 0.04 
Tryptophan 0.7 ± 0.16 0.93 ± 0.07 0.8 ± 0.19 1 ± 0.01 
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Figures: 
Figure S5.1 Concentrations of imidacloprid at 10 µg/L in cupper-free water every 
8 hours of 48 subsequent hours. (n=3, error bars = SE, *=p<0.05). 
 
Figure S5.2 Concentrations of imidacloprid at 1000 µg/L in cupper-free water 
every 8 hours of 48 subsequent hours. (n=3, error bars = SE, *=p<0.05). 
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Figure S5.3 Actual measured imidacloprid concentrations per exposure group in 
µg/L in 48 subsequent hours. (n=5, error bars = SE, *=p<0.05). 
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Figure S5.4 Fold changes for the quantified neurotransmitters, precursors and metabolites in L. stagnalis CNS exposed to 
different imidacloprid concentrations. 
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Figure S5.5 Average AChE activity in L. stagnalis CNS after 10 days of exposure 
to increasing concentrations of imidacloprid (n=10; error bars = SE). 
 
 
Figure S5.6 AChE activity inhibition % in CNS samples after 20 minutes of 
incubation to imidacloprid and chlorpyrifos, normalized for the controls. (n=3; 
error bars=SE; *p-value <0.05). 
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Figure S5.7 Imidacloprid effect on the number of laid eggs (A) and dried egg 
clutches weights (B) of the freshwater snail L. stagnalis. 
 
(A) Average number of eggs per snail per day within 
groups exposed to different concentrations of 
imidacloprid for ten days. (n=10, error bars = SE, 
*p<0.05). 
 
(B) Average of the dry weight of egg clutches per 
snail per day within groups exposed to different 
concentrations of imidacloprid for ten days. (n=10, 
error bars = SE, * p<0.05) 
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Figure S5.8 ROC curves for acetylcholine in the CNS of L. stagnalis exposed to 
increasing concentration of imidacloprid. 
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Abstract 
Many chemicals in use end up in the aquatic environment. The toxicity of water 
samples can be tested with bioassays, but a metabolomic approach has the 
advantage that multiple endpoints can simultaneously be measured and the affected 
pathways can be revealed. A current challenge in metabolomics is the study of 
mixture effects. This study aims at investigating the toxicity of an environmental 
extract and its most abundant chemicals identified by chemical analysis and Effect-
Directed Analysis (EDA) using the acetylcholinesterase (AChE) bioassay and 
metabolomics. Surface water from an agricultural area was sampled with a large 
volume solid phase extraction device (LVSPE) using three different cartridges 
containing a neutral, anionic and cationic sorbent. Targeted chemical analysis and 
the AChE bioassay were performed on the cartridge extracts. The neutral cartridge 
extract contained most chemicals, mainly imidacloprid, thiacloprid and pirimicarb, 
and showed to be the most potent in the AChE bioassay. Using an EDA approach 
other AChE inhibiting candidates were identified in the neutral extract, such as 
carbendazim and esprocarb. Additionally, a metabolomics experiment on the 
central nervous system of the freshwater snail Lymnaea stagnalis was conducted. 
The snails were exposed to the neutral extract, the three most abundant chemicals 
individually and a mixture of these. The neutral extract disturbed more metabolic 
pathways than the three most abundant chemicals individually, indicating the 
contribution of other chemicals. Most perturbed pathways by the neutral extract 
exposure overlapped with neonicotinoids exposure, like the polyamine metabolism 
involved in central nervous system (CNS) injuries. Nevertheless, even for exposure 
to pesticides with the same mode of action differences in metabolic alteration were 
observed. 
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Introduction 
The number of chemicals produced and used in our modern world is constantly 
growing. Many of those chemicals, like pesticides, household chemicals and 
mixtures of various chemicals in industrial waste end up in the environment and 
can cause a negative impact on the environment
1
. Chemicals in the aquatic 
ecosystem can influence the water quality, which may potentially have adverse 
effects on drinking water quality and biodiversity
2
. Effect-Directed Analysis 
(EDA) is one of the strategies to assess water quality. It is proposed to be 
integrated in the Water Framework Directive (WFD)
3
. EDA can potentially 
identify chemicals in complex mixtures that show a toxic response in a bioassay
4,5
. 
The bioassays often used focus on one specific toxicological endpoint, like 
estrogenic activity or photosynthetic inhibition
6–8
. In the EDA approach 
environmental extract that show toxicity will be fractionated to reduce the 
complexity of the mixture of chemicals. Those fractions will be tested with the 
bioassay and the active fractions will be subjected to chemical analyses in order to 
identify the chemicals that cause the toxicity. Usually, chromatographic techniques 
such as gas chromatography (GC) or liquid chromatography (LC) coupled to mass 
spectrometry (MS) are applied to identify these chemicals
9,10
. A commonly used 
bioassay to determine a toxic effect induced by pesticides exposure is the  llman’s 
acetylcholinesterase (AChE) bioassay, which is linked to organophosphate (OP) 
and/or carbamate pesticides, which inhibit the enzyme AChE
11
. However, 
pesticides like the neonicotinoids cannot be detected with the AChE bioassay since 
they are acting as acetylcholine receptor agonists
12
. Therefore, when only a 
bioassay with one specific mode of action is applied to test the quality of water 
samples, the toxicity of other classes of compounds will never be detected. An 
alternative strategy to test water quality and overcome the major pitfall of current 
biotesting strategies is metabolomics
11,12
. With this approach multiple endpoints 
can be measured simultaneously in the whole organism to mimic a more realistic 
environmental exposure scenario
13
. Many studies in environmental metabolomics 
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have investigated the effect of single compounds or a simple mixture of 
compounds
14–18
. One of the current challenges in environmental metabolomics is 
the study of complex chemical mixture effects, like an environmental sample. In 
the current study the toxicological effects of an environmental water extract and its 
most abundant chemicals were investigated by applying an EDA using the AChE 
bioassay, and metabolomics on the CNS of the freshwater snail Lymnaea stagnalis. 
Surface water was sampled in an agricultural area of the Netherlands where 
pesticide pollution was monitored. A large solid phase water extraction device 
(LVSPE) was used and equipped with three cartridges placed in series comprising 
neutral, anionic and cationic sorbents. Targeted chemical analysis on 119 
chemicals was performed on the extracts of the three cartridges and their AChE 
inhibition potency was tested by the AChE bioassay. This was followed by an EDA 
study using an on-line high pressure liquid chromatography - time of flight (HPLC-
ToF) micro-fractionation system. Fractions were tested with the AChE bioassay in 
order to identify active chemicals in the extracts. In parallel, targeted and non-
targeted metabolomics were carried out on the CNS of L. stagnalis exposed to the 
neutral extract, three most abundant chemicals individually, and a mixture of these 
chemicals. The biological interpretation was facilitated by the use of biochemical 
mapping and hierarchical clustering to identify the correlation between the surface 
water toxicity and its most abundant chemicals. 
 
Materials and Methods 
Water sampling and extraction 
Forty-five L of surface water was sampled at a location in the province Zuid-
Holland of the Netherlands (geographical coordinates of 52°00'08.5"N and 
4°17'35.2"E). Chemicals in this surface water were extracted by a LVSPE, in 
which three different filter cartridges were placed in series. The first cartridge 
contained a neutral sorbent (HR-X), the second anionic sorbent (HR-XAW) and the 
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last cartridge a cationic sorbent (HR-XCW). The chemicals in the neutral cartridge 
were eluted with 200 mL methanol (MeOH):ethylacetate 50:50 v/v, the chemicals 
in the anionic cartridge with 100 mL MeOH 2% ammonia 7N, and the chemicals in 
the cationic cartridge with 100 mL 1.7% formic acid (Fluka, Steinheim, Germany). 
As a blank, 45 L of bottled water (Gerolsteiner, Gerolstein, Germany) underwent 
the same processes.  
Each cartridge extracts was divided into aliquots for the different experiments. For 
the AChE bioassay 2 mL of each extract were concentrated by drying to 0.2 mL, 
corresponding to 150 times higher concentration than the original water sample 
(environmental concentration factor, ECF). The same process was used for the 
EDA study. For the metabolomics experiment, 84 mL of the extract were dissolved 
in 1.2 L of cupper free water suitable for the snails exposure. The final 
concentration in the snail exposure media corresponded to 16 ECF. 
Targeted chemical analysis 
A list of 119 emerging organic micro-pollutants (see Table S6.1) was selected for 
chemical screening of the surface waters extracts. The selection criteria of the 
candidate substances were based on: (i) occurrence in surface water, (ii) broad 
range of physicochemical properties and (iii) biological activity. This large list was 
classified according to their different uses, namely: pharmaceuticals and 
metabolites (55), herbicides and metabolites (32), insecticides (7), fungicides (2), 
flame retardants (5), plasticizers (1), industrial chemicals (14), and artificial 
sweeteners (3). This targeted chemical analysis was conducted by using an 
Orbitrap interfaced with a HPLC-system (Thermo Electron GmbH, Bremen, 
Germany) (see Supporting information).  
Acetylcholinesterase bioassay 
The extracts of the neutral, anionic and cationic cartridges were tested on AChE 
inhibition with the AChE bioassay. As a first step glycerol (purity ≥ 99%, Sigma-
Aldrich) was added to all extracts, at a final concentration of 50 mg/mL. To the 
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cationic extracts an additional 10% of ammonia hydroxide was added to buffer the 
pH. The extracts were dried with a gentle nitrogen flow and reconstituted with 
potassium-phosphate buffer (0.1 M, 7.5 pH) in such an amount that the extracts 
were concentrated with a factor of 10. In addition, three procedural blanks 
consisting of the same solvents as the cartridge extracts were prepared to check the 
effect of the solvent on AChE inhibition. In Supporting information the adopted 
bioassay procedure is described. 
Effect-directed analysis (EDA) 
The most active cartridge extract and its corresponding blank were fractionated in 
an EDA approach to identify the causative compounds of the AChE inhibition. 
Before fractionation, the neutral and the neutral blank extracts were dried 
completely with a gentle nitrogen flow and were subsequently reconstituted with 
water (H2O):acetonitrile (ACN) 90:10 v/v. These two extracts were fractionated 
using an on-line HPLC-micro-fractionation system with in parallel a ToF-MS to 
identify the compounds of interest. The experimental setup is described in 
Supporting information. Analytical standards were used to calibrate the fraction 
system (Table S6.2).  
L. stagnalis exposure 
L. stagnalis snails were taken from a synchronized population and cultured at the 
VU University Amsterdam, The Netherlands as described by Tufi et al. (2015)
19
. 
The neutral and neutral blank extracts were used to expose the snails. The extract 
was dried using a Buchi syncore combined to a BUCHI vacuum pump V-700 with 
vacuum controller V885 and a Buchi recirculating chiller F-108 (Buchi, Flawil, 
Switzerland) for 3 h at 240 mbar with 300 rpm, rack temperature of 50 °C and lid 
temperature of 60 °C, followed by 1 h at 120 mbar. Afterwards, the extracts were 
diluted with copper free water to a concentration factor of 16 ECF.  
Besides the neutral extract and neutral blank, the snails were also exposed to i) to 
the three most abundant chemicals (imidacloprid, thiacloprid, and pirimicarb) 
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individually at concentrations corresponding to the neutral extract, and ii) to a 
mixture of them at the same concentration levels. Also a control group was 
assessed without an exposure. Imidacloprid, thiacloprid, and pirimicarb were 
dissolved in copper free water. 
For each exposure group seven snails were exposed. Each snail was placed in a 
beaker glass with ± 150 mL copper free water and were fed with 250 µL Tetraphyll 
(133 g/L in copper free water; Tetra, Melle, Germany). After 2 days of 
conditioning, the snails were placed in a new beaker glass with 150 mL of the 
exposure waters. After 48 hours of exposure the snails were put in an aluminium 
box (Sanbio, Uden, The Netherlands), snap frozen in liquid nitrogen and the CNSs 
dissected. The CNS samples were stored in 0.5 mL precellys vials (Bertin 
Technologies, France) containing ± 10 ceramic beads (1.4 mm, zirconium oxide; 
MO Bio Laboratories, CA, USA) and were snap frozen in liquid nitrogen. 
Subsequently, the samples were stored at -80 °C. 
Actual exposure concentrations 
Samples of the exposure media were collected at the start of each experiment and 
were analysed with LC-MS to determine actual exposure concentrations of 
pirimicarb, imidacloprid and thiacloprid (see Supporting information and Tables 
S6.3-S6.4).  
Targeted and non-targeted metabolomics 
The CNS samples were processed and analyzed with the non-targeted and targeted 
metabolomics approaches described by Tufi et al. (2015)
19,20
. The extracted 
metabolites were analyzed by using the hydrophilic interaction chromatography 
(HILIC) coupled to a ToFMS (Bruker Daltonics). For the non-targeted platform 
standards from the MS Metabolite Library of Standards (MSMLS; IROA 
Technologies, MI, USA) were analyzed to determine the retention time and mass 
spectrum. The chromatograms were processed with Bruker Daltonics Compass 
PathwayScreener (Bruker Daltonics) to perform batch targeted analyses by 
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screening for metabolites of the MSMLS library. Multiple hypotheses testing was 
performed using the areas of the detected metabolites and Bruker Daltonics 
Compass ProfileAnalysis (Bruker Daltonics). A t-tests analysis was conducted on 
areas of the detected metabolites comparing two different exposure groups and 
FDR correction (p-value < 0.05, t-test).  
Biochemical networks and Heatmap 
From the detected metabolites biochemical networks were built with Metamapp 
setting the threshold at 0.7 for the chemical similarity
21
. The formed network, 
based on chemical similarities and biochemical interactions was uploaded in 
Cytoscape (v3.1.0) in which metabolic changes between the control group and 
different exposure groups were visualized
22
. Fold changes were calculated by 
dividing the average of metabolites in exposed groups by the average of 
metabolites in the control group. Visualization was based on fold change and p-
values. Exposure to the neutral extract was compared to the neutral blank extract, 
and exposures to the individual and mixture of chemicals were compared to the 
control group. A heatmap was formed based on the fold change using MatLab 
(vR2015a). Furthermore, metabolites were clustered on fold change. Biological 
interpretation of the results was performed using the small molecular databases: 
Kyoto Encyclopedia of Genes and Genomes (KEGG), Human Metabolome 
Database (HDMB), Small Molecule Pathway Database (SMPD) and Biocyc 
database collection. 
 
Results and Discussions 
Selection of the most active environmental extract  
40 chemicals were quantified in the extracts and the concentrations of those 
compounds detected above the level of 10 ng/L are shown in Table 6.1. The 
highest concentrations were found in the neutral extract suggesting a higher 
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retention of this sorbent for organic compounds. High concentrations of some 
chemicals were also found in the anionic extract indicating a potential cartridge 
breakthrough due to the overloaded capacity of the first neutral sorbent. 
The most abundant chemicals in the neutral extract were the carbamate pesticide 
pirimicarb (0.27 µg/l), and two neonicotinoid pesticides imidacloprid (0.21 µg/l) 
and thiacloprid (0.16 µg/l) (Table 6.1). Their concentrations exceed the normative 
levels. Pirimicarb exceeded the maximum permissible risk (MPR) concentration 4-
fold, imidacloprid four times the annual average environmental quality standard 
(AA-EQS), and thiacloprid exceeded the AA-EQS up to 20-fold, when the 
concentrations quantified in the neutral, cationic and anionic extracts were 
summed. 
The high presence of pesticides is consistent with the sampling location which is an 
agricultural area with greenhouses. From other studies it is well known that 
pesticides can be transferred through runoff waters into surface waters
23
. Our 
results showed comparable levels as found in monitoring programs at this location. 
Thiacloprid was not detected in the latest available data from these monitoring 
programs of 2013, suggesting that thiacloprid has been widely used in that area 
after. 
Chapter 6   Pesticide mixture toxicity 
178 
 
Table 6.1. Results of the targeted chemical analysis, showing the most abundant chemicals identified. The columns 4-9 show 
the concentrations of the compounds in the extracts in ng/L (ND = not detected).Ins: Insectides, Ph: Pharmaceutical, Herb: 
Herbicides, Herb M: Herbicide metabolite, Fung: Fungicide, FR: Flame Retardant, OC:Organic compound, IC: Industrial 
chemical. AA-EQS: annual average environmental quality standard, MAC-EQS: maximum allowable concentration-EQS, MPR: 
maximum permissible risk concentration.  
Compound Class 
Norm levels 
(µg/L)1 
Neutral 
Extract 
(µg/L) 
Neutral Blank 
(µg/L) 
Anionic 
Extract 
(µg/L) 
Anionic Blank 
(µg/L) 
Cationic Extract 
(µg/L) 
Cationic blank 
(µg/L) 
Pirimicarb Ins 0.090 (MPR) 0.27 ND 0.099 ND 0.001 ND 
Imidacloprid Ins 
0.067 (AA) 0.2 
(MAC) 
0.21 ND 0.063 ND 0.001 ND 
Thiacloprid Ins 
0.01 (AA) 0.11 
(MAC) 
0.16 ND 0.044 ND ND ND 
Caffeine Ph ND 0.052 0.001 0.012 ND 0.004 0.003 
MCPA Herb 
1.4 (AA) 
15 (MAC) 
0.034 ND 0.032 ND 0.001 ND 
Carbendazim Fung 
0.6 ( AA) 
0.6 (MAC) 
0.031 ND 0.017 ND ND ND 
2.4-Dinitrophenol Herb 0.001 (MPR) 0.017 ND 0.023 ND ND ND 
4.6-dinitro-o-cresol Herb 
9.2 (AA) 
9.2 (MAC) 
0.017 ND 0.013 ND ND ND 
2.6-Dichloro benzamide Herb. M. 1000 (MPR) 0.015 ND 0.006 ND 0.002 ND 
Triethyl phosphate FR 440 (MPR) 0.015 0.7 0.005 0.6 0.009 0.009 
Mecoprop Herb 
18 (AA) 
160 (MAC) 
0.014 ND 0.011 ND 0.1 ND 
Metalaxalyl-M Fung 9.7 (MPR) 0.010 ND 0.003 ND ND ND 
HMMM OC 810 (MPR) 0.009 ND 0.005 0.1 ND ND 
4-Methyl-1H-benzotriazole IC ND 0.008 ND 0.005 ND ND ND 
Paracetamol Ph ND 0.005 ND 0.005 ND 0.003 ND 
Chapter 6  Pesticide mixture toxicity 
179 
 
The neutral extract showed the most inhibitory potential of the AChE (Figure 6.1). 
 
Figure 6.1. Results of AChE bioassay on the extracts. A) The AChE activity of the 
neutral extract with an IC50 of 33.39 ECF (n=3, p-values <  . 5, Tukey’s test). B) 
The AChE activity of the anionic and cationic extracts, not showing any AChE 
inhibition (n=3, p-values <  . 5, Tukey’s test). 
These results are in accordance with the targeted chemical analysis which showed 
that the neutral extract contained most chemicals. A surprising result was obtained 
for the anionic extract, which expressed an AChE stimulation at 15 and 60 ECF. 
This trend was also observed for the cationic extract, however, not statistically 
different from the blank. In the literature AChE inhibiting effects have been 
described extensively. However, AChE stimulating effects are seldom reported. A 
study conducted by López et al. (2015) described an AChE activating effect of 
monoterpenoids, plant oils, which showed an AChE stimulation effect at low 
concentrations (0.04 mM) but an AChE inhibiting effect at high concentration (5 
mM). There is a possibility that the anionic and cationic extracts contain chemicals 
which exert such effects. Another possible explanation for the observed AChE 
stimulation might be the presence of humic substances, like humic and fulvic acids, 
which are major components of natural organic matter in soil and water. These 
acids have a light yellow to dark brown color
24
. A yellow color was indeed 
observed in the anionic extract and might therefore indicate the presence of humic 
substances. It has been shown that humic substances can be co-extracted by solid-
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phase extractions and can have a stimulating effect on the AChE inhibition assay
25
. 
However, it is unclear whether this effect is caused by interaction of humic 
substances with the enzyme AChE or due to its colour, which might have 
overlapping absorption spectra with dithiobisnitrobenzoate (DTNB).  
Effect-Directed Analysis  
The targeted chemical analysis showed that pirimicarb and the fungicide 
carbendazim could be responsible for the observed AChE inhibition. These 
chemicals are mainly interacting with the mitotic division, but they also have 
AChE inhibiting properties
26
. In order to identify other potential candidates that 
contributed to the AChE inhibition in the neutral extract, the neutral extract and 
blank were fractionated and tested with the AChE assay. The most active fractions 
of the neutral extract are shown in Figure S6.1. Some of the compounds present in 
these fractions were identified to be carbamate pesticides. Aldicarb was found in 
fraction 13, pirimicarb in fraction 19, and esprocarb in fractions 36 and 37. Even 
though these chemicals could potentially explain part the AChE inhibition of the 
neutral extract, identification of the chemicals in the active fractions 15, which had 
the highest inhibition potency, and fraction 23 was not successful.  
Metabolomics of the neutral surface water extract, its most abundant 
chemicals, and mixture 
Freshwater snails were exposed to: (i) the neutral extract, (ii) three of the most 
abundant chemicals (imidacloprid, pirimicarb and thiacloprid) individually and (iii) 
a mixture of these chemicals at the same levels. The measured exposure 
concentrations of the metabolomics experiments are shown in Table S6.5. The 
results show that the imidacloprid concentrations were similar among the exposure 
groups (Table S6.5). Thiacloprid concentration in the mixture was about 20% 
higher than in the neutral extract and individual exposures. Whereas pirimicarb was 
30% lower than in the neutral extract and 20% lower than in the mixture. The 
exposure of the neutral extract induced many alternations at molecular level in the 
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CNS: the levels of eighteen metabolites were found to be altered. Even though 
some altered pathways could be correlated to the three most abundant chemicals, 
the overall metabolic change could not be explained by the simplified mixture. The 
environmental extract perturbed more metabolic pathways, indicating therefore the 
contribution of other chemicals and synergistic effects to the observed toxicity.  
To further investigate the results of the metabolomics experiments, the data were 
visualized in biochemical networks to identify affected metabolite groups and 
pathways. The comparison between the neutral extract and the neutral blank extract 
showed 18 statistically significant metabolites of which the most were down 
regulated (± 80%) (Figure 6.2). Exposure to the single pesticides, on the other 
hand, showed less statistical significant differences and in the mixture exposure 
there were only four significantly changed metabolites (Figure S6.2-S6.5).  
Chapter 6  Pesticide mixture toxicity 
182 
 
 
Figure 6.2. Biochemical network based on fold change of metabolites, comparing 
the CNS of L. stagnalis exposed to the neutral extract (16 ECF) and the neutral 
blank extract. Red and green dots indicate, respectively, a reduced or increased fold 
change, whereas grey dots indicate not detected metabolites. Big dots symbolize 
significant metabolites (n=7, p-values < 0.05, t-test). Arrows describe metabolic 
interactions and dashed lines chemical similarities. 
Exposure to pirimicarb only showed to disturb several metabolites including 
methionine, 4-hydroxy-L-proline, inosine and hypoxanthine (ca. 3 fold increase). 
Increased hypoxanthine levels were to increased oxygen radicals
27
. A study 
conducted by Wang et al. (2014) showed that pirimicarb exposure caused increased 
oxidative stress, which might be associated to the observed increased level of 
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hypoxanthine. Furthermore, pirimicarb was related to a disturbed energy 
metabolism
28
.  
The metabolite patterns in the CNS of L. stagnalis exposed to imidacloprid or 
thiacloprid are expected to be comparable, since these chemicals have the same 
mode of action and therefore their effect should be additive (concentration addition 
model). Therefore, it was expected that they would affected the same metabolites. 
Thiacloprid and imidacloprid indeed showed many similar metabolic alterations. 
They were decreasing the levels of the metabolites ornithine and lysine. Ornithine 
is involved in multiple metabolic pathways, including the spermidine and spermine 
biosynthesis, and in arginine and proline metabolism. Imidacloprid showed a 
significant decrease in spermidine, proline and arginine levels, which indicates 
involvement of these pathways. A study conducted by Moser et al. (2015), who 
exposed rats to imidacloprid, showed the same altered pattern for ornithine, proline 
and spermidine. Furthermore, they showed that citrulline, also involved in the 
arginine and proline metabolism, was decreased as well
29
. This supports the 
hypothesis that neonicotinoids play a role in these pathways. Although 
imidacloprid and thiacloprid have overlapping metabolic patterns, some differences 
were also observed. For instance, glucosamine, involved in amino sugar 
metabolism, was up-regulated after imidacloprid exposure and downregulated after 
thiacloprid exposure. Glucosamine is related to chitin metabolism and is for 
example used as building block for the exoskeletons of arthropods, like insects and 
crustaceans, the shells of mollusks and the cell walls of fungi
30
. Dondero et al. 
(2010) showed that thiacloprid exposure, in comparison to imidacloprid, resulted in 
severely decreased chitinase mRNA in the marine mussel Mytilus 
galloprovincialis, which is also involved in chitin metabolism
30
.  
The effects of the exposures to the three single pesticides showed to be levelled out 
for most endpoints when they were used in a mixture, showing only four 
significantly different metabolites. The decrease of lysine, observed for all three 
single compounds, was levelled out in the mixture. This effect has been already 
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observed in other studies as well
28,30
 and might be caused by interaction effects
31
. 
These interactions might be due to the internal dose or bioavailable concentration 
of the chemical by its toxicokinetics (absorption, distribution, metabolism and 
excretion) and/or to the chemical toxicodynamics thought the binding of one of 
more chemicals to a receptor through which toxicity may be mediated. 
Moreover, it has been shown that chemicals with the same mode of action, did not 
show additive effects when mixed, suggesting that these chemicals have non-
similar effects, probably due to differences in compounds-specific 
toxicodynamics
14,30,32
. 
The neutral extract exposure showed many significantly changed metabolites and 
most of them were not found after the single pesticide exposure indicating that 
other chemicals in this extract also play a big role in the changes. Only a few 
metabolites were also found after the individual pesticide exposures. For instance, 
the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA; ca. 3 fold decrease) 
was also decreased with the same fold change after the thiacloprid exposure. The 
metabolites guanosine, adenosine, adenine, inosine and hypoxanthine showed to be 
affected by the compounds as well. These metabolites are involved in purine 
nucleotide degradation, which has been linked to lymphocyte deficiencies
33
, and 
lymphocyte deficiencies have been related to thiacloprid exposure
30
. Furthermore, 
imidacloprid has shown to affect purine nucleotide degradation by increasing the 
activity of xanthine oxidase, converting hypoxanthine to xanthine. This reaction is 
responsible for the release of oxygen radicals, which can cause additional damage 
and disturbances in tissues and organs
34
. Pirimicarb showed to disturb the purine 
nucleotide metabolism by increasing hypoxanthine.  
The neutral extract also affected the spermidine and spermine biosynthesis, which 
was also affected by imidacloprid and thiacloprid but other metabolites changed in 
this pathway (ornithine and spermidine instead of 5’-methylthioadenosine, N(1)-
acetylspermine, N-acetylputrescine and putrescine) (Figure 6.3). 
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Figure 6.3. Polyamine metabolism pathway, highlighting the catabolic and synthetic reaction and metabolites and enzymes 
involved (A). Metabolites of the polyamine pathway after exposure to the neutral cartridge extract (NEUTRAL) and 
imidacloprid (IMI) and thiacloprid (THIA) (B). The metabolites permutation is shown with a green arrow indicating an up-
regulation and with a red arrow a down-regulation. The amplitude of these changes is given by the corresponding fold changes. 
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It seemed that chemicals in the neutral extract were blocking the putrescine break 
down, resulting in an increased putrescine level. Putrescine can react with S-
adenosylmethioninamine to form spermidine and 5’-methylthioadenosine, or can 
be degraded to N-acetylputrescine. Spermidine, 5’-methylthioadenosine and N-
acetylputrescine showed decreased fold changes, supporting the hypothesis that 
putrescine break down is inhibited. Furthermore, N(1)-acetylspermine, a break 
down product of spermine or a building block of spermidine, was decreased as 
well, which might indicate a shift in the formation of spermidine through a 
different route. Increases in putrescine levels have been related to pathological 
changes that cause cell injury in the CNS, like severe metabolic stress, exposure to 
neurotoxins and seizure
35
. These increased putrescine levels are mainly caused by 
an increased activity of the enzyme ornithine decarboxylase (ODC), which 
degrades ornithine into putrescine
35–37
. Furthermore, S-adenosylmethionine (SAM) 
and the enzyme S-adenosylmethionine decarboxylase which transforms SAM into 
S-adenosylmethioninamine (dcSAM) might be depleted or inhibited, respectively, 
after CNS injury
38
. Additionally, the effects on spermine and spermidine showed to 
be unaltered or slightly changed in most CNS injury cases
37,38
. 
The observed effects of the neutral extract on the spermidine and spermine 
biosynthesis might partially be explained by the neonicotinoids imidacloprid and 
thiacloprid. The observed effects of the neutral extract on the metabolites histidine, 
kynurenic acid, trigonelline and cytosine cannot be assigned to one of the three 
most abundant chemicals and, therefore, these effects were probably caused by 
other chemicals in the extract. For instance, decreased kynurenic acid levels have 
been related to pyrethroid exposure, which might be present in the extract
39
. 
Furthermore, paracetamol, which was detected in the neutral extract, has been 
related to decreased trigonelline levels as well as decreased SAM
40
. 
In conclusion, the observed toxicity of the neutral extract in the metabolomics 
experiment could not be explained entirely by the most abundant chemicals in the 
extract, although some metabolic patterns were overlapping with the neutral extract 
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exposure. Nevertheless, the use of metabolomics in environmental extract exposure 
studies is promising, since it showed to be more sensitive and capable to focus on 
many endpoints at the same time and provide information on the pathways 
affected. The use of an aquatic model organism requiring a smaller volume of 
water, like Daphnia magna, can be advantageous for further research. With such 
organisms dose response effects of water extracts can be studied, even with small 
amounts of water extract. 
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Chapter 6 - Supporting Information 
Material and methods 
Reagents and Materials 
Methanol (MeOH) was purchased from JT Baker Chemical (NJ, USA), and 
acetonitrile (ACN), chloroform, ammonia 7N in MeOH and ethyl acetate were 
purchased from Sigma-Aldrich (Schnelldorf, Germany). MS grade formic acid 
(98% purity) and sodium formate salt (purity ≥ 99%) were obtained from Fluka 
(Steinheim, Germany). MilliQ water was obtained from a Millipore purification 
system (Waters Corporation, Milford, MA, USA). The MS metabolite library of 
standards (MSMLS) was obtained from IROA Technologies (Ann Arbor, 
Michigan, USA) and the mixtures of metabolites were prepared as described by the 
manufacturer.  
The analytical standards of neurochemicals analysed with targeted metabolomics 
approach were 3-MT, 5-HIAA, 5-hydroxy-L-trypthophan, acetylcholine, choline, 
DOPA, dopamine, epinephrine, GABA, glutamate, glutamine, histamine, histidine, 
norepinephrine, normetanephrine, phenylalanine, serotonin, tryptophan, tyramine, 
tyrosine and all were obtained from Sigma-Aldrich. The stable isotope-labelled 
internal standards of 3-MT-d4, acetylcholine-d4, serotonin-d4, 5-HIAA-d5, L-
tryptophan-d3 and GABA-d6 were from CND Isotopes (Quebec, Canada). DOPA-
d3, dopamine-d4, L-tyrosine-d4, epinephrine-
13
C2 
15
N, choline-d
13
 and glutamate-d5 
were obtained from Cambridge Isotope Laboratories (Andover, MA, USA). 
Glutamine-
13
C 
15
N, norepinephrine-d6 and 5-hydroxy-L-tryptophan-d4 were bought 
from Toronto Research Chemicals (Toronto, Ontario, Canada). Imidacloprid, 
thiachloprid, pirimicar, esprocarb and carbendazim analytical standard (99.9%) and 
imidacloprid-d4 were purchased from Sigma-Aldrich. The 96-wells plates, with flat 
bottom, were purchased from Greiner Bio-One (NC, USA) and the 150 mL beaker 
glasses from VWR (PA, USA). 
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Targeted chemical analysis 
The targeted chemical analysis was conducted by KWR, Watercycle Research 
Institute (Nieuwegein, NL). Acetone (HPLC grade) and petroleum ether (ultraresi-
analyzed) were purchased from Mallinckrodt Baker B.V. (Deventer, the 
Netherlands). Stock solutions of individual compounds were prepared in ACN 
(1000 mg/L) or in ACN/MeOH (50:50, v/v). Working solutions (0.01–1.0mg/L) 
were prepared in a mixture of ultrapure water and ACN (90:10, v/v). For further 
chemical analysis, dried extracts were further re-dissolved in a mixture of ultrapure 
water and ACN (90:10, v/v) containing internal standards, yielding 1,000-fold 
concentrated extracts. Ten microliters of the final analytical extract were injected 
into the LC system. Chromatographic separation was achieved using an 
XBridgeC18 column (150 mm × 2.0 mm i.d.; 3.5 µm particle size) (Waters 
Milford, MA, USA) and an AquaC18- Guard column (4.0mm × 3.0mm i.d.) 
(Phenomenex). Both columns were maintained at a temperature of 21 °C in a 
column thermostat. For both positive and negative ionization modes, a linear 
gradient of ACN (3 to 100%) and ultrapure water with 0.05% formic acid was used 
in 41 min and held at this composition for an additional 7 min. The analytical 
column was re-equilibrated for 10 min between consecutive runs. The flow rate of 
the mobile phase was 0.3 mL/min. Target compounds were analysed using a hybrid 
linear trap-Fourier transform ion cyclotron resonance MS (LTQ FT Orbitrap) 
interfaced with a HPLC-pump and autosampler Acela (Thermo Electron GmbH, 
Bremen, Germany). The linear ion trap (LTQ) part of the hybrid MS system was 
equipped with an Ion Max Electrospray Ionization (ESI) probe operating in both 
positive and negative ionization modes. Full-scan accurate mass spectra (mass 
range from 50 to 1000 Da) were obtained at high resolution (30,000 FWHM) and 
processed using Xcalibur v.2.0 software. The ESI conditions were: capillary 
voltage 3.0 kV, heated capillary temperature 300 °C, capillary voltage 35.5 V, and 
tube lens 70 V. The mass spectrometer was operated in a data dependent 
acquisition (DDA) mode in which both MS and MS
2
 spectra were acquired. In this 
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mode, the acquisition software probes the MS spectra in real-time on a scan-by-
scan basis to select the most intense parent ions for MS
2
 analysis. The products 
ions were generated in the LTQ trap at a normalized collision energy setting of 
35% and using an isolation width of 2 Da. Identification and confirmation of target 
compounds was achieved by: (i) accurate mass measurements of the protonated 
and deprotonated molecular ions within a mass window of 5 ppm; (ii) retention 
time match (≤ 0.25 min) of analytes detected in samples with corresponding 
standards in calibration solution; (iii) match between fragmentation ions of analytes 
acquired at low resolution (nominal mass) previously identified in calibration 
solution and those determined in samples. Thus, the acquisition of a high resolution 
precursor ion in combination with at least one product ion and the LC relative 
retention time met the minimum requirement of 4 identification points. 
Quantification of the compounds was performed by internal standard calibration 
using a calibration standard solution ranged between 0.01 and 1 mg/L. 
Acetylcholinesterase bioassay 
For the AChE bioassay 10 µL extract or compound were added to a well in a 96-
wells plate. Different dilutions of the extracts and procedural blanks were tested in 
triplicate, ranging from 0.07 to 150 Environmental Concentration Factor (ECF). 40 
µL of 0.125 U/mL electric eel AChE (Sigma-Aldrich) were added to all wells, 
followed by 20 minutes of incubation at room temperature. A mixture of 5 mM 
5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB; Sigma-Aldrich) and 0.8 mM s-
acetylthiocholine-iodide (ATC; Sigma-Aldrich), both dissolved in P-P buffer, was 
added to all wells (100 µL DTNB:ATC 50:50 v/v). Finally, the light intensity was 
measured at 414 nm for 40 times with an interval of 30 seconds using a Multiskan 
FC microplate photometer (Thermo Fisher Scientific, MA, USA). As positive 
control aldicarb (Fluka) was used, ranging from 0.5 to 1000 ng/mL. In the negative 
control 40 µL of P-P buffer was used instead of electric eel AChE and as normal 
control 10 µL of P-P buffer was used instead of a compound. The 
spectrophotometric data were exported to Excel in which the light intensity of the 
Chapter 6   Supporting Information 
194 
 
extracts was expressed as a percentage of the corresponding blank and the positive 
control as a percentage of the normal control. Results were visualized in dose-
response curves using GraphPad Prism Software (v5.04). Statistical significant 
differences in AChE activity between the extracts and corresponding blanks were 
measured with Tukey’s test (p-value < 0.05). The positive control and standards 
were compared to the normal control with Dunnett’s test (p-value < 0.05). 
Effect directed analysis (EDA) 
An Agilent 1290 Infinity Binary LC System (Agilent, Palo Alto, USA) was 
coupled with a splitter (Analytical Scientific Instruments, CA, USA) to an Agilent 
1260 Infinity microfractionator (Agilent) and a Bruker Daltonics MicroToF II 
(Bruker Daltonics, Bremen, Germany) equipped with an ESI source. The injection 
volume was set at 10 µL with a flow rate of 0.3 mL/min using a pentafluorophenyl 
(PFP) column (100x2.1 mm, 2.6 µm particle size; Phenomenex, CA, USA). As 
mobile phases H2O (A) and ACN (B) were used in a gradient elution, increasing B 
from 10 to 70% in 25 minutes. The splitter transferred 1/5 part to the ToF-MS, 
which scanned in a range of 50 to 1000 m/z. The end plate offset was set at 500 V, 
the capillary at 4500 V, the nebulizer at 4.0 bar, the dry-gas at 8.0 L/min and the 
dry-temperature at 250 °C. The other part entering the splitter was transferred to 
the microfractionator (4/5 part). The microfractionator collected 45 fractions from 
the 1-25 minute in a 96-wells plate which was already filled with 10 µL MeOH 
with 10% glycerol per well. Both extracts were injected in duplicates and analyzed 
in positive ionization mode of the ESI. In addition, a pesticide mixture was injected 
four times, of which two in positive mode. This mixture consisted of 28 pesticide 
standards (Table S6.2) and could be used for the identification and confirmation of 
pesticides in the extracts. After fractionation the 96-wells plates were sealed using 
a Water Heat Sealer (Waters Corporation, Milford, MA, USA) and were stored at -
80 °C. The 96-wells plates were dried in a Labconco Centrivap Cold Trap 
combined with a Labconco Concentrator (Labconco Corporation, MO, USA) at 40 
°C for 240 minutes. For the AChE bioassay 50 µL electric eel AChE (0.125 U/mL) 
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were added to all wells prior the incubation. The procedure followed as described 
before. 
The MS data was used to identify potential chemicals in the fractions. For this 
potential identification a pesticide target list obtained from (Waters Corporation, 
Milford, MA, USA) was used for non-targeted screening, which screened on 502 
pesticides. The potentially identified pesticides in the interesting fractions were 
confirmed using standards bought from Sigma-Aldrich or were already confirmed 
with the pesticide mixture. Pesticides identification took place using the same LC-
ToF settings as used for the fractionation. 
Actual exposure concentration 
To determine actual exposure concentrations of pirimicarb, imidacloprid and 
thiacloprid, samples of the exposure media were collected at the start of each 
experiment and were analyzed with RPLC-ESI-QqQ. An Agilent 1290 Infinity 
Binary LC System was combined with an Agilent 6400 Series Triple Quadrupole 
equipped with an ESI source (Agilent). The injection volume was set at 5 µL with 
a flow rate of 0.4 mL/min using a Kinetex XB-C18 column (100 x 4.6 mm, 5 µm 
particle size; Phenomenex). Mobile phase A consisted of H2O:MeOH 95:5 v/v and 
was acidified with formic acid to pH 2.8 and buffered with 5 mM ammonium 
formate. Mobile phase B consisted of MeOH. A gradient elution was used, 
increasing B from 5 to 60% after 3 minutes followed by an increase to 95% after 
17 minutes. The MS was operating with capillary voltage at 4000 V, nebulizer 
pressure at 4.14 bar, gas flow at 13 L/min, gas temperature at 350 °C and the ESI in 
positive mode. The calibration range consisted of the analytical standards 
pirimicarb, imidacloprid and thiacloprid and the internal standards, pirimicarb-d6 
and –imidacloprid-d4. Multiple reaction monitoring (MRM) was used to analyze 
the compounds and internal standards, using two MRM transitions each (Table 
S6.3). The data acquired were analyzed with the Agilent Masshunter Qualitative 
Analysis and Quantitative Analysis programs (Agilent). First, all MRM transitions 
in the chromatograms were integrated with Qualitative Analysis and when 
Chapter 6   Supporting Information 
196 
 
necessary the integrations were adjusted manually. The MRM transition with the 
highest intensity was used for quantification, measured with Quantitative Analysis. 
The intensities of the calibration range of analytical standards were used for 
quantification and were normalized for internal standards. The method 
quantification parameters are reported in Table S6.4. The actual media exposure 
concentrations are shown in Table S6.5. 
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Tables: 
Table S6.1 List of target compounds and the used internal standards. 
Target compound Group/Use CAS 
Chemical 
Formula 
Molecular 
weight 
Internal standard 
Acesulfame Artificial Sweeteners 33665-90-6 C4H5NO4S 163.152 Acesulfame-d4 
Saccharin Artificial Sweeteners 81-07-2 C7H5NO3S 183.184 Sacharine-d4 
Aspartame Artificial Sweeteners 22839-47-0 C14H18N2O5 294.303 Aspartame-d3 
4,4'-sulfonyldiphenol Plasticizers 80-09-1 C12H10O4S 250.27 Carbamazepine-d10 
2,4-dinitrofenol Insecticides 120-83-2 C6H4Cl2O 184.106 Bentazone-d6 
DNOC Herbicides 534-52-1 C7H6N2O5 198.133 Bentazone-d6 
Bromacil Herbicides 314-40-9 C9H13BrN2O2 261.116 Atrazine-d5 
Carbendazim Fungicides 10605-21-7 C9H9N3O2 191.187 Phenazone-d3 
Caffeine Pharmaceuticals 58-08-2 C8H10N4O2 194.191 Phenazone-d3 
Triethylphosphate Flame retardants 78-40-0 C6H15O4P 182.155 Sulfamethoxazole-d4 
2'-aminoacetophenone Industrial chemicals 551-93-9 C8H9NO 135.163 Bentazone-d6 
Metoxuron Herbicides 19937-59-8 C10H13ClN2O2 228.675 Sulfamethoxazole-d4 
Chlorpyrifos-ethyl Insecticides 2921-88-2 C9H11Cl3NO3PS 350.586 Atrazine-d5 
2,4-Dichlorophenol Herbicides 120-83-2 C6H4Cl2O 163.001 Bentazone-d6 
Chlorotoluron Herbicides 15545-48-9 C10H13ClN2O 212.676 Bentazone-d6 
Dimethenamid-p Herbicides 163515-14-8 C12H18ClNO2S 275.795 Bentazone-d6 
Azinfos-methyl Herbicides 86-50-0 C10H12N3O3PS2 317.324 Atrazine-d5 
Simazine Herbicides 122-34-09 C7H12ClN5 201.657 Atrazine-d5 
6-Deisopropylatrazine Herbicides (metabolite) 1007-28-9 C5H8ClN5 173.604 Atrazine-d5 
Desethylatrazine Herbicides (metabolite) 6190-65-4 C6H10ClN5 187.63 Atrazine-d5 
Dimethoate Insecticides 60-51-5 C5H12NO3PS2 229.257 Bentazone-d6 
BAM Herbicides (metabolite) 2008-58-4 C7H5Cl2NO 190.027 1-H-Benzotriazole-d4 
Diuron Herbicides 330-54-1 C9H10Cl2N2O 233.094 Bentazone-d6 
Monuron Herbicides 150-68-5 C9H11ClN2O 198.649 Atrazine-d5 
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MCPA Herbicides 94-74-6 C9H9ClO3 200.619 Bentazone-d6 
Metazachlor Herbicides 67129-08-2 C14H16ClN3O 277.749 Atrazine-d5 
Terbuthylazine Herbicides 5915-41-3 C9H16ClN5 229.71 Atrazine-d5 
Bentazone Herbicides 25057-89-0 C10H12N2O3S 240.279 Bentazone-d6 
Chloridazon Herbicides 1698-60-8 C10H8ClN3O 221.643 Sulfamethoxazole-d4 
2,4-Dichlorophenoxyacetic acid Herbicides 94-75-7 C8H6Cl2O3 221.037 Bentazone-d6 
DEET Insecticides 134-62-3 C12H17NO 191.27 Bentazone-d6 
Triphenylphosphan-oxid Flame retardants 791-28-6 C18H15OP 278.285 Carbamazepine-d10 
Metribuzin Herbicides 21087-64-9 C8H14N4OS 214.288 Atrazine-d5 
Mecoprop Herbicides 7085-19-0 C10H11ClO3 214.645 Bentazone-d6 
Isoproturon Herbicides 34123-59-6 C12H18N2O 206.284 Bentazone-d6 
Linuron Herbicides 330-55-2 C9H10Cl2N2O2 249.094 Atrazine-d5 
Metobromuron Herbicides 3060-89-7 C9H11BrN2O2 259.1 Atrazine-d5 
Pirimicarb Insecticides 23103-98-2 C11H18N4O2 238.286 Phenazone-d3 
Metolachlor Herbicides 51218-45-2 C15H22ClNO2 283.794 Bentazone-d6 
Trenbolone Pharmaceuticals 10161-33-8 C18H22O2 270.366 Estrone-d4 
Nicosulfuron Herbicides 111991-09-4 C15H18N6O6S 410.405 Sulfamethoxazole-d4 
β-Estradiol Pharmaceuticals 50-28-2 C18H24O2 272.382 
17-α-Ethynylestradiol-
d4 
Progesterone Pharmaceuticals 57-83-0 C21H30O2 314.462 Estrone-d4 
Testosterone Pharmaceuticals 58-22-0 C19H28O2 288.424 Estrone-d4 
4-Nitroquinoline 1-oxide Industrial chemicals 56-57-5 C9H6N2O3 190.156 Atrazine-d5 
Thiacloprid Insecticide 111988-49-9 C10H9ClN4S 252.723 Sulfamethoxazole-d4 
Metamitron Herbicides 41394-05-2 C10H10N4O 202.213 Phenazone-d3 
Amidosulfuron Herbicides 120923-37-7 C9H15N5O7S2 369.375 Sulfamethoxazole-d4 
Mepanipyrim Herbicides 110235-47-7 C14H13N3 223.273 Atrazine-d5 
Naphtalen-2-amine Industrial chemicals 91-59-8 C10H9N 143.185 1-H-Benzotriazole-d4 
Triphenyl phosphate Flame retardants 115-86-6 C18H15O4P 326.283 Carbamazepine-d10 
Ethinylestradiol Pharmaceuticals 57-63-6 C20H24O2 296.403 
17-α-Ethynylestradiol-
d4 
Cortisol Pharmaceuticals 50-23-7 C21H30O5 362.46 Estrone-d4 
Dexamethasone Pharmaceuticals 50-02-2 C22H29FO5 392.461 Carbamazepine-d10 
Dihydrotestosterone Pharmaceuticals 521-18-6 C19H30O2 290.44 Estrone-d4 
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Levonorgestrel Pharmaceuticals 797-63-7 C21H28O2 312.446 Estrone-d4 
2-Amino-3-methyl-3H-imidazo(4,5-
f)quinoline 
Industrial chemicals 76180-96-6 C11H10N4 198.224 Metformin-d6 
Triiodothyronine Industrial chemicals 6893-02-3 C15H12I3NO4 650.974 Carbamazepine-d10 
Prednisone Pharmaceuticals 53-03-2 C21H26O5 358.428 
17-α-Ethynylestradiol-
d4 
α-estradiol Pharmaceuticals 57-91-0 C18H24O2 272.382 
17-α-Ethynylestradiol-
d4 
Diglyme Industrial chemicals 111-96-6 C6H14O3 134.174 Phenazone-d3 
Triglyme Industrial chemicals 112-49-2 C8H18O4 178.226 Phenazone-d3 
Tetraglyme Industrial chemicals 143-24-8 C10H22O5 222.279 Phenazone-d3 
Aclonifen Herbicides 74070-46-5 C12H9ClN2O3 264.664 Atrazine-d5 
2-Aminobenzothiazole Industrial chemicals 136-95-8 C7H6N2S 150.201 1-H-Benzotriazole-d4 
1-H-benzotriazole Industrial chemicals 95-14-7 C6H5N3 119.124 1-H-Benzotriazole-d4 
4-Methyl-1H-benzotriazole Industrial chemicals 29878-31-7 C7H7N3 133.151 1-H-Benzotriazole-d4 
5-Methyl-1H-benzotriazole Industrial chemicals 136-85-6 C7H7N3 133.151 1-H-Benzotriazole-d4 
5-Chloro-1H-benzotriazole Industrial chemicals 94-97-3 C6H4ClN3 153.569 Carbamazepine-d10 
5,6-Dimethyl-1H-benzotriazole 
monohydrate 
Industrial chemicals 4184-79-6 C8H11N3O 147.177 1-H-Benzotriazole-d4 
2-(Methylthio)benzothiazole Herbicides (metabolite) 615-22-5 C8H7NS2 181.278 1-H-Benzotriazole-d4 
N-Methyl-N'-phenylacetohydrazide Pharmaceuticals 38604-70-5 C9H12N2O 164.204 Atrazine-d5 
Furosemide Pharmaceuticals 54-31-9 C12H11ClN2O5S 330.744 Bentazone-d6 
Sulfadiazine Pharmaceuticals 68-35-9 C10H10N4O2S 250.277 Sulfamethoxazole-d4 
Venlafaxine Pharmaceuticals 93413-69-5 C17H27NO2 277.402 Carbamazepine-d10 
Fluoxetine Pharmaceuticals 54910-89-3 C17H18F3NO 309.326 Fluoxetine-d5 
Clindamycin Pharmaceuticals 18323-44-9 C18H33ClN2O5S 424.983 Carbamazepine-d10 
Prednisolone Pharmaceuticals 50-24-8 C21H28O5 360.444 
17-α-Ethynylestradiol-
d4 
Sulfaquinoxaline Pharmaceuticals 59-40-5 C14H12N4O2S 300.336 Carbamazepine-d10 
Clofibric acid 
Pharmaceuticals 
(metabolite) 
882-09-7 C10H11ClO3 214.645 Bentazone-d6 
Gemfibrozil Pharmaceuticals 25812-30-0 C15H22O3 250.333 Bentazone-d6 
Ketoprofen Pharmaceuticals 22071-15-4 C16H14O3 254.281 Bentazone-d6 
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Diclofenac Pharmaceuticals 15307-86-5 C14H11Cl2NO2 296.149 Bentazone-d6 
Bezafibrate Pharmaceuticals 41859-67-0 C19H20ClNO4 361.819 Bentazone-d6 
Guanylurea 
Pharmaceuticals 
(metabolite) 
10310-28-8 C2H6N4O 102.095 Metformin-d6 
Tertbutaline Pharmaceuticals 23031-25-6 C12H19NO3 225.284 Paracetamol-d3 
Salbutamol Pharmaceuticals 18559-94-9 C13H21NO3 239.311 Atenolol-d7 
Pindolol Pharmaceuticals 13523-86-9 C14H20N2O2 248.321 Phenazone-d3 
Propanolol Pharmaceuticals 318-98-9 C16H21NO2 259.343 Atenolol-d7 
Atenolol Pharmaceuticals 29122-68-7 C14H22N2O3 266.336 Atenolol-d7 
Metoprolol Pharmaceuticals 37350-58-6 C15H25NO3 267.364 Atenolol-d7 
Sotalol Pharmaceuticals 3930-20-9 C12H20N2O3S 272.364 Atenolol-d7 
Clenbuterol Pharmaceuticals 37148-27-9 C12H18Cl2N2O 277.19 Phenazone-d3 
Trimethoprim Pharmaceuticals 738-70-5 C14H18N4O3 290.318 Sulfamethoxazole-d4 
Phenazone Pharmaceuticals 60-80-0 C11H12N2O 188.226 Phenazone-d3 
Aminophenazone Pharmaceuticals 58-15-1 C13H17N3O 231.294 Phenazone-d3 
Carbamazepine Pharmaceuticals 298-46-4 C15H12N2O 236.269 Carbamazepine-d10 
Sulfamethoxazole Pharmaceuticals 723-46-6 C10H11N3O3S 253.278 Sulfamethoxazole-d4 
Ciclophosphamide Pharmaceuticals 50-18-0 C7H15Cl2N2O2P 261.086 Carbamazepine-d10 
Pentoxyfyline Pharmaceuticals 6493-05-6 C13H18N4O3 278.307 Sulfamethoxazole-d4 
Atrazine Herbicides 1912-24-9 C8H14ClN5 215.683 Atrazine-d5 
Cortisone Pharmaceuticals 53-06-5 C21H28O5 360.444 Carbamazepine-d10 
Ifosfamide Pharmaceuticals 3778-73-2 C7H15Cl2N2O2P 261.086 Sulfamethoxazole-d4 
Lincomycin Pharmaceuticals 154-21-2 C18H34N2O6S 406.537 Phenazone-d3 
Metronidazole Pharmaceuticals 443-48-1 C6H9N3O3 171.154 Atenolol-d7 
Niacin Pharmaceuticals 59-67-6 C6H5NO2 123.109 Metformin-d6 
Paroxetine Pharmaceuticals 61869-08-7 C19H20FNO3 329.365 Fluoxetine-d5 
Sulphachloropyridazine Pharmaceuticals 23282-55-5 C10H9ClN4O2S 284.722 Sulfamethoxazole-d4 
Tramadol Pharmaceuticals 27203-92-5 C16H25NO2 263.375 Phenazone-d3 
Paracetamol Pharmaceuticals 103-90-2 C8H9NO2 151.163 Paracetamol-d3 
Metformin Pharmaceuticals 657-24-9 C4H11N5 129.164 Metformin-d6 
Tributyl phosphate Flame retardants 126-73-8 C12H27O4P 266.314 Carbamazepine-d10 
Estrone Pharmaceuticals 53-16-7 C18H22O2 270.366 Estrone-d4 
Metalaxalyl-M Fungicides 57837-19-1 C15H21NO4 279.332 Bentazone-d6 
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Imidacloprid Insecticides 138261-41-3 C9H10ClN5O2 255.661 Atrazine-d5 
Nandrolone Pharmaceuticals 434-22-0 C18H26O2 274.398 Estrone-d4 
Betamethasone Pharmaceuticals 378-44-9 C22H29FO5 392.461 Carbamazepine-d10 
Tembotrione Herbicides 335104-84-2 C17H16ClF3O6S 440.819 
17-α-Ethynylestradiol-
d4 
Tris(2-chloroethyl) phosphate Flame retardants 115-96-8 C6H12Cl3O4P 285.49 Carbamazepine-d10 
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Table S6.2. Analytical standards which were used in the pesticide mix for the EDA 
study. 
Analytical standard Molecular weight CAS 
3-hydroxycarbofuran 237.25 16655-82-6 
Aldicarb 190.078 116-06-3 
Aldicarb sulfone 222.067 1646-88-4 
Aldicarb sulfoxide 206.073 1646-87-3 
Bioallethrin 302.188 028434-00-6 
Carbaryl 201.079 63-25-2 
Carbofuran 221.105 1563-66-2 
Chlorpirifos-oxon 332.949 5598-15-2 
Chlorpyrifos 348.926 2921-88-2 
Cypermethrin 415.074 52315-07-8 
Diazinon 304.101 333-41-5 
Diazinon-O analog 288.124 962-58-3 
Dichlorvos 219.946 62-73-7 
Dimethoate 229.26 60-51-5 
Endosulfan 403.817 115-29-7 
Imidacloprid 255.66 138261-41-3 
Methiocarb 225.082 2032-65-7 
Methiocarb sulfone 257.072 2179-25-1 
Methiocarb sulfoxide 241.077 2635-10-1 
Methomyl 162.046 16752-77-5 
Omethoate 213.022 1113-02-6 
Oxamyl 219.068 23135-22-0 
Paraoxon-ethyl 275.056 311-45-5 
Parathion-ethyl 291.033 56-38-2 
Permethrin 390.079 52645-53-1 
Pirimicarb 238.143 23103-98-2 
Propoxur 209.105 114-26-1 
Thiacloprid 252.72 111988-49-9 
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Table S6.3. MRM operating values with the m/z ratios of the precursor and 
product ions and the corresponding voltage settings in the collision quadrupole for 
the quantification of the actual exposure concentrations.  
Compound Precursor ion Product ion Frag (V) Collision energy (V) 
Imidacloprid 256.1 209.0 77 30 
Imidacloprid 256.1 175.0 77 18 
Pirimicarb 239.1 182.1 110 12 
Pirimicarb 239.1 72.0 110 20 
Thiacloprid 253.1 126.0 90 25 
Thiacloprid 253.1 90.1 90 40 
D4-Imidacloprid 260.1 213.1 77 35 
D4-Imidacloprid 260.1 179.2 77 30 
D6-Pirimicarb 245.3 185.2 50 16 
D6-Pirimicarb 245.3 78.1 50 20 
 
Table S6.4.The parameters of the quantification method for imidacloprid, 
thiacloprid and pirimicarb, showing the LOQ in ng/mL and the R
2
 of the specified 
linear range.  
 
LOQ (ng/mL) R
2 
Linear range (ng/mL) 
Imidacloprid 0.5 0.999 0.5 - 1000 
Thiacloprid 0.5 0.994 0.5 - 1000 
Pirimicarb 0.5 0.998 0.5 - 1000 
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Table S6.5. Actual exposure concentrations of the metabolomics experiments. The 
columns show the different exposure waters and the rows the concentrations of 
imidacloprid, thiacloprid or pirimicarb in the exposure media in ng/mL ± standard 
deviation (n=3). 
 Actual exposure media concentrations (ng/mL) 
 
Neutral Mixture Imidaclop
rid 
Thiachlop
rid 
Pirimica
rb 
Contr
ol 
 
Imidaclop
rid 
2.97 ± 
0.05 
2.68 ± 
0.03 
2.92 ± 0.08 - - - 
- Thiaclopri
d 
1.50 ± 
0.05 
2.16 ± 
0.02 
- 1.59 ± 0.01 -  
Pirimicarb 5.32 ± 
0.04 
4.59 ± 
0.18 
- - 3.62 ± 
0.01 
- 
 
Figures: 
Figure S6.1. AChE inhibition of fractions of the neutral environmental extract in 
comparison to the neutral blank extract at 150 ECF. Only the most active fractions 
showing an AChE inhibition are shown. 
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Figure S6.2. Biochemical network based on fold change of metabolites comparing 
the CNS of L. stagnalis exposed to imidacloprid (3.3 ng/mL; 16 ECF) and a control 
condition. Red and green dots indicate, respectively, a reduced or increased fold 
change, whereas grey dots indicate not detected metabolites. Big dots symbolize 
significant metabolites (n=7, p-values < 0.05, t-test). Arrows describe metabolic 
interactions and dashed lines chemical similarities.  
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Figure S6.3. Biochemical network based on fold change of metabolites comparing 
the CNS of L. stagnalis exposed to thiacloprid (2.5 ng/mL; 16 ECF) and a control 
condition. Red and green dots indicate, respectively, a reduced or increased fold 
change, whereas grey dots indicate not detected metabolites. Big dots symbolize 
significant metabolites (n=7, p-values < 0.05, t-test). Arrows describe metabolic 
interactions and dashed lines chemical similarities.  
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Figure S6.4. Biochemical network based on fold change of metabolitescomparing 
the CNS of L. stagnalis exposed to pirimicarb (4.2 ng/mL; 16 ECF) and a control 
condition. Red and green dots indicate, respectively, a reduced or increased fold 
change, whereas grey dots indicate not detected metabolites. Big dots symbolize 
significant metabolites (n=7, p-values < 0.05, t-test). Arrows describe metabolic 
interactions and dashed lines chemical similarities.  
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Figure S6.5. Biochemical network based on fold change of metabolites comparing 
the CNS of L. stagnalis exposed to the standard mixture (equal to 16 ECF) and a 
control condition. Red and green dots indicate, respectively, a reduced or increased 
fold change, whereas grey dots indicate not detected metabolites. Big dots 
symbolize significant metabolites (n=7, p-values < 0.05, t-test). Arrows describe 
metabolic interactions and dashed lines chemical similarities.  
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Discussion 
 
Technological aspects of metabolomics 
Metabolomics is a technologically driven research area, which is enforced by high 
end analytical techniques. Despite advancement in the development of more 
sophisticated and reliable instrumentation, metabolomics is currently facing several 
technological challenges regardless of its application field. The most important 
difficulty is the chemical identification of endogenous metabolites by mass 
spectrometry (MS), which is the bottleneck of the data analysis pipeline. The 
difficulty of the identification of unknown compounds is also affecting other 
disciplines based on screening and profiling. In the field of environmental chemical 
analysis, for instance, the identification of unknowns is crucial and might be the 
limiting factor for the discovery of new pollutants of concern in environmental 
samples. This is also true for metabolomics since limited identification ability 
hinders or, in the worst case scenario, impedes biomarker discovery. The use of 
MS/MS can aid the identification of unknowns by querying the fragmentation 
spectra in MS metabolite databases. Nevertheless, these databases are limited to 
commercially available metabolite standards and many fragments designate the 
metabolite class and not the specific metabolite, making the identification complex 
and time consuming. Therefore, instead of non-targeted profiling strategies, a 
targeted approach based on a biological hypothesis and pseudo-targeted 
approAChEs based on a list of suspects might be more suitable to increase the 
biological value that can be derived from the acquired metabolomic MS data.  
On the basis of the hypothesis that pesticides would induce molecular alterations in 
the neuronal metabolism, a new targeted strategy based on liquid chromatography 
coupled to triple quadrupole MS was developed and validated to quantify the main 
neurotransmitters, their precursors and their metabolites (Chapter 2). Due to the 
high polarity of the neuro-active metabolites, the chromatographic separation of 
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these compounds was carried out by adopting a niche technique: hydrophilic 
interaction liquid chromatography (HILIC). The developed methodology has been 
applied to profile the main neurotransmitters in the central nervous system (CNS) 
of L. stagnalis and zebrafish embryos and larvae for environmental applications but 
this methodology can be transferred to other fields such as developmental biology 
or the study of neurological diseases. Even though the separation of twenty 
neurotransmitters was successfully obtained and the method validated, the 
catecholamines dopamine, norepinephrine and normetanephrine were not detected 
in both the CNS of L. stagnalis and zebrafish embryos and larvae. Due to the low 
levels of these metabolites and the insufficient sensitivity of the method, an 
additional step in the sample preparation or an online enrichment to concentrate 
them would be needed
1,2
. The application of different techniques such as GC-MS 
or RPLC, after dansyl chloride derivatization
3,4
 or with the aid of an ion-pairing 
agent
5
, can be explored to analyze these analytes. 
Although RPLC is still the dominating method in metabolomics and other fields, 
HILIC is becoming more popular and its application is increasing. This rising trend 
can be explained by the need to retain the polar fraction of the entire metabolome. 
As a consequence of the large heterogeneity in the physical and chemical 
properties of endogenous metabolites, more analytical platforms need to be 
integrated to resolve the metabolome puzzle. Each analytical platform is biased 
since it focuses only on certain classes of metabolites, depicting only a small slice 
of the entire metabolome. The literature is full of platform-specific strategies and 
the application of only one platform is a disadvantage as unavoidably many 
metabolites will remain undetected. However, by applying orthogonal analytical 
platforms, a broad range of metabolites belonging to various metabolic pathways 
could be determined. Using this approach, differences in the metabolome of the 
different organs of L. stagnalis have been indicated (Chapter 4). The inventory of 
the organ metabolomes also provided support for the experimental setup of later 
studies with L. stagnalis in terms of sufficient replicates to ensure adequate 
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reproducibility with the applied analytical platforms. Since this was the first 
metabolomics study on this species the acquired biological information represents 
the base of knowledge for future metabolism studies in this species.  
A pseudo-targeted approach can also enhance the amount of extracted information 
from a metabolomics experiment. To this extent, the use of large standards libraries 
can facilitate the identification of metabolites even though it is limited to known 
metabolites that are commercially available. The use of such a large library of 
standards leads to the accurate detection and identification of a higher number of 
analytes.  
Multiple expertises in different areas of research is needed to carry out a 
meaningful metabolomic study and this represents another challenging aspect of 
this field. Metabolomics not only requires knowhow and experience to work with 
sophisticated analytical techniques but also demands rigorous knowledge of a wide 
array of statistical tools that are crucial for data analysis in combination with deep 
biochemical understanding of metabolism for adequate biological interpretation. 
 
Relevance of the findings and environmental implications 
In this thesis pesticide-induced toxicity was studied in i) the invertebrate non-target 
species L. stagnalis because it enabled to focus on the CNS due to its relatively 
large size and ii) D. rerio embryos and larvae. In contrast to bioassays that are 
usually designed for a specific model organism, metabolomics is a very suitable 
tool in environmental studies since it can be applied to non-target species for which 
the base of knowledge is very limited. Because of the lack of metabolomic data of 
L. stagnalis, the assessment of its normal metabolic operating range was the 
starting point prior to studying the metabolism under stress conditions such as 
exposure to environmentally relevant levels of modern pesticides like imidacloprid. 
To underline the importance of the availability of metabolomic data of model 
organisms like L. stagnalis, the Metabolomic Society has recently established a 
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task group that will focus on the generation of this type of data and that strives to 
accomplish access to this baseline data for researchers in the field of metabolomics. 
The application of metabolomics in environmental studies is particularly suited 
since changes at the molecular level generally occur at lower concentrations than 
toxic responses of the currently employed endpoints
6
. Targeted metabolomics 
could revealed changes on the neuronal metabolism of D. rerio larvae exposed to 
eight different pesticides at no observed effect concentration (NOEC) determined 
with the zebrafish embryo toxicity test (ZFET) (Chapter 3). Thus, the metabolomic 
approach showed to be more sensitive than the commonly applied ZFET protocol 
and zebrafish embryos showed their usefulness as model organism to study 
neurochemical changes during normal neurodevelopment and after pesticide 
exposure. Due to the high sensitivity, our approach can be adopted as an alternative 
test to assess neurotoxicological effects in zebrafish and might be suited for testing 
environmental extracts with low concentrations of toxicants.  
A great advantage over traditional toxicity testing is the capability of metabolomics 
to simultaneously focus on multiple endpoints in-vivo. This attractive feature is 
very relevant to investigate the toxicity of compounds for which bioassays are not 
available. For instance, there are no bioassays designed to target the neurotoxicity 
of the neonicotinoids, a novel class of pesticides. To test the toxicity of 
neonicotinoids, the acetylcholinesterase (AChE) enzyme activity has been 
proposed as biomarker of exposure
7,8
. However, the use of the AChE bioassay for 
the assessment of neurotoxicity of the neonicotinoids is very controversial since in 
the literature are reported inconsistent results of enzyme inhibition or induction or 
not significant changes in AChE activity. In this thesis, no effects were reported for 
the AChE activity of the CNS of L. stagnalis that were exposed for ten days to 
environmentally relevant concentrations of imidacloprid, the most commonly 
applied neonicotinoid pesticide. In contrast, significant changes in many metabolic 
pathways and several metabolite levels were found using a metabolomics approach 
(Chapter 5). Based on the observed increase of the choline/acetylcholine ratio it 
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may be hypothesized that, instead of acting on the enzymatic activity, exposure to 
imidacloprid might induce an enhancement of the cholinergic gene expression. In 
the presence of imidacloprid, an agonist of the nicotinic acetylcholine receptor 
(nAChR), an increase of acetylcholine in the synaptic cleft would be expected 
since the pesticide occupies the acetylcholine binding site. Our finding suggests an 
opposite mechanism in which acetylcholine decreases due to a possible increase in 
AChE production.  
Since in many cases metabolites are conserved across different species, 
metabolomics is a powerful tool to discover common endpoints between species. 
For instance, an increase of the choline/acetylcholine ratio was also observed in 
zebrafish exposed to imidacloprid (Chapter 2). In addition, also other pesticides 
like the organoposphate and carbamate pesticides could induce this metabolic 
change. This is in accordance with previous research that demonstrated an 
induction of cholinergic gene expression after exposure to AChE inhibitors
9
.  
Using well-designed metabolomics, exposure-specific metabolic profiles can be 
obtained and possibly one or more biomarkers of exposure can be identified. For 
imidacloprid, several metabolites in the CNS characterizing the its exposure profile 
were indicated as potential markers of exposure at environmentally relevant 
concentrations (Chapter 5). Due to its unbiased nature, nontargeted metabolomics 
can unravel the involvement of not only expected but also unexpected metabolic 
pathways, which may be illustrated by the observation of alterations in the CNS of 
the levels of metabolites involved in injuries of neurons and inflammation 
processes.  
Metabolomics proved to be successful in identifying changes in model organisms 
at the molecular level after exposure to very low and environmentally relevant 
concentrations of toxicants. These features highlight the suitability of 
metabolomics for studying sublethal effects under realistic exposure scenarios to 
assess e.g. mixture toxicity in environmental samples or extracts. Despite these 
advantages and the importance of mixture toxicity in the fields of toxicology and 
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risk assessment, only few studies have been reported that involved the effects of 
mixtures on the metabolome. Baylay et al. 2012 found distinct metabolic 
alterations in the earthworm Lumbricus rubellus exposed to two pesticides 
belonging to the neonicotinoids and with the same mode of action, thiacloprid and 
imidacloprid. Remarkably, a non-interactive independent effect was observed
10
, 
demonstrating a deviation from the concentration addition model that is the 
dominating concept for mixture toxicity of toxicants exhibiting the same mode of 
action. In this thesis, the alterations in the metabolome of the CNS of L. stagnalis 
after exposure to a surface water extract have been investigated in relation to the 
most abundant chemicals present: the carbamate pirimicarb and the neonicotinoids 
imidacloprid and thiacloprid. Interestingly, despite the high concentrations of these 
three pesticides, the exposure to the surface water extract that was known to 
contain a relatively large number of low concentrations of e.g. other pesticides 
induced more alteration at the metabolite level. Some observations showed 
similarities with the exposure to the neonicotinoids, such as the polyamine pathway 
associated with CNS tissue injuries
11,12
. Nevertheless, even if compounds in a 
mixture share the same mode of action, divergences in the metabolome profiles 
after exposure to single compounds, mixtures as well as environmental extracts 
have been highlighted. In essence, the study of mixture toxicity and the 
toxicological assessment of real, complex through a metabolomic approach is still a 
challenge since many metabolic changes could not be explained by the most 
abundant compounds. Using other “omics” techniques to study the mixture toxicity 
of imidacloprid and thiacloprid, very different transcriptomic and proteomic 
profiles for the single compounds and their mixture were obtained, indicating the 
applicability of the model of independent action
13
. Therefore, to study the mixture 
toxicity of pesticides with the same mode of action, obviously the concentration 
addition model should not automatically be applied for ecological risk assessment. 
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Concluding remarks and outlook 
Metabolomics can reveal a better mechanistic insight into the various modes of 
action of pesticides or other chemicals in organisms. Especially when there is no 
suitable bioassay to detect the toxicity of a specific class of compounds, like in the 
case of the neonicotinoids, metabolomics can facilitate the identification of 
markers of exposure that may become target endpoints of novel bioassays. In this 
approach metabolomics acts as a guiding tool to determine interesting and 
significantly affected metabolic pathways which could be the focus of future 
bioassay development. In this thesis we have clearly shown the changes in 
neuronal metabolism of non-target species after exposure to single pesticides as 
well as to surface water extracts. In particular, for some pesticides the levels of 
choline and acetylcholine are sensitive indicators for exposure. Additionally, 
another interesting pathway associated with exposure appeared to be the polyamine 
biosynthesis. Since this pathway is related to brain injuries, the profile of the 
metabolites belonging to this metabolic pathway might be another indicator of 
neurotoxicant exposure. However, more research is needed to correlate the levels 
of these metabolites in different species with the exposure to chemicals and to 
associated effects observed in the CNS.  
Metabolomics provides an alternative to current bioassay testing strategies using 
fixed endpoints. In particular, due to its high sensitivity, the detection of alterations 
induced by exposure to pollutants at low environmentally relevant exposure 
concentrations is enabled. This can be especially helpful in the case of 
environmental extracts of which the amount of sample might be limited. To this 
extent metabolomics could be integrated in the effect directed analysis (EDA) 
setup by a using small model organism such as D. rerio larvae or Daphnia species, 
for which only a small amount of extract needs to be dosed. These model 
organisms could be used as an alternative testing protocol in EDA studies to test 
the metabolic changes of an environmental extract and its fractions. 
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On the technological side, there is a need for advancements in the identification of 
metabolites. Research is moving towards the development of novel informatics 
tools to facilitate the identification process and the promotion of data sharing in 
order to expand MS databases. To address this challenging task, the collaboration 
between scientists in different fields of research is crucial. Within the 
Metabolomics Society, scientists from the environmental field are giving their 
valuable contribution by providing their expertise on the identification of 
unknowns. The development of open source software tools like MetFrag
14
 and 
MetFusion
15
 by the Leibniz Institute of Plant Biochemistry (Halle, Germany) helps 
to build further confidence in metabolite identification. A joint initiative which 
brings the two communities together is the Critical Assessment of Small Molecule 
Identification (CASMI) Contest. By providing scientists with a common open 
dataset used to evaluate their identification methods, the CASMI Contest highlights 
and promotes the evaluation of the best identification strategy every year
16
. Other 
research fields in the environmental sciences, e.g. that of EDA, will benefit from 
this collaborative effort. On the other hand, from an environmental perspective the 
NORMAN working group on EDA focuses on building LC-MS libraries and 
strategies for non-target screening and identification of unknown compounds 
which is in turn beneficial for the Metabolomics Society. 
Further developments in the field of separation science are of great interest and 
extremely beneficial for metabolomics research. For instance, the application of 
multiple analytical platforms is crucial to allow the detection of a broad range of 
metabolites. Metabolomics would benefit from the development of more 
comprehensive analytical methods to reliably quantify as many metabolites as 
possible. To this extent, comprehensive techniques such as LC × LC and GC × GC 
chromatography, with their intrinsic capacity to separate large numbers of very 
different compounds, are particularly suitable
17,18
. Even though these techniques 
are of great advantage due to the use of orthogonal chromatography and the 
inherent increased peak capacity, the data processing of the acquired 
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chromatograms for non-targeted analysis is not sufficiently well established for 
routine analysis, which is the main challenge for their application in metabolomics. 
Therefore, developments in computational tools allowing a more automated data 
treatment for two-dimensional chromatography will be key to facilitate their future 
application in metabolomics.  
A very promising though not (yet) extensively applied chemometrics tools in 
environmental metabolomics is the ANOVA-simultaneous component analysis 
(ASCA). This method facilitates the interpretation of the contribution of the 
different factors from the metabolomics design
19
. In the example of an 
environmental study with more than one exposure time and dosing level tested, 
ASCA can unravel either the contribution of the factors singularly or their 
interaction.  
The application of metabolomics to investigate the metabolic state of an organism 
after exposure to a certain stressor may lead to novel insights and biological 
hypotheses that might require the support of other omics techniques. However, due 
to the complexity of data analysis and interpretation, the integration of 
metabolomics with e.g. transcriptomics and proteomics is still in its infancy. This 
systems biology approach would be extremely useful in the field of environmental 
quality assessment, since effects caused by pollutants can be simultaneously 
observed along the whole biochemical cascade from genes to metabolites enabling 
to focus on key genes, proteins and metabolites associated with a specific altered 
pathway.   
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Summary 
Traditional toxicity tests in the field of ecotoxicology may suffer from insufficient 
sensitivity limited by the concentration range they are covering and do provide 
limited insight in the changes that occur in cells or organisms upon exposure to 
chemical stressors. Therefore, there is a need for new concepts for toxicity testing 
to improve environmental risk assessment. Encouraging alternatives emerging 
from the “omics” field provide options to accurately determine the mechanism of 
toxicity. Among the “omics” techniques, metabolomics has the potential to 
overcome a major pitfall of traditional toxicity testing by its usability at realistic 
environmental exposure scenarios. In addition, since metabolites are often highly 
conserved across different species, predictions can be made with regard to 
interspecies shared endpoints. One group of pollutants of concern is the 
neonicotinoid insecticides that are currently dominating the pesticide market and 
are causing adverse effects in non-target species living in the aquatic ecosystem. 
To evaluate pesticide-induced toxicity the acetylcholine esterase (AChE) inhibition 
assay is commonly applied. The use of this assay addressing only a single endpoint 
is, however, restricted to carbamates and organophosphate pesticides, which induce 
a direct enzyme inhibition. Since neonicotinoids have a different mode of action, 
they bind to the nicotinic acetylcholine receptor (nAChR), an alternative testing 
strategy is needed to study the toxic effects of these compounds in detail. 
Metabolomics is an excellent tool to address this challenge.  
In chapter 2, a new analytical strategy based on interaction hydrophilic liquid 
chromatography (HILIC) and mass spectrometry (MS) was developed and 
validated to quantify metabolites involved in neuronal metabolism, such as the 
main neurotransmitters, their precursors and their metabolites. For the method 
optimization, different HILIC columns were tested to separate twenty compounds 
(3-methoxytyramine, 5-hydroxyindoleacetic acid, 5-hydroxy-L-tryptophan, 
acetylcholine, choline, L-3,4-dihydroxyphenylalanine, dopamine, epinephrine, γ-
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aminobutyric acid, glutamate, glutamine, histamine, histidine, L-tryptophan, L-
tyrosine, norepinephrine, normetanephrine, phenylalanine, serotonin and tyramine). 
To assess column performance the linear correlation between retention and Log D, 
the capacity factor k’ and the column resolution Rs have been investigated for a 
selection of columns. The zwitterionic ZIC-cHILIC column coupled to a triple 
qradrupole MS (QqQ) was the preferred option. With this analytical method 
neurotransmitters in the central nervous system (CNS) of the freshwater snail 
Lymnaea stagnalis, a model organism in neurobiology and ecotoxicology, were 
profiled. This targeted approach was also applied to characterize the 
neurotransmitter profile during zebrafish (Danio rerio) early stage development 
(chapter 3) and to investigate the effects on neurotransmitter levels in non-target 
species after exposure to pesticides (Chapters 3, 5 and 6).  
In chapter 3, the quantification of neurotransmitters, their precursors and 
metabolites was carried out in whole zebrafish embryos and larvae from the period 
of zygote to free swimming larvae (6 dpf) with 20 embryos/larvae per sample 
enabling a high-throughput approach. A developmental stage-dependent pattern 
featured by strong changes in neuronal metabolism was observed after embryo 
hatching. Whereas the neurotransmitter levels steadily increased, many 
neurotransmitters precursor levels peaked at 3 dpf, suggesting a shift in metabolism 
from anabolism to catabolism of the precursor molecules, which are also lipids and 
protein substrates. The neuronal metabolism of zebrafish larvae exposed to 
pesticides was also affected at 5 dpf. Exposure to eight different pesticides 
(aldicarb, carbaryl, chlorpyrifos, diazinon-O-analog, dichlorfos, permethrin, 
imidacloprid and pirimicarb) was performed at their no observed effect 
concentrations (NOECs) where no phenotypic malformations were observed in the 
zebrafish embryo toxicity test (ZFET) but alterations in swimming behaviour and 
neurotransmitter levels were detected. The developed neurotransmitter method is a 
promising alternative test to investigate the toxicity of chemicals on whole 
organisms. 
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In parallel to the targeted approach a cross-platform metabolomic strategy based on 
the application of complementary analytical techniques was applied in order not to 
overlook other metabolic pathways that might be altered by toxicant exposure. The 
literature is dominated by platform-specific strategies and the most commonly 
applied is reverse phase liquid chromatography (RPLC). However, the application 
of only one platform would imply the inevitable loss of information in terms of 
detected metabolites. Therefore, to further increase metabolome coverage different 
modes of liquid chromatography (LC) with electrospray ionization (ESI) and gas 
chromatography with atmospheric pressure chemical ionization (GC-APCI) were 
coupled to high resolution Time of flight mass spectrometry (ToF MS) (Chapter 4). 
In addition to the more traditional RPLC, HILIC methods at different operating pH 
were investigated. Concerning sample preparation, two widely used tissue 
disruption methods have been evaluated: ultrasound assisted extraction and beads 
beating (BB) homogenization. In order to reduce the analysis time and increase the 
throughput, simultaneous extraction of hydrophilic and lipophilic metabolites was 
carried out by BB homogenization. The performance of each technique was 
evaluated based on the metabolome coverage, number of detected molecular 
features and reproducibility. The different analytical platforms showed different 
metabolite coverage. By changing the buffer elution, different polar metabolite 
classes showed an enhanced retention on the HILIC columns, whereas, due to the 
high polarity of the metabolites the RP column did not allow an efficient 
separation. Based on these results, the combination of HILIC and GC in 
combination with ToF-MS showed the highest metabolome coverage and was 
applied in further studies. 
In Chapter 5, the developed methodologies for targeted and non-targeted 
metabolomics (Chapters 2 and 4) were integrated and applied to investigate the 
effects of the neonicotinoid imidacloprid on the CNS of the invertebrate species L. 
stagnalis. In this study, the snails were exposed to environmentally relevant 
concentrations (0.1 µg/L and 1.0 µg/L) of imidacloprid. In addition, higher 
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exposure concentrations corresponding to 10 µg/L and 100 µg/L were also tested. 
The exposure experiment was carried out for 10 days and effects on reproduction 
and responses in the AChE bioassay of snail CNS extracts were evaluated. These 
traditional toxicological endpoints were not significantly affected by the exposure 
to imidacloprid. Metabolomics was more sensitive than traditional toxicity testing 
and revealed differences between control and exposed groups. The levels of many 
identified metabolites were found to be significantly altered and several pathways 
were significantly affected by realistic environmental exposures to imidacloprid. 
Results indicated that imidacloprid may cause inflammation and neuron cell injury. 
Moreover, since an enhancement of the ratio between choline and acetylcholine 
was observed, a possible increase in cholinergic gene expression was suggested as 
adaptive response to the binding of imidacloprid to the nAChRs. 
The integration of the combined targeted and non-targeted metabolomics strategy 
in an effect directed analysis (EDA) study was explored in Chapter 6. The 
toxicological effects of a surface water extract were related to its most abundant 
contaminants by EDA, using the AChE bioassay and metabolomics on the CNS of 
L. stagnalis. During the sampling campaign in an agricultural area of the 
Netherlands, 45 L of surface water were sampled with a large volume solid phase 
extractor (LVSPE), using three different cartridges placed in series and filled 
respectively with neutral, anionic and cationic sorbents. By target chemical 
analysis, 40 chemicals were quantified in the extracts and levels of 15 chemicals 
were above 10 ng/L. The level of pirimicarb was above the maximum permissible 
risk (MPR), while for imidacloprid and thiacloprid the annual average 
environmental quality standards (AA-EQSs) were exceeded. 
In order to detect and identify other AChE active compounds in the neutral extract 
we used an on-line HPLC-MS fractionation system in a 96 well plate and carried 
out the AChE bioassay. With this approach we could identify two carbamates in 
two different active fractions: carbendazim and esprocarb. Among all the cartridge 
extracts, only the neutral extract showed a dose response in the AChE inhibition 
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assay. Therefore, with this extract a targeted and non-targeted metabolomic 
approach was conducted uwith L. stagnalis. The snails were exposed to the neutral 
extract, the three most abundant chemicals individually, and a mixture of these. 
The observed metabolic changes in the CNS of L. stagnalis after exposure to the 
neutral extract could not be totally explained by the most abundant chemicals. The 
neutral extract disturbed more metabolic pathways than the three most abundant 
chemicals, indicating the contribution of other chemicals. However, the use of 
metabolomics for the evaluation of toxicological responses in organisms exposed 
to environmental extracts is a very promising approach since it showed to be more 
sensitive compared to traditional toxicity testing and able to focus on multiple 
endpoints simultaneously. 
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Samenvatting 
In de ecotoxicologie kunnen traditionele toxiciteitstesten te kort schieten door 
onvoldoende gevoeligheid als gevolg van het beperkte concentratiegebied dat ze 
beslaan. Ze geven ook slechts een beperkt inzicht in de veranderingen die optreden 
in cellen of organismen bij blootstelling aan chemische stressoren. Daarom is er 
behoefte aan nieuwe concepten voor toxiciteitstesten om milieurisicoanalyses te 
verbeteren. Bemoedigende alternatieven uit het onderzoeksveld van de "omics" 
bieden mogelijkheden om nauwkeurig het mechanisme van toxiciteit te bepalen. 
Onder de "omics" technieken heeft metabolomics de potentie om een belangrijke 
valkuil van de traditionele toxiciteittesten te overwinnen door werkzaam te zijn bij 
realistische blootstellingsscenario’s. Omdat metabolieten veelal ongewijzigd 
voorkomen in verschillende soorten organismen, kunnen bovendien voorspellingen 
worden gedaan met betrekking tot toxicologische responsen die gedeeld worden 
door diverse species. Een belangrijke groep verontreinigende stoffen zijn de 
neonicotinoïden: insecticiden die momenteel de markt van bestrijdingsmiddelen 
domineren en in het aquatisch ecosysteem onbedoeld nadelige effecten 
veroorzaken in andere organismen (non-target organismen) dan de insecten 
waarvoor ze ontwikkeld zijn. Om toxiciteit ten gevolge van blootstelling aan 
insecticiden te meten wordt gewoonlijk de acetylcholinesterase inhibitietest 
(AChE) toegepast. Deze test grijpt slechts op één eindpunt aan en is daarbij beperkt 
tot de carbamaten en organofosfaatpesticiden, die een rechtstreekse enzymremming 
induceren. Omdat de neonicotinoïden een ander werkingsmechanisme hebben, ze 
binden aan de nicotine acetylcholinereceptor (nAChR), is er een alternatieve 
teststrategie nodig om de toxische effecten van deze verbindingen in detail te 
bestuderen. Metabolomics is hiervoor uitstekend geschikt. 
In hoofdstuk 2 is een nieuwe analytische strategie, gebaseerd op hydrofiele 
interactie vloeistofchromatografie (HILIC) en massaspectrometrie (MS) 
ontwikkeld en gevalideerd om metabolieten die betrokken zijn bij het neuronale 
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metabolisme, zoals de belangrijkste neurotransmitters, hun precursors en 
metabolieten, te kwantificeren. Om de methode te optimaliseren zijn verschillende 
HILIC kolommen getest op hun vermogen om twintig verbindingen te scheiden, te 
weten 3-methoxytyramine, 5-hydroxyindoolazijnzuur, 5-hydroxy-L-tryptofaan, 
acetylcholine, choline, L-3,4-dihydroxyfenylalanine, dopamine, epinefrine, γ-
aminoboterzuur, glutamaat, glutamine, histamine, histidine, L-tryptofaan, L-
tyrosine, norepinefrine, normetanefrine, fenylalanine, serotonine en tyramine. Om 
de prestaties van verschillende HILIC kolommen te beoordelen is de lineaire 
correlatie tussen retentie en Log D, de capaciteitsfactor k' en de kolomresolutie Rs 
onderzocht. De zwitter-ionische ZIC-cHILIC kolom gekoppeld aan een triple 
qradrupole MS (QqQ) is hierbij naar voren gekomen als beste keuze. Deze 
analysemethode is gebruikt om het profiel van neurotransmitters in het centrale 
zenuwstelsel (CNS) van de zoetwaterslak Lymnaea stagnalis, een modelorganisme 
in de neurobiologie en ecotoxicologie,  in kaart te brengen. Deze doelgerichte 
aanpak is ook toegepast bij de karakterisering van neurotransmitters in de zebravis 
(Danio rerio) in een vroeg ontwikkelingsstadium (hoofdstuk 3). Daarnaast is de 
methode gebruikt om de veranderingen in de niveaus van de diverse  
neurotransmitters  te onderzoeken na blootstelling van non-target organismen aan 
een selectie van pesticiden (hoofdstuk 3, 5 en 6). 
In hoofdstuk 3 is de snelle kwantificering van neurotransmitters, hun precursors en 
metabolieten uitgevoerd in zebravis embryo's en larven in de ontwikkelingsstadia 
van zygote tot vrij zwemmende larven (6 dpf) met 20 embryo's/larven per monster. 
Na het uitkomen van embryo’s werden er grote veranderingen in het neuronale 
metabolisme waargenomen die sterk afhankelijk waren van het 
ontwikkelingsstadium van de larven. Terwijl de neurotransmitter niveaus 
geleidelijk toenamen, vertoonden de precursors een piek op 3 dpf, wat een 
verschuiving in het metabolisme van anabolisme naar katabolisme van de 
precursors suggereert, die ook als substraat dienen voor lipiden en eiwitten. Het 
neuronale metabolisme van aan pesticiden blootgestelde zebravislarven wordt ook 
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beïnvloed op 5 dpf. Blootstelling aan acht verschillende pesticiden (aldicarb, 
carbaryl, chloorpyrifos, diazinon-O-analoog, dichlorfos, permethrine, imidacloprid 
en pirimicarb) is uitgevoerd bij hun "no observed effect concentration" (NOEC), 
waarbij geen fenotypische misvormingen zijn waargenomen in de zebravis 
embryotoxiciteitstest (ZFET). Er werden echter wel veranderingen in zowel het 
zwemgedrag als neurotransmitterniveaus waargenomen. De ontwikkelde 
analysemethode voor neurotransmitters, hun precursors en metabolieten is een 
veelbelovende alternatieve strategie om de toxiciteit van chemische stoffen op 
organismen te onderzoeken. 
Parallel aan de doelgerichte aanpak is een cross-platform strategie voor 
metabolomics ontwikkeld, gebaseerd op de combinatie van complementaire 
analytische technieken. Dit analytische platform is toegepast om te onderzoeken of 
er naast de neurotransmitters nog andere metabole routes worden beïnvloed door 
blootstelling aan toxische stoffen. De literatuur wordt gedomineerd door platform-
specifieke strategieën en de meest toegepaste is reversed phase vloeistof 
chromatografie (RP-LC). Echter,  de toepassing van een enkel platform impliceert 
het onvermijdelijke verlies van informatie met betrekking tot gedetecteerde 
metabolieten. Om een groter deel van het metabolome te bestrijken, zijn 
vloeistofchromatografie (LC) met electrospray ionisatie (ESI) en 
gaschromatografie met chemische ionisatie onder atmosferische druk (GC-APCI) 
gekoppeld aan hoge resolutie Time of Flight massaspectrometrie (ToF MS) 
toegepast (hoofdstuk 4). Naast de traditionele RP-LC zijn diverse HILIC methoden 
bij verschillende pH's onderzocht. Voor de monstervoorbereiding zijn twee veel 
gebruikte methoden geëvalueerd om weefsel optimaal toegankelijk te maken: 
ultrasone extractie en homogenisatie door middel van krachtig schudden met 
sferische, keramische deeltjes (’beads beating’ of BB). Om de analysetijd te 
beperken en de doorvoersnelheid te verhogen is een gelijktijdige extractie van 
hydrofiele en lipofiele metabolieten met behulp van BB homogenisering 
uitgevoerd. De resultaten van elke techniek zijn geëvalueerd op basis van de 
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metabolome dekking, het aantal gedetecteerde moleculaire signalen (‘molecular 
features’) en de reproduceerbaarheid.  lk analytisch platform heeft zijn eigen 
bereik voor het aantonen van verschillende metabolieten. Door aanpassingen in de 
gebruikte mobiele fase vertoonden verschillende groepen van polaire metabolieten 
een verbeterde retentie bij gebruik van HILIC kolommen. Dit in tegenstelling tot 
de RP kolom, waarbij vanwege de hoge polariteit van de metabolieten geen 
efficiënte scheiding werd verkregen. De combinatie van HILIC en GC met ToF-
MS liet de hoogste metabolome dekking laten zien en is toegepast in verdere 
studies. 
In hoofdstuk 5 zijn de ontwikkelde methoden voor gerichte en niet-gerichte 
metabolomics (hoofdstukken 2 en 4) geïntegreerd en toegepast om de effecten van 
de neonicotinoïde imidacloprid op het CNS van de zoetwaterslak  Lymnaea 
stagnalis te onderzoeken. In deze  studiezijn de slakken blootgesteld aan 
milieurelevante concentraties imidacloprid (0.1 µg/L en 1.0 µg/L). Daarnaast zijn 
ook hogere blootstellingsconcentraties overeenkomend met 10 µg/L en 100 µg/L 
getest. Het blootstellingsexperiment is uitgevoerd gedurende 10 dagen en de 
effecten op de voortplanting en de  respons van de extracten van het centraal 
zenuwstelsel van de slak in de AChE inhibitietest zijn geëvalueerd. Deze 
traditionele toxicologische responsen werden niet significant beïnvloed door de 
blootstelling aan imidacloprid. Metabolomics is gevoeliger dan de traditionele 
toxiciteitstesten en laat verschillen tussen de controlegroep en de blootgestelde 
groep zien. Veel niveaus van geïdentificeerde metabolieten waren significant 
veranderd en verschillende metabole routes werden significant beïnvloed door de 
blootstelling aan aan milieurelevante concentraties imidacloprid. De resultaten 
laten zien dat imidacloprid ontstekingen en letsel aan de zenuwcel kan 
veroorzaken. Omdat er een vergroting van de verhouding tussen choline en 
acetylcholine is waargenomen bestaat bovendien de suggestie dat de mogelijke 
verhoging van genexpressie van choline een aanpassingsreactie is op de binding 
van imidacloprid aan de nAChRs. 
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De integratie van een gecombineerde strategie gebaseerd op gerichte- en niet-
gerichte metabolomics in een effectgestuurde analyse (EDA) is onderzocht in 
hoofdstuk 6. De toxicologische effecten van een oppervlaktewaterextract zijn 
gerelateerd aan de meest voorkomende contaminanten met behulp van EDA, de 
AChE inhihbitietest en metabolomics van het CNS van L. stagnalis. Tijdens de 
bemonstering in een agrarisch gebied in Nederland is 45 L oppervlaktewater 
bemonsterd met een apparaat dat geschikt is voor vaste fase extractie van een groot 
volume water (LVSPE), waarbij gebruik is gemaakt van drie verschillende in serie 
geplaatste patronen die respectievelijk waren gevuld met een neutrale-, anionische- 
en kationische sorberend materiaal. Door doelgerichte chemische analyse zijn 40 
stoffen gekwantificeerd in de extracten, waarbij de niveaus van 15 chemische 
stoffen hoger waren dan 10 ng/L. Het niveau van pirimicarb is boven het maximaal 
toelaatbare risico (MTR), terwijl voor imidacloprid en thiacloprid het 
jaargemiddelde van de milieukwaliteitsnormen (AA- EQSs) was overschreden. 
Om andere AChE actieve verbindingen te detecteren en te identificeren in het 
neutrale extract dat werd verkregen met LVSPE is een on-line HPLC-MS systeem 
voor fractionering in een 96 well plaat toegepast en is de AChE inhibitietest 
uitgevoerd. Met deze aanpak konden twee carbamaten in twee verschillende 
actieve fracties worden geïdentificeerd: carbendazim en esprocarb. Van alle 
extracten liet alleen het neutrale extract een dosis-responsrelatie laten zien in de 
AChE inhibitietest. Daarom is met dit extract een gerichte en niet-gerichte 
metabolomics studie uitgevoerd op L. stagnalis. De slakken zijn blootgesteld aan 
het neutrale extract, afzonderlijk aan de drie meest voorkomende chemicaliën en 
een mengsel daarvan. De waargenomen metaboleveranderingen in het CNS van L. 
stagnalis na blootstelling aan het neutrale extract konden niet volledig worden 
verklaard door de meest voorkomende stoffen. Het neutrale extract verstoort meer 
metabole routes dan de drie meest voorkomende stoffen, wat bijdragen van andere 
actieve stoffen suggereert. Het gebruik van metabolomics voor de evaluatie van 
toxicologische responsen in organismen die blootgesteld zijn aan milieuextracten is 
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niettemin een veelbelovende benadering omdat de methode gevoeliger is in 
vergelijking met traditionele toxiciteitstesten en meerdere eindpunten tegelijk 
kunnen worden bestudeerd. 
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